id	sid	tid	token	lemma	pos
cord-321267-ihd30qi0	1	1	key	key	JJ
cord-321267-ihd30qi0	1	2	:	:	:
cord-321267-ihd30qi0	1	3	cord-321267-ihd30qi0	cord-321267-ihd30qi0	NNS
cord-321267-ihd30qi0	1	4	authors	author	NNS
cord-321267-ihd30qi0	1	5	:	:	:
cord-321267-ihd30qi0	1	6	Daughton	Daughton	NNP
cord-321267-ihd30qi0	1	7	,	,	,
cord-321267-ihd30qi0	1	8	Christian	christian	JJ
cord-321267-ihd30qi0	1	9	G.	G.	NNP
cord-321267-ihd30qi0	1	10	title	title	NN
cord-321267-ihd30qi0	1	11	:	:	:
cord-321267-ihd30qi0	1	12	Natural	natural	JJ
cord-321267-ihd30qi0	1	13	experiment	experiment	NN
cord-321267-ihd30qi0	1	14	concept	concept	NN
cord-321267-ihd30qi0	1	15	to	to	TO
cord-321267-ihd30qi0	1	16	accelerate	accelerate	VB
cord-321267-ihd30qi0	1	17	the	the	DT
cord-321267-ihd30qi0	1	18	Re	re	NN
cord-321267-ihd30qi0	1	19	-	-	NN
cord-321267-ihd30qi0	1	20	purposing	purposing	NN
cord-321267-ihd30qi0	1	21	of	of	IN
cord-321267-ihd30qi0	1	22	existing	exist	VBG
cord-321267-ihd30qi0	1	23	therapeutics	therapeutic	NNS
cord-321267-ihd30qi0	1	24	for	for	IN
cord-321267-ihd30qi0	1	25	Covid-19	covid-19	NN
cord-321267-ihd30qi0	1	26	date	date	NN
cord-321267-ihd30qi0	1	27	:	:	:
cord-321267-ihd30qi0	1	28	2020	2020	CD
cord-321267-ihd30qi0	1	29	-	-	HYPH
cord-321267-ihd30qi0	1	30	05	05	CD
cord-321267-ihd30qi0	1	31	-	-	SYM
cord-321267-ihd30qi0	1	32	15	15	CD
cord-321267-ihd30qi0	1	33	journal	journal	NN
cord-321267-ihd30qi0	1	34	:	:	:
cord-321267-ihd30qi0	2	1	Glob	glob	NN
cord-321267-ihd30qi0	2	2	Epidemiol	epidemiol	NN
cord-321267-ihd30qi0	2	3	DOI	doi	NN
cord-321267-ihd30qi0	2	4	:	:	:
cord-321267-ihd30qi0	2	5	10.1016	10.1016	CD
cord-321267-ihd30qi0	2	6	/	/	SYM
cord-321267-ihd30qi0	2	7	j.gloepi.2020.100026	j.gloepi.2020.100026	NN
cord-321267-ihd30qi0	2	8	sha	sha	NNP
cord-321267-ihd30qi0	2	9	:	:	:
cord-321267-ihd30qi0	2	10	e169fcd3d0b5df283ef2703057590403120e244b	e169fcd3d0b5df283ef2703057590403120e244b	NNP
cord-321267-ihd30qi0	2	11	doc_id	doc_id	NN
cord-321267-ihd30qi0	2	12	:	:	:
cord-321267-ihd30qi0	2	13	321267	321267	CD
cord-321267-ihd30qi0	2	14	cord_uid	cord_uid	NNS
cord-321267-ihd30qi0	2	15	:	:	:
cord-321267-ihd30qi0	2	16	ihd30qi0	ihd30qi0	CD
cord-321267-ihd30qi0	2	17	One	one	CD
cord-321267-ihd30qi0	2	18	of	of	IN
cord-321267-ihd30qi0	2	19	the	the	DT
cord-321267-ihd30qi0	2	20	many	many	JJ
cord-321267-ihd30qi0	2	21	questions	question	NNS
cord-321267-ihd30qi0	2	22	with	with	IN
cord-321267-ihd30qi0	2	23	respect	respect	NN
cord-321267-ihd30qi0	2	24	to	to	IN
cord-321267-ihd30qi0	2	25	controlling	control	VBG
cord-321267-ihd30qi0	2	26	the	the	DT
cord-321267-ihd30qi0	2	27	novel	novel	JJ
cord-321267-ihd30qi0	2	28	coronavirus	coronavirus	NN
cord-321267-ihd30qi0	2	29	pandemic	pandemic	NN
cord-321267-ihd30qi0	2	30	is	be	VBZ
cord-321267-ihd30qi0	2	31	whether	whether	IN
cord-321267-ihd30qi0	2	32	existing	exist	VBG
cord-321267-ihd30qi0	2	33	drugs	drug	NNS
cord-321267-ihd30qi0	2	34	can	can	MD
cord-321267-ihd30qi0	2	35	be	be	VB
cord-321267-ihd30qi0	2	36	re	re	VBN
cord-321267-ihd30qi0	2	37	-	-	JJ
cord-321267-ihd30qi0	2	38	purposed	purpose	VBN
cord-321267-ihd30qi0	2	39	(	(	-LRB-
cord-321267-ihd30qi0	2	40	re	re	VB
cord-321267-ihd30qi0	2	41	-	-	JJ
cord-321267-ihd30qi0	2	42	positioned	position	VBN
cord-321267-ihd30qi0	2	43	)	)	-RRB-
cord-321267-ihd30qi0	2	44	for	for	IN
cord-321267-ihd30qi0	2	45	the	the	DT
cord-321267-ihd30qi0	2	46	prevention	prevention	NN
cord-321267-ihd30qi0	2	47	or	or	CC
cord-321267-ihd30qi0	2	48	treatment	treatment	NN
cord-321267-ihd30qi0	2	49	of	of	IN
cord-321267-ihd30qi0	2	50	Covid-19	covid-19	NN
cord-321267-ihd30qi0	2	51	-	-	:
cord-321267-ihd30qi0	2	52	or	or	CC
cord-321267-ihd30qi0	2	53	for	for	IN
cord-321267-ihd30qi0	2	54	any	any	DT
cord-321267-ihd30qi0	2	55	future	future	JJ
cord-321267-ihd30qi0	2	56	epidemic	epidemic	NN
cord-321267-ihd30qi0	2	57	.	.	.
cord-321267-ihd30qi0	3	1	The	the	DT
cord-321267-ihd30qi0	3	2	usefulness	usefulness	NN
cord-321267-ihd30qi0	3	3	of	of	IN
cord-321267-ihd30qi0	3	4	existing	exist	VBG
cord-321267-ihd30qi0	3	5	approaches	approach	NNS
cord-321267-ihd30qi0	3	6	for	for	IN
cord-321267-ihd30qi0	3	7	re	re	JJ
cord-321267-ihd30qi0	3	8	-	-	JJ
cord-321267-ihd30qi0	3	9	purposing	purposing	JJ
cord-321267-ihd30qi0	3	10	range	range	NN
cord-321267-ihd30qi0	3	11	from	from	IN
cord-321267-ihd30qi0	3	12	computational	computational	JJ
cord-321267-ihd30qi0	3	13	modeling	modeling	NN
cord-321267-ihd30qi0	3	14	to	to	IN
cord-321267-ihd30qi0	3	15	clinical	clinical	JJ
cord-321267-ihd30qi0	3	16	trials	trial	NNS
cord-321267-ihd30qi0	3	17	.	.	.
cord-321267-ihd30qi0	4	1	These	these	DT
cord-321267-ihd30qi0	4	2	are	be	VBP
cord-321267-ihd30qi0	4	3	often	often	RB
cord-321267-ihd30qi0	4	4	time	time	NN
cord-321267-ihd30qi0	4	5	-	-	HYPH
cord-321267-ihd30qi0	4	6	consuming	consume	VBG
cord-321267-ihd30qi0	4	7	,	,	,
cord-321267-ihd30qi0	4	8	resource	resource	NN
cord-321267-ihd30qi0	4	9	intensive	intensive	JJ
cord-321267-ihd30qi0	4	10	,	,	,
cord-321267-ihd30qi0	4	11	and	and	CC
cord-321267-ihd30qi0	4	12	prone	prone	JJ
cord-321267-ihd30qi0	4	13	to	to	IN
cord-321267-ihd30qi0	4	14	failure	failure	NN
cord-321267-ihd30qi0	4	15	.	.	.
cord-321267-ihd30qi0	5	1	Proposed	propose	VBN
cord-321267-ihd30qi0	5	2	here	here	RB
cord-321267-ihd30qi0	5	3	is	be	VBZ
cord-321267-ihd30qi0	5	4	a	a	DT
cord-321267-ihd30qi0	5	5	new	new	JJ
cord-321267-ihd30qi0	5	6	but	but	CC
cord-321267-ihd30qi0	5	7	simple	simple	JJ
cord-321267-ihd30qi0	5	8	concept	concept	NN
cord-321267-ihd30qi0	5	9	that	that	WDT
cord-321267-ihd30qi0	5	10	would	would	MD
cord-321267-ihd30qi0	5	11	capitalize	capitalize	VB
cord-321267-ihd30qi0	5	12	on	on	IN
cord-321267-ihd30qi0	5	13	the	the	DT
cord-321267-ihd30qi0	5	14	opportunity	opportunity	NN
cord-321267-ihd30qi0	5	15	presented	present	VBN
cord-321267-ihd30qi0	5	16	by	by	IN
cord-321267-ihd30qi0	5	17	the	the	DT
cord-321267-ihd30qi0	5	18	on	on	RB
cord-321267-ihd30qi0	5	19	-	-	HYPH
cord-321267-ihd30qi0	5	20	going	go	VBG
cord-321267-ihd30qi0	5	21	natural	natural	JJ
cord-321267-ihd30qi0	5	22	experiment	experiment	NN
cord-321267-ihd30qi0	5	23	involving	involve	VBG
cord-321267-ihd30qi0	5	24	the	the	DT
cord-321267-ihd30qi0	5	25	collection	collection	NN
cord-321267-ihd30qi0	5	26	of	of	IN
cord-321267-ihd30qi0	5	27	data	datum	NNS
cord-321267-ihd30qi0	5	28	from	from	IN
cord-321267-ihd30qi0	5	29	epidemiological	epidemiological	JJ
cord-321267-ihd30qi0	5	30	surveillance	surveillance	NN
cord-321267-ihd30qi0	5	31	screening	screening	NN
cord-321267-ihd30qi0	5	32	and	and	CC
cord-321267-ihd30qi0	5	33	diagnostic	diagnostic	JJ
cord-321267-ihd30qi0	5	34	testing	testing	NN
cord-321267-ihd30qi0	5	35	for	for	IN
cord-321267-ihd30qi0	5	36	clinical	clinical	JJ
cord-321267-ihd30qi0	5	37	treatment	treatment	NN
cord-321267-ihd30qi0	5	38	.	.	.
cord-321267-ihd30qi0	6	1	The	the	DT
cord-321267-ihd30qi0	6	2	objective	objective	NN
cord-321267-ihd30qi0	6	3	would	would	MD
cord-321267-ihd30qi0	6	4	be	be	VB
cord-321267-ihd30qi0	6	5	to	to	TO
cord-321267-ihd30qi0	6	6	also	also	RB
cord-321267-ihd30qi0	6	7	collect	collect	VB
cord-321267-ihd30qi0	6	8	for	for	IN
cord-321267-ihd30qi0	6	9	each	each	DT
cord-321267-ihd30qi0	6	10	Covid-19	covid-19	NN
cord-321267-ihd30qi0	6	11	case	case	NN
cord-321267-ihd30qi0	6	12	the	the	DT
cord-321267-ihd30qi0	6	13	patient	patient	NN
cord-321267-ihd30qi0	6	14	's	's	POS
cord-321267-ihd30qi0	6	15	prior	prior	JJ
cord-321267-ihd30qi0	6	16	usage	usage	NN
cord-321267-ihd30qi0	6	17	of	of	IN
cord-321267-ihd30qi0	6	18	existing	exist	VBG
cord-321267-ihd30qi0	6	19	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	6	20	drugs	drug	NNS
cord-321267-ihd30qi0	6	21	.	.	.
cord-321267-ihd30qi0	7	1	These	these	DT
cord-321267-ihd30qi0	7	2	drug	drug	NN
cord-321267-ihd30qi0	7	3	usage	usage	NN
cord-321267-ihd30qi0	7	4	data	datum	NNS
cord-321267-ihd30qi0	7	5	would	would	MD
cord-321267-ihd30qi0	7	6	be	be	VB
cord-321267-ihd30qi0	7	7	collected	collect	VBN
cord-321267-ihd30qi0	7	8	for	for	IN
cord-321267-ihd30qi0	7	9	several	several	JJ
cord-321267-ihd30qi0	7	10	major	major	JJ
cord-321267-ihd30qi0	7	11	test	test	NN
cord-321267-ihd30qi0	7	12	groups	group	NNS
cord-321267-ihd30qi0	7	13	-	-	:
cord-321267-ihd30qi0	7	14	those	those	DT
cord-321267-ihd30qi0	7	15	who	who	WP
cord-321267-ihd30qi0	7	16	test	test	VBP
cord-321267-ihd30qi0	7	17	positive	positive	JJ
cord-321267-ihd30qi0	7	18	for	for	IN
cord-321267-ihd30qi0	7	19	active	active	JJ
cord-321267-ihd30qi0	7	20	SARS	SARS	NNP
cord-321267-ihd30qi0	7	21	-	-	HYPH
cord-321267-ihd30qi0	7	22	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	7	23	infection	infection	NN
cord-321267-ihd30qi0	7	24	(	(	-LRB-
cord-321267-ihd30qi0	7	25	using	use	VBG
cord-321267-ihd30qi0	7	26	molecular	molecular	JJ
cord-321267-ihd30qi0	7	27	methods	method	NNS
cord-321267-ihd30qi0	7	28	)	)	-RRB-
cord-321267-ihd30qi0	7	29	and	and	CC
cord-321267-ihd30qi0	7	30	those	those	DT
cord-321267-ihd30qi0	7	31	who	who	WP
cord-321267-ihd30qi0	7	32	test	test	VBP
cord-321267-ihd30qi0	7	33	negative	negative	JJ
cord-321267-ihd30qi0	7	34	for	for	IN
cord-321267-ihd30qi0	7	35	current	current	JJ
cord-321267-ihd30qi0	7	36	infection	infection	NN
cord-321267-ihd30qi0	7	37	but	but	CC
cord-321267-ihd30qi0	7	38	also	also	RB
cord-321267-ihd30qi0	7	39	test	test	VBP
cord-321267-ihd30qi0	7	40	positive	positive	JJ
cord-321267-ihd30qi0	7	41	for	for	IN
cord-321267-ihd30qi0	7	42	past	past	JJ
cord-321267-ihd30qi0	7	43	infection	infection	NN
cord-321267-ihd30qi0	7	44	(	(	-LRB-
cord-321267-ihd30qi0	7	45	using	use	VBG
cord-321267-ihd30qi0	7	46	serologic	serologic	JJ
cord-321267-ihd30qi0	7	47	antibody	antibody	NN
cord-321267-ihd30qi0	7	48	tests	test	NNS
cord-321267-ihd30qi0	7	49	)	)	-RRB-
cord-321267-ihd30qi0	7	50	.	.	.
cord-321267-ihd30qi0	8	1	Patients	patient	NNS
cord-321267-ihd30qi0	8	2	from	from	IN
cord-321267-ihd30qi0	8	3	each	each	DT
cord-321267-ihd30qi0	8	4	of	of	IN
cord-321267-ihd30qi0	8	5	these	these	DT
cord-321267-ihd30qi0	8	6	groups	group	NNS
cord-321267-ihd30qi0	8	7	would	would	MD
cord-321267-ihd30qi0	8	8	also	also	RB
cord-321267-ihd30qi0	8	9	be	be	VB
cord-321267-ihd30qi0	8	10	categorized	categorize	VBN
cord-321267-ihd30qi0	8	11	with	with	IN
cord-321267-ihd30qi0	8	12	respect	respect	NN
cord-321267-ihd30qi0	8	13	to	to	IN
cord-321267-ihd30qi0	8	14	where	where	WRB
cord-321267-ihd30qi0	8	15	they	-PRON-	PRP
cord-321267-ihd30qi0	8	16	resided	reside	VBD
cord-321267-ihd30qi0	8	17	on	on	IN
cord-321267-ihd30qi0	8	18	the	the	DT
cord-321267-ihd30qi0	8	19	spectrum	spectrum	NN
cord-321267-ihd30qi0	8	20	of	of	IN
cord-321267-ihd30qi0	8	21	morbidities	morbidity	NNS
cord-321267-ihd30qi0	8	22	(	(	-LRB-
cord-321267-ihd30qi0	8	23	from	from	IN
cord-321267-ihd30qi0	8	24	no	no	DT
cord-321267-ihd30qi0	8	25	or	or	CC
cord-321267-ihd30qi0	8	26	mild	mild	JJ
cord-321267-ihd30qi0	8	27	symptomology	symptomology	NN
cord-321267-ihd30qi0	8	28	to	to	IN
cord-321267-ihd30qi0	8	29	severe	severe	JJ
cord-321267-ihd30qi0	8	30	)	)	-RRB-
cord-321267-ihd30qi0	8	31	.	.	.
cord-321267-ihd30qi0	9	1	By	by	IN
cord-321267-ihd30qi0	9	2	comparing	compare	VBG
cord-321267-ihd30qi0	9	3	the	the	DT
cord-321267-ihd30qi0	9	4	distribution	distribution	NN
cord-321267-ihd30qi0	9	5	of	of	IN
cord-321267-ihd30qi0	9	6	normalized	normalized	JJ
cord-321267-ihd30qi0	9	7	usage	usage	NN
cord-321267-ihd30qi0	9	8	data	datum	NNS
cord-321267-ihd30qi0	9	9	for	for	IN
cord-321267-ihd30qi0	9	10	each	each	DT
cord-321267-ihd30qi0	9	11	drug	drug	NN
cord-321267-ihd30qi0	9	12	within	within	IN
cord-321267-ihd30qi0	9	13	each	each	DT
cord-321267-ihd30qi0	9	14	group	group	NN
cord-321267-ihd30qi0	9	15	,	,	,
cord-321267-ihd30qi0	9	16	drugs	drug	NNS
cord-321267-ihd30qi0	9	17	that	that	WDT
cord-321267-ihd30qi0	9	18	are	be	VBP
cord-321267-ihd30qi0	9	19	more	more	RBR
cord-321267-ihd30qi0	9	20	associated	associate	VBN
cord-321267-ihd30qi0	9	21	with	with	IN
cord-321267-ihd30qi0	9	22	particular	particular	JJ
cord-321267-ihd30qi0	9	23	test	test	NN
cord-321267-ihd30qi0	9	24	groups	group	NNS
cord-321267-ihd30qi0	9	25	could	could	MD
cord-321267-ihd30qi0	9	26	be	be	VB
cord-321267-ihd30qi0	9	27	revealed	reveal	VBN
cord-321267-ihd30qi0	9	28	as	as	IN
cord-321267-ihd30qi0	9	29	having	have	VBG
cord-321267-ihd30qi0	9	30	potential	potential	JJ
cord-321267-ihd30qi0	9	31	prophylactic	prophylactic	JJ
cord-321267-ihd30qi0	9	32	,	,	,
cord-321267-ihd30qi0	9	33	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	9	34	,	,	,
cord-321267-ihd30qi0	9	35	or	or	CC
cord-321267-ihd30qi0	9	36	contraindicated	contraindicated	JJ
cord-321267-ihd30qi0	9	37	effects	effect	NNS
cord-321267-ihd30qi0	9	38	with	with	IN
cord-321267-ihd30qi0	9	39	respect	respect	NN
cord-321267-ihd30qi0	9	40	to	to	IN
cord-321267-ihd30qi0	9	41	disease	disease	NN
cord-321267-ihd30qi0	9	42	progression	progression	NN
cord-321267-ihd30qi0	9	43	.	.	.
cord-321267-ihd30qi0	10	1	These	these	DT
cord-321267-ihd30qi0	10	2	drugs	drug	NNS
cord-321267-ihd30qi0	10	3	could	could	MD
cord-321267-ihd30qi0	10	4	then	then	RB
cord-321267-ihd30qi0	10	5	be	be	VB
cord-321267-ihd30qi0	10	6	selected	select	VBN
cord-321267-ihd30qi0	10	7	as	as	IN
cord-321267-ihd30qi0	10	8	candidates	candidate	NNS
cord-321267-ihd30qi0	10	9	for	for	IN
cord-321267-ihd30qi0	10	10	further	further	JJ
cord-321267-ihd30qi0	10	11	evaluation	evaluation	NN
cord-321267-ihd30qi0	10	12	in	in	IN
cord-321267-ihd30qi0	10	13	fighting	fighting	NN
cord-321267-ihd30qi0	10	14	Covid-19	covid-19	NN
cord-321267-ihd30qi0	10	15	.	.	.
cord-321267-ihd30qi0	11	1	Also	also	RB
cord-321267-ihd30qi0	11	2	summarized	summarize	VBN
cord-321267-ihd30qi0	11	3	are	be	VBP
cord-321267-ihd30qi0	11	4	some	some	DT
cord-321267-ihd30qi0	11	5	of	of	IN
cord-321267-ihd30qi0	11	6	the	the	DT
cord-321267-ihd30qi0	11	7	numerous	numerous	JJ
cord-321267-ihd30qi0	11	8	attributes	attribute	NNS
cord-321267-ihd30qi0	11	9	,	,	,
cord-321267-ihd30qi0	11	10	advantages	advantage	NNS
cord-321267-ihd30qi0	11	11	,	,	,
cord-321267-ihd30qi0	11	12	and	and	CC
cord-321267-ihd30qi0	11	13	limitations	limitation	NNS
cord-321267-ihd30qi0	11	14	of	of	IN
cord-321267-ihd30qi0	11	15	the	the	DT
cord-321267-ihd30qi0	11	16	proposed	propose	VBN
cord-321267-ihd30qi0	11	17	concept	concept	NN
cord-321267-ihd30qi0	11	18	,	,	,
cord-321267-ihd30qi0	11	19	all	all	DT
cord-321267-ihd30qi0	11	20	pointing	point	VBG
cord-321267-ihd30qi0	11	21	to	to	IN
cord-321267-ihd30qi0	11	22	the	the	DT
cord-321267-ihd30qi0	11	23	need	need	NN
cord-321267-ihd30qi0	11	24	for	for	IN
cord-321267-ihd30qi0	11	25	further	further	JJ
cord-321267-ihd30qi0	11	26	discussion	discussion	NN
cord-321267-ihd30qi0	11	27	and	and	CC
cord-321267-ihd30qi0	11	28	evaluation	evaluation	NN
cord-321267-ihd30qi0	11	29	.	.	.
cord-321267-ihd30qi0	12	1	Drug	drug	NN
cord-321267-ihd30qi0	12	2	treatments	treatment	NNS
cord-321267-ihd30qi0	12	3	for	for	IN
cord-321267-ihd30qi0	12	4	Covid-19	Covid-19	NNP
cord-321267-ihd30qi0	12	5	are	be	VBP
cord-321267-ihd30qi0	12	6	urgently	urgently	RB
cord-321267-ihd30qi0	12	7	needed	need	VBN
cord-321267-ihd30qi0	12	8	.	.	.
cord-321267-ihd30qi0	13	1	Discovery	discovery	NN
cord-321267-ihd30qi0	13	2	and	and	CC
cord-321267-ihd30qi0	13	3	development	development	NN
cord-321267-ihd30qi0	13	4	of	of	IN
cord-321267-ihd30qi0	13	5	new	new	JJ
cord-321267-ihd30qi0	13	6	molecular	molecular	JJ
cord-321267-ihd30qi0	13	7	entities	entity	NNS
cord-321267-ihd30qi0	13	8	(	(	-LRB-
cord-321267-ihd30qi0	13	9	US	US	NNP
cord-321267-ihd30qi0	13	10	FDA	FDA	NNP
cord-321267-ihd30qi0	13	11	2020a	2020a	NNS
cord-321267-ihd30qi0	13	12	)	)	-RRB-
cord-321267-ihd30qi0	13	13	ultimately	ultimately	RB
cord-321267-ihd30qi0	13	14	requires	require	VBZ
cord-321267-ihd30qi0	13	15	long	long	JJ
cord-321267-ihd30qi0	13	16	and	and	CC
cord-321267-ihd30qi0	13	17	costly	costly	JJ
cord-321267-ihd30qi0	13	18	clinical	clinical	JJ
cord-321267-ihd30qi0	13	19	trials	trial	NNS
cord-321267-ihd30qi0	13	20	to	to	TO
cord-321267-ihd30qi0	13	21	gain	gain	VB
cord-321267-ihd30qi0	13	22	regulatory	regulatory	JJ
cord-321267-ihd30qi0	13	23	approval	approval	NN
cord-321267-ihd30qi0	13	24	.	.	.
cord-321267-ihd30qi0	14	1	The	the	DT
cord-321267-ihd30qi0	14	2	shortest	short	JJS
cord-321267-ihd30qi0	14	3	route	route	NN
cord-321267-ihd30qi0	14	4	to	to	IN
cord-321267-ihd30qi0	14	5	potential	potential	JJ
cord-321267-ihd30qi0	14	6	treatments	treatment	NNS
cord-321267-ihd30qi0	14	7	is	be	VBZ
cord-321267-ihd30qi0	14	8	the	the	DT
cord-321267-ihd30qi0	14	9	repurposing	repurposing	NN
cord-321267-ihd30qi0	14	10	(	(	-LRB-
cord-321267-ihd30qi0	14	11	repositioning	reposition	VBG
cord-321267-ihd30qi0	14	12	)	)	-RRB-
cord-321267-ihd30qi0	14	13	of	of	IN
cord-321267-ihd30qi0	14	14	existing	exist	VBG
cord-321267-ihd30qi0	14	15	approved	approve	VBN
cord-321267-ihd30qi0	14	16	drugs	drug	NNS
cord-321267-ihd30qi0	14	17	(	(	-LRB-
cord-321267-ihd30qi0	14	18	both	both	DT
cord-321267-ihd30qi0	14	19	legend	legend	NN
cord-321267-ihd30qi0	14	20	and	and	CC
cord-321267-ihd30qi0	14	21	OTC	OTC	NNP
cord-321267-ihd30qi0	14	22	)	)	-RRB-
cord-321267-ihd30qi0	14	23	for	for	IN
cord-321267-ihd30qi0	14	24	pre	pre	JJ
cord-321267-ihd30qi0	14	25	-	-	JJ
cord-321267-ihd30qi0	14	26	and	and	CC
cord-321267-ihd30qi0	14	27	post	post	JJ
cord-321267-ihd30qi0	14	28	-	-	JJ
cord-321267-ihd30qi0	14	29	exposure	exposure	JJ
cord-321267-ihd30qi0	14	30	prophylaxis	prophylaxis	NN
cord-321267-ihd30qi0	14	31	to	to	IN
cord-321267-ihd30qi0	14	32	SARS	SARS	NNP
cord-321267-ihd30qi0	14	33	-	-	HYPH
cord-321267-ihd30qi0	14	34	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	14	35	or	or	CC
cord-321267-ihd30qi0	14	36	for	for	IN
cord-321267-ihd30qi0	14	37	treatment	treatment	NN
cord-321267-ihd30qi0	14	38	of	of	IN
cord-321267-ihd30qi0	14	39	COVID-19	COVID-19	NNP
cord-321267-ihd30qi0	14	40	.	.	.
cord-321267-ihd30qi0	15	1	The	the	DT
cord-321267-ihd30qi0	15	2	concept	concept	NN
cord-321267-ihd30qi0	15	3	presented	present	VBN
cord-321267-ihd30qi0	15	4	here	here	RB
cord-321267-ihd30qi0	15	5	is	be	VBZ
cord-321267-ihd30qi0	15	6	intended	intend	VBN
cord-321267-ihd30qi0	15	7	to	to	TO
cord-321267-ihd30qi0	15	8	rapidly	rapidly	RB
cord-321267-ihd30qi0	15	9	reveal	reveal	VB
cord-321267-ihd30qi0	15	10	if	if	IN
cord-321267-ihd30qi0	15	11	any	any	DT
cord-321267-ihd30qi0	15	12	existing	exist	VBG
cord-321267-ihd30qi0	15	13	drugs	drug	NNS
cord-321267-ihd30qi0	15	14	have	have	VBP
cord-321267-ihd30qi0	15	15	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	15	16	potential	potential	NN
cord-321267-ihd30qi0	15	17	(	(	-LRB-
cord-321267-ihd30qi0	15	18	or	or	CC
cord-321267-ihd30qi0	15	19	those	those	DT
cord-321267-ihd30qi0	15	20	that	that	WDT
cord-321267-ihd30qi0	15	21	could	could	MD
cord-321267-ihd30qi0	15	22	be	be	VB
cord-321267-ihd30qi0	15	23	contraindicated	contraindicate	VBN
cord-321267-ihd30qi0	15	24	)	)	-RRB-
cord-321267-ihd30qi0	15	25	in	in	IN
cord-321267-ihd30qi0	15	26	treating	treat	VBG
cord-321267-ihd30qi0	15	27	Covid-19	covid-19	NN
cord-321267-ihd30qi0	15	28	.	.	.
cord-321267-ihd30qi0	15	29	Drug	drug	NN
cord-321267-ihd30qi0	15	30	"	"	``
cord-321267-ihd30qi0	15	31	repurposing	repurposing	NN
cord-321267-ihd30qi0	15	32	"	"	''
cord-321267-ihd30qi0	15	33	in	in	IN
cord-321267-ihd30qi0	15	34	this	this	DT
cord-321267-ihd30qi0	15	35	article	article	NN
cord-321267-ihd30qi0	15	36	refers	refer	VBZ
cord-321267-ihd30qi0	15	37	to	to	IN
cord-321267-ihd30qi0	15	38	the	the	DT
cord-321267-ihd30qi0	15	39	use	use	NN
cord-321267-ihd30qi0	15	40	of	of	IN
cord-321267-ihd30qi0	15	41	existing	exist	VBG
cord-321267-ihd30qi0	15	42	approved	approve	VBN
cord-321267-ihd30qi0	15	43	drugs	drug	NNS
cord-321267-ihd30qi0	15	44	for	for	IN
cord-321267-ihd30qi0	15	45	the	the	DT
cord-321267-ihd30qi0	15	46	treatment	treatment	NN
cord-321267-ihd30qi0	15	47	of	of	IN
cord-321267-ihd30qi0	15	48	a	a	DT
cord-321267-ihd30qi0	15	49	never	never	RB
cord-321267-ihd30qi0	15	50	-	-	HYPH
cord-321267-ihd30qi0	15	51	considered	consider	VBN
cord-321267-ihd30qi0	15	52	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	15	53	indication	indication	NN
cord-321267-ihd30qi0	15	54	-in	-in	.
cord-321267-ihd30qi0	15	55	this	this	DT
cord-321267-ihd30qi0	15	56	case	case	NN
cord-321267-ihd30qi0	15	57	,	,	,
cord-321267-ihd30qi0	15	58	Covid-19	Covid-19	NNP
cord-321267-ihd30qi0	15	59	.	.	.
cord-321267-ihd30qi0	16	1	Just	just	RB
cord-321267-ihd30qi0	16	2	considering	consider	VBG
cord-321267-ihd30qi0	16	3	unique	unique	JJ
cord-321267-ihd30qi0	16	4	small	small	JJ
cord-321267-ihd30qi0	16	5	-	-	HYPH
cord-321267-ihd30qi0	16	6	molecule	molecule	NN
cord-321267-ihd30qi0	16	7	drug	drug	NN
cord-321267-ihd30qi0	16	8	entities	entity	NNS
cord-321267-ihd30qi0	16	9	,	,	,
cord-321267-ihd30qi0	16	10	the	the	DT
cord-321267-ihd30qi0	16	11	universe	universe	NN
cord-321267-ihd30qi0	16	12	of	of	IN
cord-321267-ihd30qi0	16	13	those	those	DT
cord-321267-ihd30qi0	16	14	already	already	RB
cord-321267-ihd30qi0	16	15	approved	approve	VBN
cord-321267-ihd30qi0	16	16	in	in	IN
cord-321267-ihd30qi0	16	17	the	the	DT
cord-321267-ihd30qi0	16	18	US	US	NNP
cord-321267-ihd30qi0	17	1	-for	-for	NFP
cord-321267-ihd30qi0	17	2	multitudes	multitude	NNS
cord-321267-ihd30qi0	17	3	of	of	IN
cord-321267-ihd30qi0	17	4	different	different	JJ
cord-321267-ihd30qi0	17	5	medical	medical	JJ
cord-321267-ihd30qi0	17	6	conditions	condition	NNS
cord-321267-ihd30qi0	18	1	-might	-might	:
cord-321267-ihd30qi0	18	2	number	number	NN
cord-321267-ihd30qi0	18	3	several	several	JJ
cord-321267-ihd30qi0	18	4	thousand	thousand	CD
cord-321267-ihd30qi0	19	1	(	(	-LRB-
cord-321267-ihd30qi0	19	2	Kinch	Kinch	NNP
cord-321267-ihd30qi0	19	3	et	et	NNP
cord-321267-ihd30qi0	19	4	al	al	NNP
cord-321267-ihd30qi0	19	5	.	.	NNP
cord-321267-ihd30qi0	19	6	2014	2014	CD
cord-321267-ihd30qi0	19	7	)	)	-RRB-
cord-321267-ihd30qi0	20	1	;	;	:
cord-321267-ihd30qi0	20	2	the	the	DT
cord-321267-ihd30qi0	20	3	numbers	number	NNS
cord-321267-ihd30qi0	20	4	of	of	IN
cord-321267-ihd30qi0	20	5	biologics	biologic	NNS
cord-321267-ihd30qi0	20	6	and	and	CC
cord-321267-ihd30qi0	20	7	biosimilars	biosimilar	NNS
cord-321267-ihd30qi0	20	8	expand	expand	VBP
cord-321267-ihd30qi0	20	9	this	this	DT
cord-321267-ihd30qi0	20	10	universe	universe	NN
cord-321267-ihd30qi0	20	11	considerably	considerably	RB
cord-321267-ihd30qi0	20	12	(	(	-LRB-
cord-321267-ihd30qi0	20	13	Kinch	Kinch	NNP
cord-321267-ihd30qi0	20	14	2015	2015	CD
cord-321267-ihd30qi0	20	15	)	)	-RRB-
cord-321267-ihd30qi0	20	16	.	.	.
cord-321267-ihd30qi0	21	1	10	10	CD
cord-321267-ihd30qi0	21	2	April	April	NNP
cord-321267-ihd30qi0	21	3	2020	2020	CD
cord-321267-ihd30qi0	22	1	(	(	-LRB-
cord-321267-ihd30qi0	22	2	revised	revise	VBN
cord-321267-ihd30qi0	22	3	11	11	CD
cord-321267-ihd30qi0	22	4	May	May	NNP
cord-321267-ihd30qi0	22	5	)	)	-RRB-
cord-321267-ihd30qi0	22	6	draft	draft	VB
cord-321267-ihd30qi0	22	7	for	for	IN
cord-321267-ihd30qi0	22	8	Global	Global	NNP
cord-321267-ihd30qi0	22	9	Epidemiology	Epidemiology	NNP
cord-321267-ihd30qi0	22	10	Christian	Christian	NNP
cord-321267-ihd30qi0	22	11	G.	G.	NNP
cord-321267-ihd30qi0	22	12	Daughton	Daughton	NNP
cord-321267-ihd30qi0	22	13	Drug	Drug	NNP
cord-321267-ihd30qi0	22	14	repurposing	repurposing	NN
cord-321267-ihd30qi0	22	15	has	have	VBZ
cord-321267-ihd30qi0	22	16	proved	prove	VBN
cord-321267-ihd30qi0	22	17	to	to	TO
cord-321267-ihd30qi0	22	18	be	be	VB
cord-321267-ihd30qi0	22	19	a	a	DT
cord-321267-ihd30qi0	22	20	successful	successful	JJ
cord-321267-ihd30qi0	22	21	enterprise	enterprise	NN
cord-321267-ihd30qi0	22	22	over	over	IN
cord-321267-ihd30qi0	22	23	the	the	DT
cord-321267-ihd30qi0	22	24	years	year	NNS
cord-321267-ihd30qi0	22	25	(	(	-LRB-
cord-321267-ihd30qi0	22	26	Baker	Baker	NNP
cord-321267-ihd30qi0	22	27	2018	2018	CD
cord-321267-ihd30qi0	22	28	;	;	:
cord-321267-ihd30qi0	22	29	Pizzorno	Pizzorno	NNP
cord-321267-ihd30qi0	22	30	et	et	NNP
cord-321267-ihd30qi0	22	31	al	al	NNP
cord-321267-ihd30qi0	22	32	.	.	.
cord-321267-ihd30qi0	23	1	2019	2019	CD
cord-321267-ihd30qi0	23	2	;	;	:
cord-321267-ihd30qi0	23	3	Shameer	Shameer	NNP
cord-321267-ihd30qi0	23	4	et	et	NNP
cord-321267-ihd30qi0	23	5	al	al	NNP
cord-321267-ihd30qi0	23	6	.	.	.
cord-321267-ihd30qi0	23	7	2017	2017	CD
cord-321267-ihd30qi0	23	8	)	)	-RRB-
cord-321267-ihd30qi0	23	9	.	.	.
cord-321267-ihd30qi0	24	1	It	-PRON-	PRP
cord-321267-ihd30qi0	24	2	is	be	VBZ
cord-321267-ihd30qi0	24	3	often	often	RB
cord-321267-ihd30qi0	24	4	guided	guide	VBN
cord-321267-ihd30qi0	24	5	by	by	IN
cord-321267-ihd30qi0	24	6	virtual	virtual	JJ
cord-321267-ihd30qi0	24	7	screening	screening	NN
cord-321267-ihd30qi0	24	8	methods	method	NNS
cord-321267-ihd30qi0	24	9	such	such	JJ
cord-321267-ihd30qi0	24	10	as	as	IN
cord-321267-ihd30qi0	24	11	computational	computational	JJ
cord-321267-ihd30qi0	24	12	approaches	approach	NNS
cord-321267-ihd30qi0	24	13	and	and	CC
cord-321267-ihd30qi0	24	14	bioinformatics	bioinformatic	NNS
cord-321267-ihd30qi0	24	15	to	to	TO
cord-321267-ihd30qi0	24	16	reveal	reveal	VB
cord-321267-ihd30qi0	24	17	possible	possible	JJ
cord-321267-ihd30qi0	24	18	druggable	druggable	JJ
cord-321267-ihd30qi0	24	19	pathways	pathway	NNS
cord-321267-ihd30qi0	24	20	(	(	-LRB-
cord-321267-ihd30qi0	24	21	e.g.	e.g.	RB
cord-321267-ihd30qi0	24	22	,	,	,
cord-321267-ihd30qi0	24	23	see	see	VB
cord-321267-ihd30qi0	24	24	:	:	:
cord-321267-ihd30qi0	24	25	Smith	Smith	NNP
cord-321267-ihd30qi0	24	26	and	and	CC
cord-321267-ihd30qi0	24	27	Smith	Smith	NNP
cord-321267-ihd30qi0	24	28	2020	2020	CD
cord-321267-ihd30qi0	24	29	;	;	:
cord-321267-ihd30qi0	24	30	Pizzorno	Pizzorno	NNP
cord-321267-ihd30qi0	24	31	2019	2019	CD
cord-321267-ihd30qi0	24	32	)	)	-RRB-
cord-321267-ihd30qi0	24	33	or	or	CC
cord-321267-ihd30qi0	24	34	even	even	RB
cord-321267-ihd30qi0	24	35	by	by	IN
cord-321267-ihd30qi0	24	36	traditional	traditional	JJ
cord-321267-ihd30qi0	24	37	literature	literature	NN
cord-321267-ihd30qi0	24	38	-	-	HYPH
cord-321267-ihd30qi0	24	39	mining	mining	NN
cord-321267-ihd30qi0	24	40	and	and	CC
cord-321267-ihd30qi0	24	41	synthesis	synthesis	NN
cord-321267-ihd30qi0	24	42	(	(	-LRB-
cord-321267-ihd30qi0	24	43	e.g.	e.g.	RB
cord-321267-ihd30qi0	24	44	,	,	,
cord-321267-ihd30qi0	24	45	Cahill	Cahill	NNP
cord-321267-ihd30qi0	24	46	et	et	NNP
cord-321267-ihd30qi0	24	47	al	al	NNP
cord-321267-ihd30qi0	24	48	.	.	NNP
cord-321267-ihd30qi0	24	49	2020	2020	CD
cord-321267-ihd30qi0	24	50	)	)	-RRB-
cord-321267-ihd30qi0	24	51	.	.	.
cord-321267-ihd30qi0	25	1	But	but	CC
cord-321267-ihd30qi0	25	2	even	even	RB
cord-321267-ihd30qi0	25	3	these	these	DT
cord-321267-ihd30qi0	25	4	approaches	approach	NNS
cord-321267-ihd30qi0	25	5	often	often	RB
cord-321267-ihd30qi0	25	6	end	end	VBP
cord-321267-ihd30qi0	25	7	up	up	RP
cord-321267-ihd30qi0	25	8	selecting	select	VBG
cord-321267-ihd30qi0	25	9	potential	potential	JJ
cord-321267-ihd30qi0	25	10	drug	drug	NN
cord-321267-ihd30qi0	25	11	candidates	candidate	NNS
cord-321267-ihd30qi0	25	12	that	that	WDT
cord-321267-ihd30qi0	25	13	eventually	eventually	RB
cord-321267-ihd30qi0	25	14	prove	prove	VBP
cord-321267-ihd30qi0	25	15	ineffective	ineffective	JJ
cord-321267-ihd30qi0	25	16	in	in	IN
cord-321267-ihd30qi0	25	17	subsequent	subsequent	JJ
cord-321267-ihd30qi0	25	18	clinical	clinical	JJ
cord-321267-ihd30qi0	25	19	trials	trial	NNS
cord-321267-ihd30qi0	25	20	.	.	.
cord-321267-ihd30qi0	26	1	And	and	CC
cord-321267-ihd30qi0	26	2	these	these	DT
cord-321267-ihd30qi0	26	3	approaches	approach	NNS
cord-321267-ihd30qi0	26	4	are	be	VBP
cord-321267-ihd30qi0	26	5	seldom	seldom	RB
cord-321267-ihd30qi0	26	6	used	use	VBN
cord-321267-ihd30qi0	26	7	for	for	IN
cord-321267-ihd30qi0	26	8	predicting	predict	VBG
cord-321267-ihd30qi0	26	9	drugs	drug	NNS
cord-321267-ihd30qi0	26	10	that	that	WDT
cord-321267-ihd30qi0	26	11	would	would	MD
cord-321267-ihd30qi0	26	12	be	be	VB
cord-321267-ihd30qi0	26	13	contraindicated	contraindicate	VBN
cord-321267-ihd30qi0	26	14	-in	-in	.
cord-321267-ihd30qi0	26	15	this	this	DT
cord-321267-ihd30qi0	26	16	case	case	NN
cord-321267-ihd30qi0	26	17	,	,	,
cord-321267-ihd30qi0	26	18	those	those	DT
cord-321267-ihd30qi0	26	19	that	that	WDT
cord-321267-ihd30qi0	26	20	could	could	MD
cord-321267-ihd30qi0	26	21	adversely	adversely	RB
cord-321267-ihd30qi0	26	22	interact	interact	VB
cord-321267-ihd30qi0	26	23	with	with	IN
cord-321267-ihd30qi0	26	24	Covid-19	Covid-19	NNP
cord-321267-ihd30qi0	26	25	or	or	CC
cord-321267-ihd30qi0	26	26	with	with	IN
cord-321267-ihd30qi0	26	27	co	co	VBN
cord-321267-ihd30qi0	26	28	-	-	JJ
cord-321267-ihd30qi0	26	29	administered	administer	VBN
cord-321267-ihd30qi0	26	30	drugs	drug	NNS
cord-321267-ihd30qi0	26	31	.	.	.
cord-321267-ihd30qi0	27	1	Computational	computational	JJ
cord-321267-ihd30qi0	27	2	approaches	approach	NNS
cord-321267-ihd30qi0	27	3	are	be	VBP
cord-321267-ihd30qi0	27	4	also	also	RB
cord-321267-ihd30qi0	27	5	unable	unable	JJ
cord-321267-ihd30qi0	27	6	to	to	TO
cord-321267-ihd30qi0	27	7	easily	easily	RB
cord-321267-ihd30qi0	27	8	identify	identify	VB
cord-321267-ihd30qi0	27	9	multiple	multiple	JJ
cord-321267-ihd30qi0	27	10	drugs	drug	NNS
cord-321267-ihd30qi0	27	11	that	that	WDT
cord-321267-ihd30qi0	27	12	might	may	MD
cord-321267-ihd30qi0	27	13	be	be	VB
cord-321267-ihd30qi0	27	14	effective	effective	JJ
cord-321267-ihd30qi0	27	15	as	as	IN
cord-321267-ihd30qi0	27	16	combination	combination	NN
cord-321267-ihd30qi0	27	17	therapies	therapy	NNS
cord-321267-ihd30qi0	27	18	.	.	.
cord-321267-ihd30qi0	28	1	Proposed	propose	VBN
cord-321267-ihd30qi0	28	2	here	here	RB
cord-321267-ihd30qi0	28	3	is	be	VBZ
cord-321267-ihd30qi0	28	4	a	a	DT
cord-321267-ihd30qi0	28	5	simple	simple	JJ
cord-321267-ihd30qi0	28	6	,	,	,
cord-321267-ihd30qi0	28	7	straightforward	straightforward	JJ
cord-321267-ihd30qi0	28	8	approach	approach	NN
cord-321267-ihd30qi0	28	9	to	to	TO
cord-321267-ihd30qi0	28	10	possibly	possibly	RB
cord-321267-ihd30qi0	28	11	accelerate	accelerate	VB
cord-321267-ihd30qi0	28	12	the	the	DT
cord-321267-ihd30qi0	28	13	identification	identification	NN
cord-321267-ihd30qi0	28	14	of	of	IN
cord-321267-ihd30qi0	28	15	existing	exist	VBG
cord-321267-ihd30qi0	28	16	drugs	drug	NNS
cord-321267-ihd30qi0	28	17	for	for	IN
cord-321267-ihd30qi0	28	18	potential	potential	JJ
cord-321267-ihd30qi0	28	19	repurposing	repurposing	NN
cord-321267-ihd30qi0	28	20	and	and	CC
cord-321267-ihd30qi0	28	21	to	to	TO
cord-321267-ihd30qi0	28	22	quickly	quickly	RB
cord-321267-ihd30qi0	28	23	identify	identify	VB
cord-321267-ihd30qi0	28	24	candidates	candidate	NNS
cord-321267-ihd30qi0	28	25	more	more	RBR
cord-321267-ihd30qi0	28	26	likely	likely	JJ
cord-321267-ihd30qi0	28	27	to	to	TO
cord-321267-ihd30qi0	28	28	succeed	succeed	VB
cord-321267-ihd30qi0	28	29	in	in	IN
cord-321267-ihd30qi0	28	30	phase	phase	NN
cord-321267-ihd30qi0	28	31	3	3	CD
cord-321267-ihd30qi0	28	32	-	-	SYM
cord-321267-ihd30qi0	28	33	4	4	CD
cord-321267-ihd30qi0	28	34	clinical	clinical	JJ
cord-321267-ihd30qi0	28	35	trials	trial	NNS
cord-321267-ihd30qi0	28	36	.	.	.
cord-321267-ihd30qi0	29	1	These	these	DT
cord-321267-ihd30qi0	29	2	candidates	candidate	NNS
cord-321267-ihd30qi0	29	3	should	should	MD
cord-321267-ihd30qi0	29	4	also	also	RB
cord-321267-ihd30qi0	29	5	have	have	VB
cord-321267-ihd30qi0	29	6	better	well	JJR
cord-321267-ihd30qi0	29	7	safety	safety	NN
cord-321267-ihd30qi0	29	8	profiles	profile	NNS
cord-321267-ihd30qi0	29	9	than	than	IN
cord-321267-ihd30qi0	29	10	by	by	IN
cord-321267-ihd30qi0	29	11	trialing	triale	VBG
cord-321267-ihd30qi0	29	12	candidates	candidate	NNS
cord-321267-ihd30qi0	29	13	selected	select	VBN
cord-321267-ihd30qi0	29	14	by	by	IN
cord-321267-ihd30qi0	29	15	other	other	JJ
cord-321267-ihd30qi0	29	16	means	mean	NNS
cord-321267-ihd30qi0	29	17	,	,	,
cord-321267-ihd30qi0	29	18	especially	especially	RB
cord-321267-ihd30qi0	29	19	by	by	IN
cord-321267-ihd30qi0	29	20	avoiding	avoid	VBG
cord-321267-ihd30qi0	29	21	the	the	DT
cord-321267-ihd30qi0	29	22	selection	selection	NN
cord-321267-ihd30qi0	29	23	of	of	IN
cord-321267-ihd30qi0	29	24	drugs	drug	NNS
cord-321267-ihd30qi0	29	25	that	that	WDT
cord-321267-ihd30qi0	29	26	adversely	adversely	RB
cord-321267-ihd30qi0	29	27	interact	interact	VBP
cord-321267-ihd30qi0	29	28	with	with	IN
cord-321267-ihd30qi0	29	29	other	other	JJ
cord-321267-ihd30qi0	29	30	drugs	drug	NNS
cord-321267-ihd30qi0	29	31	.	.	.
cord-321267-ihd30qi0	30	1	At	at	IN
cord-321267-ihd30qi0	30	2	the	the	DT
cord-321267-ihd30qi0	30	3	same	same	JJ
cord-321267-ihd30qi0	30	4	time	time	NN
cord-321267-ihd30qi0	30	5	,	,	,
cord-321267-ihd30qi0	30	6	it	-PRON-	PRP
cord-321267-ihd30qi0	30	7	could	could	MD
cord-321267-ihd30qi0	30	8	also	also	RB
cord-321267-ihd30qi0	30	9	potentially	potentially	RB
cord-321267-ihd30qi0	30	10	reveal	reveal	VB
cord-321267-ihd30qi0	30	11	drug	drug	NN
cord-321267-ihd30qi0	30	12	combinations	combination	NNS
cord-321267-ihd30qi0	30	13	that	that	WDT
cord-321267-ihd30qi0	30	14	provide	provide	VBP
cord-321267-ihd30qi0	30	15	enhanced	enhanced	JJ
cord-321267-ihd30qi0	30	16	clinical	clinical	JJ
cord-321267-ihd30qi0	30	17	outcomes	outcome	NNS
cord-321267-ihd30qi0	30	18	.	.	.
cord-321267-ihd30qi0	31	1	A	a	DT
cord-321267-ihd30qi0	31	2	method	method	NN
cord-321267-ihd30qi0	31	3	that	that	WDT
cord-321267-ihd30qi0	31	4	could	could	MD
cord-321267-ihd30qi0	31	5	rapidly	rapidly	RB
cord-321267-ihd30qi0	31	6	narrow	narrow	VB
cord-321267-ihd30qi0	31	7	the	the	DT
cord-321267-ihd30qi0	31	8	initial	initial	JJ
cord-321267-ihd30qi0	31	9	selection	selection	NN
cord-321267-ihd30qi0	31	10	of	of	IN
cord-321267-ihd30qi0	31	11	potential	potential	JJ
cord-321267-ihd30qi0	31	12	candidates	candidate	NNS
cord-321267-ihd30qi0	31	13	(	(	-LRB-
cord-321267-ihd30qi0	31	14	including	include	VBG
cord-321267-ihd30qi0	31	15	combinations	combination	NNS
cord-321267-ihd30qi0	31	16	)	)	-RRB-
cord-321267-ihd30qi0	31	17	for	for	IN
cord-321267-ihd30qi0	31	18	repurposing	repurpose	VBG
cord-321267-ihd30qi0	31	19	with	with	IN
cord-321267-ihd30qi0	31	20	Covid-19	covid-19	NN
cord-321267-ihd30qi0	31	21	(	(	-LRB-
cord-321267-ihd30qi0	31	22	and	and	CC
cord-321267-ihd30qi0	31	23	also	also	RB
cord-321267-ihd30qi0	31	24	avoiding	avoid	VBG
cord-321267-ihd30qi0	31	25	contraindications	contraindication	NNS
cord-321267-ihd30qi0	31	26	)	)	-RRB-
cord-321267-ihd30qi0	31	27	could	could	MD
cord-321267-ihd30qi0	31	28	greatly	greatly	RB
cord-321267-ihd30qi0	31	29	streamline	streamline	VB
cord-321267-ihd30qi0	31	30	the	the	DT
cord-321267-ihd30qi0	31	31	conventional	conventional	JJ
cord-321267-ihd30qi0	31	32	approaches	approach	NNS
cord-321267-ihd30qi0	31	33	for	for	IN
cord-321267-ihd30qi0	31	34	repurposing	repurpose	VBG
cord-321267-ihd30qi0	31	35	.	.	.
cord-321267-ihd30qi0	32	1	It	-PRON-	PRP
cord-321267-ihd30qi0	32	2	could	could	MD
cord-321267-ihd30qi0	32	3	reduce	reduce	VB
cord-321267-ihd30qi0	32	4	the	the	DT
cord-321267-ihd30qi0	32	5	probability	probability	NN
cord-321267-ihd30qi0	32	6	of	of	IN
cord-321267-ihd30qi0	32	7	candidate	candidate	NN
cord-321267-ihd30qi0	32	8	drugs	drug	NNS
cord-321267-ihd30qi0	32	9	failing	fail	VBG
cord-321267-ihd30qi0	32	10	trials	trial	NNS
cord-321267-ihd30qi0	32	11	and	and	CC
cord-321267-ihd30qi0	32	12	thereby	thereby	RB
cord-321267-ihd30qi0	32	13	reduce	reduce	VB
cord-321267-ihd30qi0	32	14	the	the	DT
cord-321267-ihd30qi0	32	15	wasting	wasting	NN
cord-321267-ihd30qi0	32	16	of	of	IN
cord-321267-ihd30qi0	32	17	time	time	NN
cord-321267-ihd30qi0	32	18	and	and	CC
cord-321267-ihd30qi0	32	19	resources	resource	NNS
cord-321267-ihd30qi0	32	20	.	.	.
cord-321267-ihd30qi0	33	1	An	an	DT
cord-321267-ihd30qi0	33	2	additional	additional	JJ
cord-321267-ihd30qi0	33	3	important	important	JJ
cord-321267-ihd30qi0	33	4	point	point	NN
cord-321267-ihd30qi0	33	5	is	be	VBZ
cord-321267-ihd30qi0	33	6	that	that	IN
cord-321267-ihd30qi0	33	7	data	datum	NNS
cord-321267-ihd30qi0	33	8	mined	mine	VBN
cord-321267-ihd30qi0	33	9	by	by	IN
cord-321267-ihd30qi0	33	10	this	this	DT
cord-321267-ihd30qi0	33	11	approach	approach	NN
cord-321267-ihd30qi0	33	12	during	during	IN
cord-321267-ihd30qi0	33	13	an	an	DT
cord-321267-ihd30qi0	33	14	epidemic	epidemic	NN
cord-321267-ihd30qi0	33	15	could	could	MD
cord-321267-ihd30qi0	33	16	also	also	RB
cord-321267-ihd30qi0	33	17	have	have	VB
cord-321267-ihd30qi0	33	18	the	the	DT
cord-321267-ihd30qi0	33	19	potential	potential	NN
cord-321267-ihd30qi0	33	20	to	to	IN
cord-321267-ihd30qi0	33	21	short	short	JJ
cord-321267-ihd30qi0	33	22	-	-	HYPH
cord-321267-ihd30qi0	33	23	circuit	circuit	NN
cord-321267-ihd30qi0	33	24	imprudent	imprudent	JJ
cord-321267-ihd30qi0	33	25	decisions	decision	NNS
cord-321267-ihd30qi0	33	26	to	to	TO
cord-321267-ihd30qi0	33	27	investigate	investigate	VB
cord-321267-ihd30qi0	33	28	whether	whether	IN
cord-321267-ihd30qi0	33	29	drugs	drug	NNS
cord-321267-ihd30qi0	33	30	rumored	rumor	VBN
cord-321267-ihd30qi0	33	31	to	to	TO
cord-321267-ihd30qi0	33	32	be	be	VB
cord-321267-ihd30qi0	33	33	effective	effective	JJ
cord-321267-ihd30qi0	33	34	treatments	treatment	NNS
cord-321267-ihd30qi0	33	35	actually	actually	RB
cord-321267-ihd30qi0	33	36	have	have	VBP
cord-321267-ihd30qi0	33	37	any	any	DT
cord-321267-ihd30qi0	33	38	potential	potential	NN
cord-321267-ihd30qi0	33	39	.	.	.
cord-321267-ihd30qi0	34	1	During	during	IN
cord-321267-ihd30qi0	34	2	the	the	DT
cord-321267-ihd30qi0	34	3	Covid-19	covid-19	NN
cord-321267-ihd30qi0	34	4	epidemic	epidemic	NN
cord-321267-ihd30qi0	34	5	,	,	,
cord-321267-ihd30qi0	34	6	one	one	CD
cord-321267-ihd30qi0	34	7	of	of	IN
cord-321267-ihd30qi0	34	8	the	the	DT
cord-321267-ihd30qi0	34	9	best	good	JJS
cord-321267-ihd30qi0	34	10	examples	example	NNS
cord-321267-ihd30qi0	34	11	was	be	VBD
cord-321267-ihd30qi0	34	12	hydroxychloroquine	hydroxychloroquine	NN
cord-321267-ihd30qi0	34	13	and	and	CC
cord-321267-ihd30qi0	34	14	chloroquine	chloroquine	NN
cord-321267-ihd30qi0	34	15	.	.	.
cord-321267-ihd30qi0	35	1	Rumors	rumor	NNS
cord-321267-ihd30qi0	35	2	of	of	IN
cord-321267-ihd30qi0	35	3	effectiveness	effectiveness	NN
cord-321267-ihd30qi0	35	4	caused	cause	VBD
cord-321267-ihd30qi0	35	5	shortages	shortage	NNS
cord-321267-ihd30qi0	35	6	for	for	IN
cord-321267-ihd30qi0	35	7	their	-PRON-	PRP$
cord-321267-ihd30qi0	35	8	approved	approve	VBN
cord-321267-ihd30qi0	35	9	critical	critical	JJ
cord-321267-ihd30qi0	35	10	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	35	11	uses	use	NNS
cord-321267-ihd30qi0	35	12	as	as	IN
cord-321267-ihd30qi0	35	13	anti	anti	JJ
cord-321267-ihd30qi0	35	14	-	-	JJ
cord-321267-ihd30qi0	35	15	malarials	malarial	NNS
cord-321267-ihd30qi0	35	16	and	and	CC
cord-321267-ihd30qi0	35	17	anti	anti	JJ
cord-321267-ihd30qi0	35	18	-	-	JJ
cord-321267-ihd30qi0	35	19	rheumatics	rheumatics	JJ
cord-321267-ihd30qi0	35	20	(	(	-LRB-
cord-321267-ihd30qi0	35	21	Yazdany	Yazdany	NNP
cord-321267-ihd30qi0	35	22	and	and	CC
cord-321267-ihd30qi0	35	23	Kim	Kim	NNP
cord-321267-ihd30qi0	35	24	2020	2020	CD
cord-321267-ihd30qi0	35	25	)	)	-RRB-
cord-321267-ihd30qi0	35	26	.	.	.
cord-321267-ihd30qi0	36	1	This	this	DT
cord-321267-ihd30qi0	36	2	proposed	propose	VBN
cord-321267-ihd30qi0	36	3	approach	approach	NN
cord-321267-ihd30qi0	36	4	would	would	MD
cord-321267-ihd30qi0	36	5	capitalize	capitalize	VB
cord-321267-ihd30qi0	36	6	on	on	IN
cord-321267-ihd30qi0	36	7	a	a	DT
cord-321267-ihd30qi0	36	8	unique	unique	JJ
cord-321267-ihd30qi0	36	9	opportunity	opportunity	NN
cord-321267-ihd30qi0	36	10	presented	present	VBN
cord-321267-ihd30qi0	36	11	by	by	IN
cord-321267-ihd30qi0	36	12	a	a	DT
cord-321267-ihd30qi0	36	13	"	"	``
cord-321267-ihd30qi0	36	14	natural	natural	JJ
cord-321267-ihd30qi0	36	15	experiment	experiment	NN
cord-321267-ihd30qi0	36	16	"	"	''
cord-321267-ihd30qi0	36	17	inherent	inherent	JJ
cord-321267-ihd30qi0	36	18	in	in	IN
cord-321267-ihd30qi0	36	19	the	the	DT
cord-321267-ihd30qi0	36	20	ongoing	ongoing	JJ
cord-321267-ihd30qi0	36	21	clinical	clinical	JJ
cord-321267-ihd30qi0	36	22	treatment	treatment	NN
cord-321267-ihd30qi0	36	23	and	and	CC
cord-321267-ihd30qi0	36	24	epidemiological	epidemiological	JJ
cord-321267-ihd30qi0	36	25	examination	examination	NN
cord-321267-ihd30qi0	36	26	of	of	IN
cord-321267-ihd30qi0	36	27	the	the	DT
cord-321267-ihd30qi0	36	28	Covid-19	covid-19	JJ
cord-321267-ihd30qi0	36	29	epidemic	epidemic	NN
cord-321267-ihd30qi0	36	30	.	.	.
cord-321267-ihd30qi0	37	1	This	this	DT
cord-321267-ihd30qi0	37	2	approach	approach	NN
cord-321267-ihd30qi0	37	3	would	would	MD
cord-321267-ihd30qi0	37	4	also	also	RB
cord-321267-ihd30qi0	37	5	be	be	VB
cord-321267-ihd30qi0	37	6	applicable	applicable	JJ
cord-321267-ihd30qi0	37	7	to	to	IN
cord-321267-ihd30qi0	37	8	any	any	DT
cord-321267-ihd30qi0	37	9	future	future	JJ
cord-321267-ihd30qi0	37	10	epidemic	epidemic	NN
cord-321267-ihd30qi0	37	11	,	,	,
cord-321267-ihd30qi0	37	12	including	include	VBG
cord-321267-ihd30qi0	37	13	the	the	DT
cord-321267-ihd30qi0	37	14	possible	possible	JJ
cord-321267-ihd30qi0	37	15	seasonal	seasonal	JJ
cord-321267-ihd30qi0	37	16	resurgence	resurgence	NN
cord-321267-ihd30qi0	37	17	in	in	IN
cord-321267-ihd30qi0	37	18	Covid-19	covid-19	NN
cord-321267-ihd30qi0	37	19	.	.	.
cord-321267-ihd30qi0	37	20	Opportunities	opportunity	NNS
cord-321267-ihd30qi0	37	21	for	for	IN
cord-321267-ihd30qi0	37	22	natural	natural	JJ
cord-321267-ihd30qi0	37	23	experiments	experiment	NNS
cord-321267-ihd30qi0	37	24	present	present	VBP
cord-321267-ihd30qi0	37	25	themselves	-PRON-	PRP
cord-321267-ihd30qi0	37	26	without	without	IN
cord-321267-ihd30qi0	37	27	active	active	JJ
cord-321267-ihd30qi0	37	28	human	human	JJ
cord-321267-ihd30qi0	37	29	intervention	intervention	NN
cord-321267-ihd30qi0	37	30	.	.	.
cord-321267-ihd30qi0	38	1	Natural	natural	JJ
cord-321267-ihd30qi0	38	2	experiments	experiment	NNS
cord-321267-ihd30qi0	38	3	can	can	MD
cord-321267-ihd30qi0	38	4	reside	reside	VB
cord-321267-ihd30qi0	38	5	in	in	IN
cord-321267-ihd30qi0	38	6	an	an	DT
cord-321267-ihd30qi0	38	7	event	event	NN
cord-321267-ihd30qi0	38	8	where	where	WRB
cord-321267-ihd30qi0	38	9	different	different	JJ
cord-321267-ihd30qi0	38	10	subpopulations	subpopulation	NNS
cord-321267-ihd30qi0	38	11	are	be	VBP
cord-321267-ihd30qi0	38	12	suspected	suspect	VBN
cord-321267-ihd30qi0	38	13	of	of	IN
cord-321267-ihd30qi0	38	14	experiencing	experience	VBG
cord-321267-ihd30qi0	38	15	a	a	DT
cord-321267-ihd30qi0	38	16	spectrum	spectrum	NN
cord-321267-ihd30qi0	38	17	of	of	IN
cord-321267-ihd30qi0	38	18	exposures	exposure	NNS
cord-321267-ihd30qi0	38	19	,	,	,
cord-321267-ihd30qi0	38	20	ranging	range	VBG
cord-321267-ihd30qi0	38	21	from	from	IN
cord-321267-ihd30qi0	38	22	none	none	NN
cord-321267-ihd30qi0	38	23	to	to	TO
cord-321267-ihd30qi0	38	24	extensive	extensive	JJ
cord-321267-ihd30qi0	38	25	.	.	.
cord-321267-ihd30qi0	39	1	The	the	DT
cord-321267-ihd30qi0	39	2	archetype	archetype	NN
cord-321267-ihd30qi0	39	3	example	example	NN
cord-321267-ihd30qi0	39	4	is	be	VBZ
cord-321267-ihd30qi0	39	5	the	the	DT
cord-321267-ihd30qi0	39	6	historic	historic	JJ
cord-321267-ihd30qi0	39	7	1854	1854	CD
cord-321267-ihd30qi0	39	8	London	London	NNP
cord-321267-ihd30qi0	39	9	cholera	cholera	NN
cord-321267-ihd30qi0	39	10	outbreak	outbreak	NN
cord-321267-ihd30qi0	39	11	,	,	,
cord-321267-ihd30qi0	39	12	where	where	WRB
cord-321267-ihd30qi0	39	13	Dr.	Dr.	NNP
cord-321267-ihd30qi0	39	14	John	John	NNP
cord-321267-ihd30qi0	39	15	Snow	Snow	NNP
cord-321267-ihd30qi0	39	16	was	be	VBD
cord-321267-ihd30qi0	39	17	able	able	JJ
cord-321267-ihd30qi0	39	18	to	to	TO
cord-321267-ihd30qi0	39	19	identify	identify	VB
cord-321267-ihd30qi0	39	20	the	the	DT
cord-321267-ihd30qi0	39	21	route	route	NN
cord-321267-ihd30qi0	39	22	of	of	IN
cord-321267-ihd30qi0	39	23	transmission	transmission	NN
cord-321267-ihd30qi0	39	24	and	and	CC
cord-321267-ihd30qi0	39	25	propose	propose	VB
cord-321267-ihd30qi0	39	26	the	the	DT
cord-321267-ihd30qi0	39	27	solution	solution	NN
cord-321267-ihd30qi0	39	28	for	for	IN
cord-321267-ihd30qi0	39	29	ending	end	VBG
cord-321267-ihd30qi0	39	30	the	the	DT
cord-321267-ihd30qi0	39	31	epidemic	epidemic	NN
cord-321267-ihd30qi0	39	32	.	.	.
cord-321267-ihd30qi0	40	1	The	the	DT
cord-321267-ihd30qi0	40	2	proposed	propose	VBN
cord-321267-ihd30qi0	40	3	approach	approach	NN
cord-321267-ihd30qi0	40	4	would	would	MD
cord-321267-ihd30qi0	40	5	identify	identify	VB
cord-321267-ihd30qi0	40	6	all	all	DT
cord-321267-ihd30qi0	40	7	drugs	drug	NNS
cord-321267-ihd30qi0	40	8	used	use	VBN
cord-321267-ihd30qi0	40	9	by	by	IN
cord-321267-ihd30qi0	40	10	each	each	DT
cord-321267-ihd30qi0	40	11	of	of	IN
cord-321267-ihd30qi0	40	12	two	two	CD
cord-321267-ihd30qi0	40	13	groups	group	NNS
cord-321267-ihd30qi0	40	14	of	of	IN
cord-321267-ihd30qi0	40	15	patient	patient	JJ
cord-321267-ihd30qi0	40	16	cases	case	NNS
cord-321267-ihd30qi0	40	17	defined	define	VBN
cord-321267-ihd30qi0	40	18	by	by	IN
cord-321267-ihd30qi0	40	19	whether	whether	IN
cord-321267-ihd30qi0	40	20	they	-PRON-	PRP
cord-321267-ihd30qi0	40	21	test	test	VBP
cord-321267-ihd30qi0	40	22	positive	positive	JJ
cord-321267-ihd30qi0	40	23	or	or	CC
cord-321267-ihd30qi0	40	24	negative	negative	JJ
cord-321267-ihd30qi0	40	25	for	for	IN
cord-321267-ihd30qi0	40	26	exposure	exposure	NN
cord-321267-ihd30qi0	40	27	to	to	IN
cord-321267-ihd30qi0	40	28	SARS	SARS	NNP
cord-321267-ihd30qi0	40	29	-	-	HYPH
cord-321267-ihd30qi0	40	30	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	40	31	and/or	and/or	CC
cord-321267-ihd30qi0	40	32	test	test	VBP
cord-321267-ihd30qi0	40	33	positive	positive	JJ
cord-321267-ihd30qi0	40	34	or	or	CC
cord-321267-ihd30qi0	40	35	negative	negative	JJ
cord-321267-ihd30qi0	40	36	for	for	IN
cord-321267-ihd30qi0	40	37	active	active	JJ
cord-321267-ihd30qi0	40	38	disease	disease	NN
cord-321267-ihd30qi0	40	39	.	.	.
cord-321267-ihd30qi0	41	1	Each	each	DT
cord-321267-ihd30qi0	41	2	potential	potential	JJ
cord-321267-ihd30qi0	41	3	drug	drug	NN
cord-321267-ihd30qi0	41	4	candidate	candidate	NN
cord-321267-ihd30qi0	41	5	could	could	MD
cord-321267-ihd30qi0	41	6	be	be	VB
cord-321267-ihd30qi0	41	7	revealed	reveal	VBN
cord-321267-ihd30qi0	41	8	by	by	IN
cord-321267-ihd30qi0	41	9	whether	whether	IN
cord-321267-ihd30qi0	41	10	its	-PRON-	PRP$
cord-321267-ihd30qi0	41	11	per	per	IN
cord-321267-ihd30qi0	41	12	capita	capita	FW
cord-321267-ihd30qi0	41	13	usage	usage	NN
cord-321267-ihd30qi0	41	14	rate	rate	NN
cord-321267-ihd30qi0	41	15	for	for	IN
cord-321267-ihd30qi0	41	16	test	test	NN
cord-321267-ihd30qi0	41	17	each	each	DT
cord-321267-ihd30qi0	41	18	group	group	NN
cord-321267-ihd30qi0	41	19	is	be	VBZ
cord-321267-ihd30qi0	41	20	significantly	significantly	RB
cord-321267-ihd30qi0	41	21	higher	high	JJR
cord-321267-ihd30qi0	41	22	or	or	CC
cord-321267-ihd30qi0	41	23	lower	low	JJR
cord-321267-ihd30qi0	41	24	than	than	IN
cord-321267-ihd30qi0	41	25	the	the	DT
cord-321267-ihd30qi0	41	26	usage	usage	NN
cord-321267-ihd30qi0	41	27	rates	rate	NNS
cord-321267-ihd30qi0	41	28	for	for	IN
cord-321267-ihd30qi0	41	29	the	the	DT
cord-321267-ihd30qi0	41	30	other	other	JJ
cord-321267-ihd30qi0	41	31	groups	group	NNS
cord-321267-ihd30qi0	41	32	.	.	.
cord-321267-ihd30qi0	42	1	Usage	usage	NN
cord-321267-ihd30qi0	42	2	rates	rate	NNS
cord-321267-ihd30qi0	42	3	that	that	WDT
cord-321267-ihd30qi0	42	4	have	have	VBP
cord-321267-ihd30qi0	42	5	significant	significant	JJ
cord-321267-ihd30qi0	42	6	associations	association	NNS
cord-321267-ihd30qi0	42	7	with	with	IN
cord-321267-ihd30qi0	42	8	a	a	DT
cord-321267-ihd30qi0	42	9	particular	particular	JJ
cord-321267-ihd30qi0	42	10	J	J	NNP
cord-321267-ihd30qi0	42	11	o	o	NN
cord-321267-ihd30qi0	42	12	u	u	NN
cord-321267-ihd30qi0	42	13	r	r	NN
cord-321267-ihd30qi0	42	14	n	n	NN
cord-321267-ihd30qi0	42	15	a	a	DT
cord-321267-ihd30qi0	42	16	l	l	NN
cord-321267-ihd30qi0	42	17	P	p	NN
cord-321267-ihd30qi0	42	18	r	r	NN
cord-321267-ihd30qi0	42	19	e	e	NN
cord-321267-ihd30qi0	42	20	-p	-p	NN
cord-321267-ihd30qi0	43	1	r	r	NN
cord-321267-ihd30qi0	43	2	o	o	NN
cord-321267-ihd30qi0	43	3	o	o	NN
cord-321267-ihd30qi0	44	1	f	f	LS
cord-321267-ihd30qi0	44	2	page	page	NN
cord-321267-ihd30qi0	44	3	3	3	CD
cord-321267-ihd30qi0	44	4	of	of	IN
cord-321267-ihd30qi0	44	5	16	16	CD
cord-321267-ihd30qi0	44	6	10	10	CD
cord-321267-ihd30qi0	44	7	April	April	NNP
cord-321267-ihd30qi0	44	8	2020	2020	CD
cord-321267-ihd30qi0	44	9	(	(	-LRB-
cord-321267-ihd30qi0	45	1	revised	revise	VBN
cord-321267-ihd30qi0	45	2	11	11	CD
cord-321267-ihd30qi0	45	3	May	May	NNP
cord-321267-ihd30qi0	45	4	)	)	-RRB-
cord-321267-ihd30qi0	45	5	draft	draft	VB
cord-321267-ihd30qi0	45	6	for	for	IN
cord-321267-ihd30qi0	46	1	Global	global	JJ
cord-321267-ihd30qi0	46	2	Epidemiology	Epidemiology	NNP
cord-321267-ihd30qi0	46	3	Christian	Christian	NNP
cord-321267-ihd30qi0	46	4	G.	G.	NNP
cord-321267-ihd30qi0	46	5	Daughton	Daughton	NNP
cord-321267-ihd30qi0	46	6	group	group	NN
cord-321267-ihd30qi0	46	7	may	may	MD
cord-321267-ihd30qi0	46	8	have	have	VB
cord-321267-ihd30qi0	46	9	either	either	CC
cord-321267-ihd30qi0	46	10	increased	increase	VBN
cord-321267-ihd30qi0	46	11	or	or	CC
cord-321267-ihd30qi0	46	12	reduced	reduce	VBN
cord-321267-ihd30qi0	46	13	potential	potential	NN
cord-321267-ihd30qi0	46	14	for	for	IN
cord-321267-ihd30qi0	46	15	providing	provide	VBG
cord-321267-ihd30qi0	46	16	protection	protection	NN
cord-321267-ihd30qi0	46	17	or	or	CC
cord-321267-ihd30qi0	46	18	ameliorating	ameliorate	VBG
cord-321267-ihd30qi0	46	19	adverse	adverse	JJ
cord-321267-ihd30qi0	46	20	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	46	21	outcomes	outcome	NNS
cord-321267-ihd30qi0	46	22	in	in	IN
cord-321267-ihd30qi0	46	23	treating	treat	VBG
cord-321267-ihd30qi0	46	24	Covid-19	covid-19	NN
cord-321267-ihd30qi0	46	25	.	.	.
cord-321267-ihd30qi0	47	1	Below	below	RB
cord-321267-ihd30qi0	47	2	is	be	VBZ
cord-321267-ihd30qi0	47	3	an	an	DT
cord-321267-ihd30qi0	47	4	outline	outline	NN
cord-321267-ihd30qi0	47	5	of	of	IN
cord-321267-ihd30qi0	47	6	this	this	DT
cord-321267-ihd30qi0	47	7	proposed	propose	VBN
cord-321267-ihd30qi0	47	8	approach	approach	NN
cord-321267-ihd30qi0	47	9	,	,	,
cord-321267-ihd30qi0	47	10	termed	term	VBN
cord-321267-ihd30qi0	47	11	"	"	``
cord-321267-ihd30qi0	47	12	Natural	Natural	NNP
cord-321267-ihd30qi0	47	13	Experiment	Experiment	NNP
cord-321267-ihd30qi0	47	14	for	for	IN
cord-321267-ihd30qi0	47	15	Repurposing	repurpose	VBG
cord-321267-ihd30qi0	47	16	Drugs	drug	NNS
cord-321267-ihd30qi0	47	17	for	for	IN
cord-321267-ihd30qi0	47	18	Covid-19	Covid-19	NNP
cord-321267-ihd30qi0	47	19	Therapy	Therapy	NNP
cord-321267-ihd30qi0	47	20	"	"	''
cord-321267-ihd30qi0	47	21	-or	-or	:
cord-321267-ihd30qi0	47	22	"	"	``
cord-321267-ihd30qi0	47	23	NERD	nerd	NN
cord-321267-ihd30qi0	47	24	"	"	''
cord-321267-ihd30qi0	47	25	as	as	IN
cord-321267-ihd30qi0	47	26	shorthand	shorthand	NN
cord-321267-ihd30qi0	47	27	.	.	.
cord-321267-ihd30qi0	48	1	NERD	NERD	NNP
cord-321267-ihd30qi0	48	2	would	would	MD
cord-321267-ihd30qi0	48	3	essentially	essentially	RB
cord-321267-ihd30qi0	48	4	serve	serve	VB
cord-321267-ihd30qi0	48	5	as	as	IN
cord-321267-ihd30qi0	48	6	a	a	DT
cord-321267-ihd30qi0	48	7	continually	continually	RB
cord-321267-ihd30qi0	48	8	ongoing	ongoing	JJ
cord-321267-ihd30qi0	48	9	,	,	,
cord-321267-ihd30qi0	48	10	multivariate	multivariate	JJ
cord-321267-ihd30qi0	48	11	retrospective	retrospective	JJ
cord-321267-ihd30qi0	48	12	observational	observational	JJ
cord-321267-ihd30qi0	48	13	study	study	NN
cord-321267-ihd30qi0	48	14	.	.	.
cord-321267-ihd30qi0	49	1	NERD	NERD	NNP
cord-321267-ihd30qi0	49	2	would	would	MD
cord-321267-ihd30qi0	49	3	attempt	attempt	VB
cord-321267-ihd30qi0	49	4	to	to	TO
cord-321267-ihd30qi0	49	5	guide	guide	VB
cord-321267-ihd30qi0	49	6	the	the	DT
cord-321267-ihd30qi0	49	7	repurposing	repurposing	NN
cord-321267-ihd30qi0	49	8	of	of	IN
cord-321267-ihd30qi0	49	9	currently	currently	RB
cord-321267-ihd30qi0	49	10	used	use	VBN
cord-321267-ihd30qi0	49	11	drugs	drug	NNS
cord-321267-ihd30qi0	49	12	for	for	IN
cord-321267-ihd30qi0	49	13	pre	pre	JJ
cord-321267-ihd30qi0	49	14	-	-	JJ
cord-321267-ihd30qi0	49	15	and	and	CC
cord-321267-ihd30qi0	49	16	postprophylaxis	postprophylaxis	NN
cord-321267-ihd30qi0	49	17	or	or	CC
cord-321267-ihd30qi0	49	18	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	49	19	treatment	treatment	NN
cord-321267-ihd30qi0	49	20	of	of	IN
cord-321267-ihd30qi0	49	21	Covid-19	covid-19	NN
cord-321267-ihd30qi0	49	22	.	.	.
cord-321267-ihd30qi0	49	23	NERD	NERD	NNP
cord-321267-ihd30qi0	49	24	would	would	MD
cord-321267-ihd30qi0	49	25	examine	examine	VB
cord-321267-ihd30qi0	49	26	the	the	DT
cord-321267-ihd30qi0	49	27	prior	prior	JJ
cord-321267-ihd30qi0	49	28	and	and	CC
cord-321267-ihd30qi0	49	29	current	current	JJ
cord-321267-ihd30qi0	49	30	drug	drug	NN
cord-321267-ihd30qi0	49	31	usage	usage	NN
cord-321267-ihd30qi0	49	32	among	among	IN
cord-321267-ihd30qi0	49	33	several	several	JJ
cord-321267-ihd30qi0	49	34	combinations	combination	NNS
cord-321267-ihd30qi0	49	35	of	of	IN
cord-321267-ihd30qi0	49	36	Covid-19	covid-19	JJ
cord-321267-ihd30qi0	49	37	case	case	NN
cord-321267-ihd30qi0	49	38	groups	group	NNS
cord-321267-ihd30qi0	49	39	,	,	,
cord-321267-ihd30qi0	49	40	primarily	primarily	RB
cord-321267-ihd30qi0	49	41	:	:	:
cord-321267-ihd30qi0	49	42	(	(	-LRB-
cord-321267-ihd30qi0	49	43	1	1	LS
cord-321267-ihd30qi0	49	44	)	)	-RRB-
cord-321267-ihd30qi0	49	45	those	those	DT
cord-321267-ihd30qi0	49	46	known	know	VBN
cord-321267-ihd30qi0	49	47	to	to	TO
cord-321267-ihd30qi0	49	48	have	have	VB
cord-321267-ihd30qi0	49	49	been	be	VBN
cord-321267-ihd30qi0	49	50	exposed	expose	VBN
cord-321267-ihd30qi0	49	51	or	or	CC
cord-321267-ihd30qi0	49	52	infected	infect	VBN
cord-321267-ihd30qi0	49	53	but	but	CC
cord-321267-ihd30qi0	49	54	successfully	successfully	RB
cord-321267-ihd30qi0	49	55	cleared	clear	VBD
cord-321267-ihd30qi0	49	56	the	the	DT
cord-321267-ihd30qi0	49	57	virus	virus	NN
cord-321267-ihd30qi0	49	58	and	and	CC
cord-321267-ihd30qi0	49	59	(	(	-LRB-
cord-321267-ihd30qi0	49	60	2	2	LS
cord-321267-ihd30qi0	49	61	)	)	-RRB-
cord-321267-ihd30qi0	49	62	those	those	DT
cord-321267-ihd30qi0	49	63	who	who	WP
cord-321267-ihd30qi0	49	64	required	require	VBD
cord-321267-ihd30qi0	49	65	extensive	extensive	JJ
cord-321267-ihd30qi0	49	66	medical	medical	JJ
cord-321267-ihd30qi0	49	67	interventions	intervention	NNS
cord-321267-ihd30qi0	49	68	or	or	CC
cord-321267-ihd30qi0	49	69	died	die	VBD
cord-321267-ihd30qi0	49	70	.	.	.
cord-321267-ihd30qi0	50	1	An	an	DT
cord-321267-ihd30qi0	50	2	excess	excess	JJ
cord-321267-ihd30qi0	50	3	prevalence	prevalence	NN
cord-321267-ihd30qi0	50	4	of	of	IN
cord-321267-ihd30qi0	50	5	usage	usage	NN
cord-321267-ihd30qi0	50	6	of	of	IN
cord-321267-ihd30qi0	50	7	specific	specific	JJ
cord-321267-ihd30qi0	50	8	drugs	drug	NNS
cord-321267-ihd30qi0	50	9	within	within	IN
cord-321267-ihd30qi0	50	10	one	one	CD
cord-321267-ihd30qi0	50	11	group	group	NN
cord-321267-ihd30qi0	50	12	versus	versus	IN
cord-321267-ihd30qi0	50	13	another	another	DT
cord-321267-ihd30qi0	50	14	group	group	NN
cord-321267-ihd30qi0	50	15	may	may	MD
cord-321267-ihd30qi0	50	16	reveal	reveal	VB
cord-321267-ihd30qi0	50	17	those	those	DT
cord-321267-ihd30qi0	50	18	drugs	drug	NNS
cord-321267-ihd30qi0	50	19	having	have	VBG
cord-321267-ihd30qi0	50	20	increased	increase	VBN
cord-321267-ihd30qi0	50	21	potential	potential	NN
cord-321267-ihd30qi0	50	22	to	to	TO
cord-321267-ihd30qi0	50	23	be	be	VB
cord-321267-ihd30qi0	50	24	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	50	25	or	or	CC
cord-321267-ihd30qi0	50	26	contraindicated	contraindicated	JJ
cord-321267-ihd30qi0	50	27	(	(	-LRB-
cord-321267-ihd30qi0	50	28	meriting	merit	VBG
cord-321267-ihd30qi0	50	29	avoidance	avoidance	NN
cord-321267-ihd30qi0	50	30	in	in	IN
cord-321267-ihd30qi0	50	31	prevention	prevention	NN
cord-321267-ihd30qi0	50	32	or	or	CC
cord-321267-ihd30qi0	50	33	therapy	therapy	NN
cord-321267-ihd30qi0	50	34	)	)	-RRB-
cord-321267-ihd30qi0	50	35	.	.	.
cord-321267-ihd30qi0	51	1	Important	important	JJ
cord-321267-ihd30qi0	51	2	to	to	TO
cord-321267-ihd30qi0	51	3	emphasize	emphasize	VB
cord-321267-ihd30qi0	51	4	is	be	VBZ
cord-321267-ihd30qi0	51	5	that	that	DT
cord-321267-ihd30qi0	51	6	NERD	nerd	NN
cord-321267-ihd30qi0	51	7	might	may	MD
cord-321267-ihd30qi0	51	8	prove	prove	VB
cord-321267-ihd30qi0	51	9	useful	useful	JJ
cord-321267-ihd30qi0	51	10	not	not	RB
cord-321267-ihd30qi0	51	11	just	just	RB
cord-321267-ihd30qi0	51	12	for	for	IN
cord-321267-ihd30qi0	51	13	revealing	reveal	VBG
cord-321267-ihd30qi0	51	14	potential	potential	JJ
cord-321267-ihd30qi0	51	15	therapeutics	therapeutic	NNS
cord-321267-ihd30qi0	51	16	,	,	,
cord-321267-ihd30qi0	51	17	but	but	CC
cord-321267-ihd30qi0	51	18	also	also	RB
cord-321267-ihd30qi0	51	19	reveal	reveal	VB
cord-321267-ihd30qi0	51	20	those	those	DT
cord-321267-ihd30qi0	51	21	drugs	drug	NNS
cord-321267-ihd30qi0	51	22	that	that	WDT
cord-321267-ihd30qi0	51	23	might	may	MD
cord-321267-ihd30qi0	51	24	be	be	VB
cord-321267-ihd30qi0	51	25	contraindicated	contraindicate	VBN
cord-321267-ihd30qi0	51	26	or	or	CC
cord-321267-ihd30qi0	51	27	actually	actually	RB
cord-321267-ihd30qi0	51	28	potentiate	potentiate	VB
cord-321267-ihd30qi0	51	29	the	the	DT
cord-321267-ihd30qi0	51	30	progression	progression	NN
cord-321267-ihd30qi0	51	31	of	of	IN
cord-321267-ihd30qi0	51	32	adverse	adverse	JJ
cord-321267-ihd30qi0	51	33	Covid-19	covid-19	JJ
cord-321267-ihd30qi0	51	34	outcomes	outcome	NNS
cord-321267-ihd30qi0	51	35	.	.	.
cord-321267-ihd30qi0	52	1	Many	many	JJ
cord-321267-ihd30qi0	52	2	different	different	JJ
cord-321267-ihd30qi0	52	3	scenarios	scenario	NNS
cord-321267-ihd30qi0	52	4	can	can	MD
cord-321267-ihd30qi0	52	5	be	be	VB
cord-321267-ihd30qi0	52	6	hypothesized	hypothesize	VBN
cord-321267-ihd30qi0	52	7	for	for	IN
cord-321267-ihd30qi0	52	8	how	how	WRB
cord-321267-ihd30qi0	52	9	drug	drug	NN
cord-321267-ihd30qi0	52	10	usage	usage	NN
cord-321267-ihd30qi0	52	11	might	may	MD
cord-321267-ihd30qi0	52	12	be	be	VB
cord-321267-ihd30qi0	52	13	associated	associate	VBN
cord-321267-ihd30qi0	52	14	with	with	IN
cord-321267-ihd30qi0	52	15	Covid-19	covid-19	JJ
cord-321267-ihd30qi0	52	16	clinical	clinical	JJ
cord-321267-ihd30qi0	52	17	outcomes	outcome	NNS
cord-321267-ihd30qi0	52	18	.	.	.
cord-321267-ihd30qi0	53	1	Consider	consider	VB
cord-321267-ihd30qi0	53	2	the	the	DT
cord-321267-ihd30qi0	53	3	two	two	CD
cord-321267-ihd30qi0	53	4	bookend	bookend	NN
cord-321267-ihd30qi0	53	5	case	case	NN
cord-321267-ihd30qi0	53	6	outcomes	outcome	NNS
cord-321267-ihd30qi0	53	7	for	for	IN
cord-321267-ihd30qi0	53	8	Covid-19	covid-19	NN
cord-321267-ihd30qi0	53	9	:	:	:
cord-321267-ihd30qi0	53	10	(	(	-LRB-
cord-321267-ihd30qi0	53	11	1	1	LS
cord-321267-ihd30qi0	53	12	)	)	-RRB-
cord-321267-ihd30qi0	53	13	the	the	DT
cord-321267-ihd30qi0	53	14	vast	vast	JJ
cord-321267-ihd30qi0	53	15	majority	majority	NN
cord-321267-ihd30qi0	53	16	that	that	WDT
cord-321267-ihd30qi0	53	17	resolve	resolve	VBP
cord-321267-ihd30qi0	53	18	with	with	IN
cord-321267-ihd30qi0	53	19	little	little	JJ
cord-321267-ihd30qi0	53	20	to	to	IN
cord-321267-ihd30qi0	53	21	no	no	DT
cord-321267-ihd30qi0	53	22	morbidity	morbidity	NN
cord-321267-ihd30qi0	53	23	and	and	CC
cord-321267-ihd30qi0	53	24	(	(	-LRB-
cord-321267-ihd30qi0	53	25	2	2	LS
cord-321267-ihd30qi0	53	26	)	)	-RRB-
cord-321267-ihd30qi0	53	27	the	the	DT
cord-321267-ihd30qi0	53	28	minority	minority	NN
cord-321267-ihd30qi0	53	29	that	that	WDT
cord-321267-ihd30qi0	53	30	become	become	VBP
cord-321267-ihd30qi0	53	31	acutely	acutely	RB
cord-321267-ihd30qi0	53	32	serious	serious	JJ
cord-321267-ihd30qi0	53	33	.	.	.
cord-321267-ihd30qi0	54	1	The	the	DT
cord-321267-ihd30qi0	54	2	most	most	RBS
cord-321267-ihd30qi0	54	3	general	general	JJ
cord-321267-ihd30qi0	54	4	hypothesis	hypothesis	NN
cord-321267-ihd30qi0	54	5	is	be	VBZ
cord-321267-ihd30qi0	54	6	that	that	IN
cord-321267-ihd30qi0	54	7	there	there	EX
cord-321267-ihd30qi0	54	8	are	be	VBP
cord-321267-ihd30qi0	54	9	drugs	drug	NNS
cord-321267-ihd30qi0	54	10	(	(	-LRB-
cord-321267-ihd30qi0	54	11	or	or	CC
cord-321267-ihd30qi0	54	12	combinations	combination	NNS
cord-321267-ihd30qi0	54	13	of	of	IN
cord-321267-ihd30qi0	54	14	drugs	drug	NNS
cord-321267-ihd30qi0	54	15	)	)	-RRB-
cord-321267-ihd30qi0	54	16	that	that	WDT
cord-321267-ihd30qi0	54	17	have	have	VBP
cord-321267-ihd30qi0	54	18	protective	protective	JJ
cord-321267-ihd30qi0	54	19	effects	effect	NNS
cord-321267-ihd30qi0	54	20	and	and	CC
cord-321267-ihd30qi0	54	21	perhaps	perhaps	RB
cord-321267-ihd30qi0	54	22	others	other	NNS
cord-321267-ihd30qi0	54	23	that	that	WDT
cord-321267-ihd30qi0	54	24	have	have	VBP
cord-321267-ihd30qi0	54	25	adverse	adverse	JJ
cord-321267-ihd30qi0	54	26	effects	effect	NNS
cord-321267-ihd30qi0	54	27	.	.	.
cord-321267-ihd30qi0	55	1	To	to	TO
cord-321267-ihd30qi0	55	2	explain	explain	VB
cord-321267-ihd30qi0	55	3	the	the	DT
cord-321267-ihd30qi0	55	4	lower	low	JJR
cord-321267-ihd30qi0	55	5	incidence	incidence	NN
cord-321267-ihd30qi0	55	6	of	of	IN
cord-321267-ihd30qi0	55	7	serious	serious	JJ
cord-321267-ihd30qi0	55	8	Covid-19	covid-19	JJ
cord-321267-ihd30qi0	55	9	outcomes	outcome	NNS
cord-321267-ihd30qi0	55	10	compared	compare	VBN
cord-321267-ihd30qi0	55	11	with	with	IN
cord-321267-ihd30qi0	55	12	favorable	favorable	JJ
cord-321267-ihd30qi0	55	13	outcomes	outcome	NNS
cord-321267-ihd30qi0	55	14	,	,	,
cord-321267-ihd30qi0	55	15	perhaps	perhaps	RB
cord-321267-ihd30qi0	55	16	it	-PRON-	PRP
cord-321267-ihd30qi0	55	17	is	be	VBZ
cord-321267-ihd30qi0	55	18	the	the	DT
cord-321267-ihd30qi0	55	19	drugs	drug	NNS
cord-321267-ihd30qi0	55	20	with	with	IN
cord-321267-ihd30qi0	55	21	the	the	DT
cord-321267-ihd30qi0	55	22	lowest	low	JJS
cord-321267-ihd30qi0	55	23	overall	overall	JJ
cord-321267-ihd30qi0	55	24	clinical	clinical	JJ
cord-321267-ihd30qi0	55	25	usage	usage	NN
cord-321267-ihd30qi0	55	26	rates	rate	NNS
cord-321267-ihd30qi0	55	27	that	that	WDT
cord-321267-ihd30qi0	55	28	could	could	MD
cord-321267-ihd30qi0	55	29	explain	explain	VB
cord-321267-ihd30qi0	55	30	at	at	IN
cord-321267-ihd30qi0	55	31	least	least	JJS
cord-321267-ihd30qi0	55	32	a	a	DT
cord-321267-ihd30qi0	55	33	portion	portion	NN
cord-321267-ihd30qi0	55	34	of	of	IN
cord-321267-ihd30qi0	55	35	the	the	DT
cord-321267-ihd30qi0	55	36	serious	serious	JJ
cord-321267-ihd30qi0	55	37	outcomes	outcome	NNS
cord-321267-ihd30qi0	55	38	-especially	-especially	RB
cord-321267-ihd30qi0	55	39	among	among	IN
cord-321267-ihd30qi0	55	40	clinical	clinical	JJ
cord-321267-ihd30qi0	55	41	cases	case	NNS
cord-321267-ihd30qi0	55	42	having	have	VBG
cord-321267-ihd30qi0	55	43	no	no	DT
cord-321267-ihd30qi0	55	44	apparent	apparent	JJ
cord-321267-ihd30qi0	55	45	underlying	underlying	JJ
cord-321267-ihd30qi0	55	46	risk	risk	NN
cord-321267-ihd30qi0	55	47	factors	factor	NNS
cord-321267-ihd30qi0	55	48	.	.	.
cord-321267-ihd30qi0	56	1	It	-PRON-	PRP
cord-321267-ihd30qi0	56	2	is	be	VBZ
cord-321267-ihd30qi0	56	3	likely	likely	JJ
cord-321267-ihd30qi0	56	4	that	that	IN
cord-321267-ihd30qi0	56	5	widespread	widespread	JJ
cord-321267-ihd30qi0	56	6	Covid-19	covid-19	NN
cord-321267-ihd30qi0	56	7	testing	testing	NN
cord-321267-ihd30qi0	56	8	among	among	IN
cord-321267-ihd30qi0	56	9	the	the	DT
cord-321267-ihd30qi0	56	10	general	general	JJ
cord-321267-ihd30qi0	56	11	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	56	12	population	population	NN
cord-321267-ihd30qi0	56	13	will	will	MD
cord-321267-ihd30qi0	56	14	reveal	reveal	VB
cord-321267-ihd30qi0	56	15	that	that	IN
cord-321267-ihd30qi0	56	16	its	-PRON-	PRP$
cord-321267-ihd30qi0	56	17	infected	infected	JJ
cord-321267-ihd30qi0	56	18	subpopulation	subpopulation	NN
cord-321267-ihd30qi0	56	19	is	be	VBZ
cord-321267-ihd30qi0	56	20	even	even	RB
cord-321267-ihd30qi0	56	21	larger	large	JJR
cord-321267-ihd30qi0	56	22	than	than	IN
cord-321267-ihd30qi0	56	23	currently	currently	RB
cord-321267-ihd30qi0	56	24	believed	believe	VBN
cord-321267-ihd30qi0	56	25	for	for	IN
cord-321267-ihd30qi0	56	26	the	the	DT
cord-321267-ihd30qi0	56	27	subpopulation	subpopulation	NN
cord-321267-ihd30qi0	56	28	that	that	WDT
cord-321267-ihd30qi0	56	29	progresses	progress	VBZ
cord-321267-ihd30qi0	56	30	to	to	IN
cord-321267-ihd30qi0	56	31	serious	serious	JJ
cord-321267-ihd30qi0	56	32	outcomes	outcome	NNS
cord-321267-ihd30qi0	56	33	.	.	.
cord-321267-ihd30qi0	57	1	This	this	DT
cord-321267-ihd30qi0	57	2	would	would	MD
cord-321267-ihd30qi0	57	3	point	point	VB
cord-321267-ihd30qi0	57	4	even	even	RB
cord-321267-ihd30qi0	57	5	further	far	RBR
cord-321267-ihd30qi0	57	6	to	to	IN
cord-321267-ihd30qi0	57	7	the	the	DT
cord-321267-ihd30qi0	57	8	possibility	possibility	NN
cord-321267-ihd30qi0	57	9	that	that	IN
cord-321267-ihd30qi0	57	10	perhaps	perhaps	RB
cord-321267-ihd30qi0	57	11	it	-PRON-	PRP
cord-321267-ihd30qi0	57	12	is	be	VBZ
cord-321267-ihd30qi0	57	13	the	the	DT
cord-321267-ihd30qi0	57	14	seldom	seldom	RB
cord-321267-ihd30qi0	57	15	-	-	HYPH
cord-321267-ihd30qi0	57	16	used	use	VBN
cord-321267-ihd30qi0	57	17	drugs	drug	NNS
cord-321267-ihd30qi0	57	18	that	that	WDT
cord-321267-ihd30qi0	57	19	play	play	VBP
cord-321267-ihd30qi0	57	20	a	a	DT
cord-321267-ihd30qi0	57	21	role	role	NN
cord-321267-ihd30qi0	57	22	in	in	IN
cord-321267-ihd30qi0	57	23	serious	serious	JJ
cord-321267-ihd30qi0	57	24	outcomes	outcome	NNS
cord-321267-ihd30qi0	57	25	.	.	.
cord-321267-ihd30qi0	58	1	A	a	DT
cord-321267-ihd30qi0	58	2	major	major	JJ
cord-321267-ihd30qi0	58	3	obstacle	obstacle	NN
cord-321267-ihd30qi0	58	4	to	to	TO
cord-321267-ihd30qi0	58	5	successfully	successfully	RB
cord-321267-ihd30qi0	58	6	implementing	implement	VBG
cord-321267-ihd30qi0	58	7	NERD	NERD	NNP
cord-321267-ihd30qi0	58	8	also	also	RB
cord-321267-ihd30qi0	58	9	needs	need	VBZ
cord-321267-ihd30qi0	58	10	to	to	TO
cord-321267-ihd30qi0	58	11	be	be	VB
cord-321267-ihd30qi0	58	12	stressed	stress	VBN
cord-321267-ihd30qi0	58	13	.	.	.
cord-321267-ihd30qi0	59	1	Initially	initially	RB
cord-321267-ihd30qi0	59	2	,	,	,
cord-321267-ihd30qi0	59	3	the	the	DT
cord-321267-ihd30qi0	59	4	only	only	JJ
cord-321267-ihd30qi0	59	5	type	type	NN
cord-321267-ihd30qi0	59	6	of	of	IN
cord-321267-ihd30qi0	59	7	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	59	8	drug	drug	NN
cord-321267-ihd30qi0	59	9	usage	usage	NN
cord-321267-ihd30qi0	59	10	data	datum	NNS
cord-321267-ihd30qi0	59	11	that	that	WDT
cord-321267-ihd30qi0	59	12	would	would	MD
cord-321267-ihd30qi0	59	13	be	be	VB
cord-321267-ihd30qi0	59	14	straightforward	straightforward	JJ
cord-321267-ihd30qi0	59	15	to	to	TO
cord-321267-ihd30qi0	59	16	collect	collect	VB
cord-321267-ihd30qi0	59	17	would	would	MD
cord-321267-ihd30qi0	59	18	be	be	VB
cord-321267-ihd30qi0	59	19	for	for	IN
cord-321267-ihd30qi0	59	20	drugs	drug	NNS
cord-321267-ihd30qi0	59	21	used	use	VBN
cord-321267-ihd30qi0	59	22	in	in	IN
cord-321267-ihd30qi0	59	23	long	long	JJ
cord-321267-ihd30qi0	59	24	-	-	HYPH
cord-321267-ihd30qi0	59	25	term	term	NN
cord-321267-ihd30qi0	59	26	maintenance	maintenance	NN
cord-321267-ihd30qi0	59	27	therapies	therapy	NNS
cord-321267-ihd30qi0	59	28	(	(	-LRB-
cord-321267-ihd30qi0	59	29	both	both	DT
cord-321267-ihd30qi0	59	30	small	small	JJ
cord-321267-ihd30qi0	59	31	-	-	HYPH
cord-321267-ihd30qi0	59	32	molecule	molecule	NN
cord-321267-ihd30qi0	59	33	and	and	CC
cord-321267-ihd30qi0	59	34	biologics	biologic	NNS
cord-321267-ihd30qi0	59	35	)	)	-RRB-
cord-321267-ihd30qi0	59	36	;	;	:
cord-321267-ihd30qi0	59	37	vaccines	vaccine	NNS
cord-321267-ihd30qi0	59	38	and	and	CC
cord-321267-ihd30qi0	59	39	hormonal	hormonal	JJ
cord-321267-ihd30qi0	59	40	agents	agent	NNS
cord-321267-ihd30qi0	59	41	should	should	MD
cord-321267-ihd30qi0	59	42	also	also	RB
cord-321267-ihd30qi0	59	43	be	be	VB
cord-321267-ihd30qi0	59	44	included	include	VBN
cord-321267-ihd30qi0	59	45	.	.	.
cord-321267-ihd30qi0	60	1	Therapy	therapy	NN
cord-321267-ihd30qi0	60	2	would	would	MD
cord-321267-ihd30qi0	60	3	needed	need	VBN
cord-321267-ihd30qi0	60	4	to	to	TO
cord-321267-ihd30qi0	60	5	have	have	VB
cord-321267-ihd30qi0	60	6	begun	begin	VBN
cord-321267-ihd30qi0	60	7	several	several	JJ
cord-321267-ihd30qi0	60	8	weeks	week	NNS
cord-321267-ihd30qi0	60	9	before	before	IN
cord-321267-ihd30qi0	60	10	exposure	exposure	NN
cord-321267-ihd30qi0	60	11	but	but	CC
cord-321267-ihd30qi0	60	12	exposure	exposure	NN
cord-321267-ihd30qi0	60	13	dates	date	NNS
cord-321267-ihd30qi0	60	14	would	would	MD
cord-321267-ihd30qi0	60	15	almost	almost	RB
cord-321267-ihd30qi0	60	16	always	always	RB
cord-321267-ihd30qi0	60	17	have	have	VB
cord-321267-ihd30qi0	60	18	to	to	TO
cord-321267-ihd30qi0	60	19	be	be	VB
cord-321267-ihd30qi0	60	20	inferred	infer	VBN
cord-321267-ihd30qi0	60	21	.	.	.
cord-321267-ihd30qi0	61	1	In	in	IN
cord-321267-ihd30qi0	61	2	contrast	contrast	NN
cord-321267-ihd30qi0	61	3	,	,	,
cord-321267-ihd30qi0	61	4	drugs	drug	NNS
cord-321267-ihd30qi0	61	5	used	use	VBN
cord-321267-ihd30qi0	61	6	in	in	IN
cord-321267-ihd30qi0	61	7	short	short	JJ
cord-321267-ihd30qi0	61	8	-	-	HYPH
cord-321267-ihd30qi0	61	9	term	term	NN
cord-321267-ihd30qi0	61	10	therapy	therapy	NN
cord-321267-ihd30qi0	61	11	could	could	MD
cord-321267-ihd30qi0	61	12	be	be	VB
cord-321267-ihd30qi0	61	13	problematic	problematic	JJ
cord-321267-ihd30qi0	61	14	to	to	TO
cord-321267-ihd30qi0	61	15	collect	collect	VB
cord-321267-ihd30qi0	61	16	at	at	IN
cord-321267-ihd30qi0	61	17	first	first	RB
cord-321267-ihd30qi0	61	18	because	because	IN
cord-321267-ihd30qi0	61	19	many	many	JJ
cord-321267-ihd30qi0	61	20	additional	additional	JJ
cord-321267-ihd30qi0	61	21	details	detail	NNS
cord-321267-ihd30qi0	61	22	would	would	MD
cord-321267-ihd30qi0	61	23	be	be	VB
cord-321267-ihd30qi0	61	24	needed	need	VBN
cord-321267-ihd30qi0	61	25	:	:	:
cord-321267-ihd30qi0	61	26	daily	daily	RB
cord-321267-ihd30qi0	61	27	dose	dose	NN
cord-321267-ihd30qi0	61	28	,	,	,
cord-321267-ihd30qi0	61	29	duration	duration	NN
cord-321267-ihd30qi0	61	30	of	of	IN
cord-321267-ihd30qi0	61	31	therapy	therapy	NN
cord-321267-ihd30qi0	61	32	,	,	,
cord-321267-ihd30qi0	61	33	and	and	CC
cord-321267-ihd30qi0	61	34	time	time	NN
cord-321267-ihd30qi0	61	35	-	-	HYPH
cord-321267-ihd30qi0	61	36	frame	frame	NN
cord-321267-ihd30qi0	61	37	of	of	IN
cord-321267-ihd30qi0	61	38	therapy	therapy	NN
cord-321267-ihd30qi0	61	39	.	.	.
cord-321267-ihd30qi0	62	1	Many	many	JJ
cord-321267-ihd30qi0	62	2	patients	patient	NNS
cord-321267-ihd30qi0	62	3	may	may	MD
cord-321267-ihd30qi0	62	4	be	be	VB
cord-321267-ihd30qi0	62	5	unable	unable	JJ
cord-321267-ihd30qi0	62	6	to	to	TO
cord-321267-ihd30qi0	62	7	supply	supply	VB
cord-321267-ihd30qi0	62	8	this	this	DT
cord-321267-ihd30qi0	62	9	level	level	NN
cord-321267-ihd30qi0	62	10	of	of	IN
cord-321267-ihd30qi0	62	11	detail	detail	NN
cord-321267-ihd30qi0	62	12	.	.	.
cord-321267-ihd30qi0	63	1	Moreover	moreover	RB
cord-321267-ihd30qi0	63	2	,	,	,
cord-321267-ihd30qi0	63	3	the	the	DT
cord-321267-ihd30qi0	63	4	fact	fact	NN
cord-321267-ihd30qi0	63	5	that	that	IN
cord-321267-ihd30qi0	63	6	the	the	DT
cord-321267-ihd30qi0	63	7	short	short	JJ
cord-321267-ihd30qi0	63	8	-	-	HYPH
cord-321267-ihd30qi0	63	9	term	term	NN
cord-321267-ihd30qi0	63	10	therapy	therapy	NN
cord-321267-ihd30qi0	63	11	might	may	MD
cord-321267-ihd30qi0	63	12	overlap	overlap	VB
cord-321267-ihd30qi0	63	13	with	with	IN
cord-321267-ihd30qi0	63	14	different	different	JJ
cord-321267-ihd30qi0	63	15	intervals	interval	NNS
cord-321267-ihd30qi0	63	16	of	of	IN
cord-321267-ihd30qi0	63	17	the	the	DT
cord-321267-ihd30qi0	63	18	disease	disease	NN
cord-321267-ihd30qi0	63	19	progression	progression	NN
cord-321267-ihd30qi0	63	20	would	would	MD
cord-321267-ihd30qi0	63	21	make	make	VB
cord-321267-ihd30qi0	63	22	interpretation	interpretation	NN
cord-321267-ihd30qi0	63	23	of	of	IN
cord-321267-ihd30qi0	63	24	collected	collect	VBN
cord-321267-ihd30qi0	63	25	data	datum	NNS
cord-321267-ihd30qi0	63	26	much	much	RB
cord-321267-ihd30qi0	63	27	more	more	RBR
cord-321267-ihd30qi0	63	28	challenging	challenging	JJ
cord-321267-ihd30qi0	63	29	.	.	.
cord-321267-ihd30qi0	63	30	 	 	_SP
cord-321267-ihd30qi0	64	1	(	(	-LRB-
cord-321267-ihd30qi0	64	2	1	1	LS
cord-321267-ihd30qi0	64	3	)	)	-RRB-
cord-321267-ihd30qi0	64	4	As	as	IN
cord-321267-ihd30qi0	64	5	Covid-19	covid-19	JJ
cord-321267-ihd30qi0	64	6	epidemiological	epidemiological	JJ
cord-321267-ihd30qi0	64	7	surveillance	surveillance	NN
cord-321267-ihd30qi0	64	8	screening	screening	NN
cord-321267-ihd30qi0	64	9	and	and	CC
cord-321267-ihd30qi0	64	10	diagnostic	diagnostic	JJ
cord-321267-ihd30qi0	64	11	testing	testing	NN
cord-321267-ihd30qi0	64	12	proceeds	proceed	NNS
cord-321267-ihd30qi0	64	13	,	,	,
cord-321267-ihd30qi0	64	14	a	a	DT
cord-321267-ihd30qi0	64	15	national	national	JJ
cord-321267-ihd30qi0	64	16	database	database	NN
cord-321267-ihd30qi0	64	17	would	would	MD
cord-321267-ihd30qi0	64	18	be	be	VB
cord-321267-ihd30qi0	64	19	continually	continually	RB
cord-321267-ihd30qi0	64	20	populated	populate	VBN
cord-321267-ihd30qi0	64	21	with	with	IN
cord-321267-ihd30qi0	64	22	drug	drug	NN
cord-321267-ihd30qi0	64	23	usage	usage	NN
cord-321267-ihd30qi0	64	24	data	datum	NNS
cord-321267-ihd30qi0	64	25	collected	collect	VBN
cord-321267-ihd30qi0	64	26	from	from	IN
cord-321267-ihd30qi0	64	27	each	each	DT
cord-321267-ihd30qi0	64	28	case	case	NN
cord-321267-ihd30qi0	64	29	among	among	IN
cord-321267-ihd30qi0	64	30	three	three	CD
cord-321267-ihd30qi0	64	31	different	different	JJ
cord-321267-ihd30qi0	64	32	combinations	combination	NNS
cord-321267-ihd30qi0	64	33	of	of	IN
cord-321267-ihd30qi0	64	34	sub	sub	NN
cord-321267-ihd30qi0	64	35	-	-	NNS
cord-321267-ihd30qi0	64	36	groups	group	NNS
cord-321267-ihd30qi0	64	37	based	base	VBN
cord-321267-ihd30qi0	64	38	upon	upon	IN
cord-321267-ihd30qi0	64	39	whether	whether	IN
cord-321267-ihd30qi0	64	40	they	-PRON-	PRP
cord-321267-ihd30qi0	64	41	tested	test	VBD
cord-321267-ihd30qi0	64	42	positive	positive	JJ
cord-321267-ihd30qi0	64	43	or	or	CC
cord-321267-ihd30qi0	64	44	negative	negative	JJ
cord-321267-ihd30qi0	64	45	for	for	IN
cord-321267-ihd30qi0	64	46	active	active	JJ
cord-321267-ihd30qi0	64	47	SARS	SARS	NNP
cord-321267-ihd30qi0	64	48	-	-	HYPH
cord-321267-ihd30qi0	64	49	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	64	50	infection	infection	NN
cord-321267-ihd30qi0	64	51	or	or	CC
cord-321267-ihd30qi0	64	52	tested	test	VBN
cord-321267-ihd30qi0	64	53	positive	positive	JJ
cord-321267-ihd30qi0	64	54	for	for	IN
cord-321267-ihd30qi0	64	55	past	past	JJ
cord-321267-ihd30qi0	64	56	SARS	SARS	NNP
cord-321267-ihd30qi0	64	57	-	-	HYPH
cord-321267-ihd30qi0	64	58	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	64	59	infection	infection	NN
cord-321267-ihd30qi0	64	60	(	(	-LRB-
cord-321267-ihd30qi0	64	61	see	see	VB
cord-321267-ihd30qi0	64	62	Table	table	NN
cord-321267-ihd30qi0	64	63	1	1	CD
cord-321267-ihd30qi0	64	64	)	)	-RRB-
cord-321267-ihd30qi0	64	65	.	.	.
cord-321267-ihd30qi0	65	1	Patients	patient	NNS
cord-321267-ihd30qi0	65	2	would	would	MD
cord-321267-ihd30qi0	65	3	provide	provide	VB
cord-321267-ihd30qi0	65	4	a	a	DT
cord-321267-ihd30qi0	65	5	list	list	NN
cord-321267-ihd30qi0	65	6	of	of	IN
cord-321267-ihd30qi0	65	7	all	all	DT
cord-321267-ihd30qi0	65	8	drugs	drug	NNS
cord-321267-ihd30qi0	65	9	they	-PRON-	PRP
cord-321267-ihd30qi0	65	10	have	have	VBP
cord-321267-ihd30qi0	65	11	used	use	VBN
cord-321267-ihd30qi0	65	12	over	over	IN
cord-321267-ihd30qi0	65	13	a	a	DT
cord-321267-ihd30qi0	65	14	time	time	NN
cord-321267-ihd30qi0	65	15	period	period	NN
cord-321267-ihd30qi0	65	16	that	that	WDT
cord-321267-ihd30qi0	65	17	safely	safely	RB
cord-321267-ihd30qi0	65	18	encompasses	encompass	VBZ
cord-321267-ihd30qi0	65	19	the	the	DT
cord-321267-ihd30qi0	65	20	earliest	early	JJS
cord-321267-ihd30qi0	65	21	possible	possible	JJ
cord-321267-ihd30qi0	65	22	date	date	NN
cord-321267-ihd30qi0	65	23	at	at	IN
cord-321267-ihd30qi0	65	24	which	which	WDT
cord-321267-ihd30qi0	65	25	they	-PRON-	PRP
cord-321267-ihd30qi0	65	26	could	could	MD
cord-321267-ihd30qi0	65	27	have	have	VB
cord-321267-ihd30qi0	65	28	been	be	VBN
cord-321267-ihd30qi0	65	29	exposed	expose	VBN
cord-321267-ihd30qi0	65	30	to	to	IN
cord-321267-ihd30qi0	65	31	SARS	SARS	NNP
cord-321267-ihd30qi0	65	32	-	-	HYPH
cord-321267-ihd30qi0	65	33	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	65	34	(	(	-LRB-
cord-321267-ihd30qi0	65	35	for	for	IN
cord-321267-ihd30qi0	65	36	example	example	NN
cord-321267-ihd30qi0	65	37	,	,	,
cord-321267-ihd30qi0	65	38	2	2	CD
cord-321267-ihd30qi0	65	39	months	month	NNS
cord-321267-ihd30qi0	65	40	prior	prior	RB
cord-321267-ihd30qi0	65	41	)	)	-RRB-
cord-321267-ihd30qi0	65	42	.	.	.
cord-321267-ihd30qi0	66	1	Data	datum	NNS
cord-321267-ihd30qi0	66	2	for	for	IN
cord-321267-ihd30qi0	66	3	all	all	DT
cord-321267-ihd30qi0	66	4	types	type	NNS
cord-321267-ihd30qi0	66	5	of	of	IN
cord-321267-ihd30qi0	66	6	drugs	drug	NNS
cord-321267-ihd30qi0	66	7	would	would	MD
cord-321267-ihd30qi0	66	8	be	be	VB
cord-321267-ihd30qi0	66	9	collected	collect	VBN
cord-321267-ihd30qi0	66	10	:	:	:
cord-321267-ihd30qi0	66	11	legend	legend	NN
cord-321267-ihd30qi0	66	12	,	,	,
cord-321267-ihd30qi0	66	13	OTC	OTC	NNP
cord-321267-ihd30qi0	66	14	,	,	,
cord-321267-ihd30qi0	66	15	and	and	CC
cord-321267-ihd30qi0	66	16	recreational	recreational	JJ
cord-321267-ihd30qi0	66	17	/	/	SYM
cord-321267-ihd30qi0	66	18	illicit	illicit	JJ
cord-321267-ihd30qi0	66	19	drugs	drug	NNS
cord-321267-ihd30qi0	66	20	-both	-both	CD
cord-321267-ihd30qi0	66	21	small	small	JJ
cord-321267-ihd30qi0	66	22	-	-	HYPH
cord-321267-ihd30qi0	66	23	molecule	molecule	NN
cord-321267-ihd30qi0	66	24	drugs	drug	NNS
cord-321267-ihd30qi0	66	25	and	and	CC
cord-321267-ihd30qi0	66	26	biologics	biologic	NNS
cord-321267-ihd30qi0	66	27	,	,	,
cord-321267-ihd30qi0	66	28	as	as	RB
cord-321267-ihd30qi0	66	29	well	well	RB
cord-321267-ihd30qi0	66	30	as	as	IN
cord-321267-ihd30qi0	66	31	vaccines	vaccine	NNS
cord-321267-ihd30qi0	66	32	.	.	.
cord-321267-ihd30qi0	67	1	Drug	drug	NN
cord-321267-ihd30qi0	67	2	metadata	metadata	NN
cord-321267-ihd30qi0	67	3	to	to	TO
cord-321267-ihd30qi0	67	4	collect	collect	VB
cord-321267-ihd30qi0	67	5	would	would	MD
cord-321267-ihd30qi0	67	6	include	include	VB
cord-321267-ihd30qi0	67	7	the	the	DT
cord-321267-ihd30qi0	67	8	route	route	NN
cord-321267-ihd30qi0	67	9	of	of	IN
cord-321267-ihd30qi0	67	10	administration	administration	NN
cord-321267-ihd30qi0	67	11	,	,	,
cord-321267-ihd30qi0	67	12	especially	especially	RB
cord-321267-ihd30qi0	67	13	inhalation	inhalation	NN
cord-321267-ihd30qi0	67	14	via	via	IN
cord-321267-ihd30qi0	67	15	the	the	DT
cord-321267-ihd30qi0	67	16	nose	nose	NN
cord-321267-ihd30qi0	67	17	or	or	CC
cord-321267-ihd30qi0	67	18	mouth	mouth	NN
cord-321267-ihd30qi0	67	19	,	,	,
cord-321267-ihd30qi0	67	20	as	as	IN
cord-321267-ihd30qi0	67	21	these	these	DT
cord-321267-ihd30qi0	67	22	might	may	MD
cord-321267-ihd30qi0	67	23	have	have	VB
cord-321267-ihd30qi0	67	24	a	a	DT
cord-321267-ihd30qi0	67	25	greater	great	JJR
cord-321267-ihd30qi0	67	26	chance	chance	NN
cord-321267-ihd30qi0	67	27	for	for	IN
cord-321267-ihd30qi0	67	28	adversely	adversely	RB
cord-321267-ihd30qi0	67	29	affecting	affect	VBG
cord-321267-ihd30qi0	67	30	the	the	DT
cord-321267-ihd30qi0	67	31	pulmonary	pulmonary	JJ
cord-321267-ihd30qi0	67	32	system	system	NN
cord-321267-ihd30qi0	67	33	.	.	.
cord-321267-ihd30qi0	68	1	It	-PRON-	PRP
cord-321267-ihd30qi0	68	2	might	may	MD
cord-321267-ihd30qi0	68	3	seem	seem	VB
cord-321267-ihd30qi0	68	4	that	that	IN
cord-321267-ihd30qi0	68	5	drugs	drug	NNS
cord-321267-ihd30qi0	68	6	of	of	IN
cord-321267-ihd30qi0	68	7	obvious	obvious	JJ
cord-321267-ihd30qi0	68	8	interest	interest	NN
cord-321267-ihd30qi0	68	9	during	during	IN
cord-321267-ihd30qi0	68	10	data	datum	NNS
cord-321267-ihd30qi0	68	11	collection	collection	NN
cord-321267-ihd30qi0	68	12	might	may	MD
cord-321267-ihd30qi0	68	13	be	be	VB
cord-321267-ihd30qi0	68	14	immunosuppressants	immunosuppressant	NNS
cord-321267-ihd30qi0	68	15	or	or	CC
cord-321267-ihd30qi0	68	16	antivirals	antiviral	NNS
cord-321267-ihd30qi0	68	17	,	,	,
cord-321267-ihd30qi0	68	18	especially	especially	RB
cord-321267-ihd30qi0	68	19	those	those	DT
cord-321267-ihd30qi0	68	20	to	to	TO
cord-321267-ihd30qi0	68	21	be	be	VB
cord-321267-ihd30qi0	68	22	effective	effective	JJ
cord-321267-ihd30qi0	68	23	against	against	IN
cord-321267-ihd30qi0	68	24	enveloped	enveloped	JJ
cord-321267-ihd30qi0	68	25	viruses	virus	NNS
cord-321267-ihd30qi0	68	26	.	.	.
cord-321267-ihd30qi0	69	1	But	but	CC
cord-321267-ihd30qi0	69	2	many	many	JJ
cord-321267-ihd30qi0	69	3	other	other	JJ
cord-321267-ihd30qi0	69	4	drug	drug	NN
cord-321267-ihd30qi0	69	5	classes	class	NNS
cord-321267-ihd30qi0	69	6	might	may	MD
cord-321267-ihd30qi0	69	7	also	also	RB
cord-321267-ihd30qi0	69	8	be	be	VB
cord-321267-ihd30qi0	69	9	important	important	JJ
cord-321267-ihd30qi0	69	10	.	.	.
cord-321267-ihd30qi0	70	1	A	a	DT
cord-321267-ihd30qi0	70	2	major	major	JJ
cord-321267-ihd30qi0	70	3	advantage	advantage	NN
cord-321267-ihd30qi0	70	4	of	of	IN
cord-321267-ihd30qi0	70	5	NERD	nerd	NN
cord-321267-ihd30qi0	70	6	would	would	MD
cord-321267-ihd30qi0	70	7	be	be	VB
cord-321267-ihd30qi0	70	8	that	that	IN
cord-321267-ihd30qi0	70	9	the	the	DT
cord-321267-ihd30qi0	70	10	screening	screening	NN
cord-321267-ihd30qi0	70	11	process	process	NN
cord-321267-ihd30qi0	70	12	is	be	VBZ
cord-321267-ihd30qi0	70	13	not	not	RB
cord-321267-ihd30qi0	70	14	guided	guide	VBN
cord-321267-ihd30qi0	70	15	by	by	IN
cord-321267-ihd30qi0	70	16	known	know	VBN
cord-321267-ihd30qi0	70	17	or	or	CC
cord-321267-ihd30qi0	70	18	postulated	postulate	VBN
cord-321267-ihd30qi0	70	19	pathways	pathway	NNS
cord-321267-ihd30qi0	70	20	of	of	IN
cord-321267-ihd30qi0	70	21	exposure	exposure	NN
cord-321267-ihd30qi0	70	22	,	,	,
cord-321267-ihd30qi0	70	23	infection	infection	NN
cord-321267-ihd30qi0	70	24	,	,	,
cord-321267-ihd30qi0	70	25	or	or	CC
cord-321267-ihd30qi0	70	26	disease	disease	NN
cord-321267-ihd30qi0	70	27	progression	progression	NN
cord-321267-ihd30qi0	70	28	,	,	,
cord-321267-ihd30qi0	70	29	as	as	IN
cord-321267-ihd30qi0	70	30	NERD	nerd	NN
cord-321267-ihd30qi0	70	31	would	would	MD
cord-321267-ihd30qi0	70	32	essentially	essentially	RB
cord-321267-ihd30qi0	70	33	test	test	VB
cord-321267-ihd30qi0	70	34	all	all	DT
cord-321267-ihd30qi0	70	35	drugs	drug	NNS
cord-321267-ihd30qi0	70	36	for	for	IN
cord-321267-ihd30qi0	70	37	which	which	WDT
cord-321267-ihd30qi0	70	38	usage	usage	NN
cord-321267-ihd30qi0	70	39	data	datum	NNS
cord-321267-ihd30qi0	70	40	is	be	VBZ
cord-321267-ihd30qi0	70	41	collected	collect	VBN
cord-321267-ihd30qi0	70	42	.	.	.
cord-321267-ihd30qi0	71	1	The	the	DT
cord-321267-ihd30qi0	71	2	importance	importance	NN
cord-321267-ihd30qi0	71	3	of	of	IN
cord-321267-ihd30qi0	71	4	avoiding	avoid	VBG
cord-321267-ihd30qi0	71	5	cognitive	cognitive	JJ
cord-321267-ihd30qi0	71	6	bias	bias	NN
cord-321267-ihd30qi0	71	7	is	be	VBZ
cord-321267-ihd30qi0	71	8	shown	show	VBN
cord-321267-ihd30qi0	71	9	by	by	IN
cord-321267-ihd30qi0	71	10	the	the	DT
cord-321267-ihd30qi0	71	11	evolving	evolve	VBG
cord-321267-ihd30qi0	71	12	knowledge	knowledge	NN
cord-321267-ihd30qi0	71	13	of	of	IN
cord-321267-ihd30qi0	71	14	SARS	SARS	NNP
cord-321267-ihd30qi0	71	15	-	-	HYPH
cord-321267-ihd30qi0	71	16	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	71	17	infection	infection	NN
cord-321267-ihd30qi0	71	18	,	,	,
cord-321267-ihd30qi0	71	19	where	where	WRB
cord-321267-ihd30qi0	71	20	a	a	DT
cord-321267-ihd30qi0	71	21	major	major	JJ
cord-321267-ihd30qi0	71	22	route	route	NN
cord-321267-ihd30qi0	71	23	of	of	IN
cord-321267-ihd30qi0	71	24	infection	infection	NN
cord-321267-ihd30qi0	71	25	is	be	VBZ
cord-321267-ihd30qi0	71	26	believed	believe	VBN
cord-321267-ihd30qi0	71	27	to	to	TO
cord-321267-ihd30qi0	71	28	be	be	VB
cord-321267-ihd30qi0	71	29	pulmonary	pulmonary	JJ
cord-321267-ihd30qi0	72	1	(	(	-LRB-
cord-321267-ihd30qi0	72	2	via	via	IN
cord-321267-ihd30qi0	72	3	angiotensin	angiotensin	NN
cord-321267-ihd30qi0	72	4	converting	convert	VBG
cord-321267-ihd30qi0	72	5	enzyme	enzyme	NN
cord-321267-ihd30qi0	72	6	2	2	CD
cord-321267-ihd30qi0	72	7	-ACE2	-ACE2	NNP
cord-321267-ihd30qi0	72	8	-receptors	-receptors	NNP
cord-321267-ihd30qi0	72	9	)	)	-RRB-
cord-321267-ihd30qi0	72	10	,	,	,
cord-321267-ihd30qi0	72	11	leading	lead	VBG
cord-321267-ihd30qi0	72	12	to	to	IN
cord-321267-ihd30qi0	72	13	severe	severe	JJ
cord-321267-ihd30qi0	72	14	respiratory	respiratory	JJ
cord-321267-ihd30qi0	72	15	inflammation	inflammation	NN
cord-321267-ihd30qi0	72	16	.	.	.
cord-321267-ihd30qi0	73	1	But	but	CC
cord-321267-ihd30qi0	73	2	ACE2	ACE2	NNP
cord-321267-ihd30qi0	73	3	receptors	receptor	NNS
cord-321267-ihd30qi0	73	4	not	not	RB
cord-321267-ihd30qi0	73	5	only	only	RB
cord-321267-ihd30qi0	73	6	populate	populate	VBP
cord-321267-ihd30qi0	73	7	alveolar	alveolar	JJ
cord-321267-ihd30qi0	73	8	epithelial	epithelial	JJ
cord-321267-ihd30qi0	73	9	cells	cell	NNS
cord-321267-ihd30qi0	73	10	,	,	,
cord-321267-ihd30qi0	73	11	but	but	CC
cord-321267-ihd30qi0	73	12	also	also	RB
cord-321267-ihd30qi0	73	13	endothelial	endothelial	JJ
cord-321267-ihd30qi0	73	14	cells	cell	NNS
cord-321267-ihd30qi0	73	15	,	,	,
cord-321267-ihd30qi0	73	16	which	which	WDT
cord-321267-ihd30qi0	73	17	means	mean	VBZ
cord-321267-ihd30qi0	73	18	that	that	IN
cord-321267-ihd30qi0	73	19	various	various	JJ
cord-321267-ihd30qi0	73	20	organs	organ	NNS
cord-321267-ihd30qi0	73	21	and	and	CC
cord-321267-ihd30qi0	73	22	blood	blood	NN
cord-321267-ihd30qi0	73	23	vessels	vessel	NNS
cord-321267-ihd30qi0	73	24	are	be	VBP
cord-321267-ihd30qi0	73	25	vulnerable	vulnerable	JJ
cord-321267-ihd30qi0	73	26	to	to	IN
cord-321267-ihd30qi0	73	27	inflammatory	inflammatory	JJ
cord-321267-ihd30qi0	73	28	damage	damage	NN
cord-321267-ihd30qi0	73	29	and	and	CC
cord-321267-ihd30qi0	73	30	clotting	clotting	NN
cord-321267-ihd30qi0	73	31	(	(	-LRB-
cord-321267-ihd30qi0	73	32	Phend	Phend	NNP
cord-321267-ihd30qi0	73	33	2020	2020	CD
cord-321267-ihd30qi0	73	34	)	)	-RRB-
cord-321267-ihd30qi0	73	35	.	.	.
cord-321267-ihd30qi0	74	1	The	the	DT
cord-321267-ihd30qi0	74	2	collected	collect	VBN
cord-321267-ihd30qi0	74	3	data	datum	NNS
cord-321267-ihd30qi0	74	4	would	would	MD
cord-321267-ihd30qi0	74	5	be	be	VB
cord-321267-ihd30qi0	74	6	entered	enter	VBN
cord-321267-ihd30qi0	74	7	into	into	IN
cord-321267-ihd30qi0	74	8	a	a	DT
cord-321267-ihd30qi0	74	9	computer	computer	NN
cord-321267-ihd30qi0	74	10	app	app	NN
cord-321267-ihd30qi0	74	11	that	that	WDT
cord-321267-ihd30qi0	74	12	transmits	transmit	VBZ
cord-321267-ihd30qi0	74	13	to	to	IN
cord-321267-ihd30qi0	74	14	a	a	DT
cord-321267-ihd30qi0	74	15	central	central	JJ
cord-321267-ihd30qi0	74	16	,	,	,
cord-321267-ihd30qi0	74	17	national	national	JJ
cord-321267-ihd30qi0	74	18	relational	relational	JJ
cord-321267-ihd30qi0	74	19	database	database	NN
cord-321267-ihd30qi0	74	20	pre	pre	VBN
cord-321267-ihd30qi0	74	21	-	-	VBN
cord-321267-ihd30qi0	74	22	populated	populated	JJ
cord-321267-ihd30qi0	74	23	with	with	IN
cord-321267-ihd30qi0	74	24	generic	generic	JJ
cord-321267-ihd30qi0	74	25	and	and	CC
cord-321267-ihd30qi0	74	26	trade	trade	NN
cord-321267-ihd30qi0	74	27	drug	drug	NN
cord-321267-ihd30qi0	74	28	names	name	NNS
cord-321267-ihd30qi0	74	29	cross	cross	VBP
cord-321267-ihd30qi0	74	30	-	-	VBD
cord-321267-ihd30qi0	74	31	referenced	reference	VBN
cord-321267-ihd30qi0	74	32	to	to	IN
cord-321267-ihd30qi0	74	33	their	-PRON-	PRP$
cord-321267-ihd30qi0	74	34	respective	respective	JJ
cord-321267-ihd30qi0	74	35	unique	unique	JJ
cord-321267-ihd30qi0	74	36	molecular	molecular	JJ
cord-321267-ihd30qi0	74	37	entities	entity	NNS
cord-321267-ihd30qi0	74	38	.	.	.
cord-321267-ihd30qi0	75	1	This	this	DT
cord-321267-ihd30qi0	75	2	would	would	MD
cord-321267-ihd30qi0	75	3	speed	speed	VB
cord-321267-ihd30qi0	75	4	data	datum	NNS
cord-321267-ihd30qi0	75	5	entry	entry	NN
cord-321267-ihd30qi0	75	6	,	,	,
cord-321267-ihd30qi0	75	7	ensure	ensure	VB
cord-321267-ihd30qi0	75	8	consistent	consistent	JJ
cord-321267-ihd30qi0	75	9	spelling	spelling	NN
cord-321267-ihd30qi0	75	10	,	,	,
cord-321267-ihd30qi0	75	11	and	and	CC
cord-321267-ihd30qi0	75	12	account	account	VBP
cord-321267-ihd30qi0	75	13	for	for	IN
cord-321267-ihd30qi0	75	14	multiple	multiple	JJ
cord-321267-ihd30qi0	75	15	drug	drug	NN
cord-321267-ihd30qi0	75	16	names	name	NNS
cord-321267-ihd30qi0	75	17	that	that	WDT
cord-321267-ihd30qi0	75	18	correspond	correspond	VBP
cord-321267-ihd30qi0	75	19	to	to	IN
cord-321267-ihd30qi0	75	20	the	the	DT
cord-321267-ihd30qi0	75	21	same	same	JJ
cord-321267-ihd30qi0	75	22	molecular	molecular	JJ
cord-321267-ihd30qi0	75	23	entity	entity	NN
cord-321267-ihd30qi0	75	24	.	.	.
cord-321267-ihd30qi0	76	1	Note	note	VB
cord-321267-ihd30qi0	76	2	that	that	IN
cord-321267-ihd30qi0	76	3	it	-PRON-	PRP
cord-321267-ihd30qi0	76	4	can	can	MD
cord-321267-ihd30qi0	76	5	be	be	VB
cord-321267-ihd30qi0	76	6	very	very	RB
cord-321267-ihd30qi0	76	7	challenging	challenging	JJ
cord-321267-ihd30qi0	76	8	to	to	TO
cord-321267-ihd30qi0	76	9	compile	compile	VB
cord-321267-ihd30qi0	76	10	a	a	DT
cord-321267-ihd30qi0	76	11	comprehensive	comprehensive	JJ
cord-321267-ihd30qi0	76	12	list	list	NN
cord-321267-ihd30qi0	76	13	of	of	IN
cord-321267-ihd30qi0	76	14	unique	unique	JJ
cord-321267-ihd30qi0	76	15	molecular	molecular	JJ
cord-321267-ihd30qi0	76	16	entities	entity	NNS
cord-321267-ihd30qi0	76	17	just	just	RB
cord-321267-ihd30qi0	76	18	for	for	IN
cord-321267-ihd30qi0	76	19	smallmolecule	smallmolecule	JJ
cord-321267-ihd30qi0	76	20	drugs	drug	NNS
cord-321267-ihd30qi0	77	1	(	(	-LRB-
cord-321267-ihd30qi0	77	2	Kinch	Kinch	NNP
cord-321267-ihd30qi0	77	3	et	et	NNP
cord-321267-ihd30qi0	77	4	al	al	NNP
cord-321267-ihd30qi0	77	5	.	.	NNP
cord-321267-ihd30qi0	77	6	2014	2014	CD
cord-321267-ihd30qi0	77	7	)	)	-RRB-
cord-321267-ihd30qi0	77	8	.	.	.
cord-321267-ihd30qi0	78	1	Biologics	biologic	NNS
cord-321267-ihd30qi0	78	2	and	and	CC
cord-321267-ihd30qi0	78	3	biosimilars	biosimilar	NNS
cord-321267-ihd30qi0	78	4	would	would	MD
cord-321267-ihd30qi0	78	5	present	present	VB
cord-321267-ihd30qi0	78	6	their	-PRON-	PRP$
cord-321267-ihd30qi0	78	7	own	own	JJ
cord-321267-ihd30qi0	78	8	challenges	challenge	NNS
cord-321267-ihd30qi0	78	9	(	(	-LRB-
cord-321267-ihd30qi0	78	10	e.g.	e.g.	RB
cord-321267-ihd30qi0	78	11	,	,	,
cord-321267-ihd30qi0	78	12	see	see	VB
cord-321267-ihd30qi0	78	13	:	:	:
cord-321267-ihd30qi0	78	14	Dabrowska	Dabrowska	NNP
cord-321267-ihd30qi0	78	15	2019	2019	CD
cord-321267-ihd30qi0	78	16	)	)	-RRB-
cord-321267-ihd30qi0	78	17	.	.	.
cord-321267-ihd30qi0	79	1	(	(	-LRB-
cord-321267-ihd30qi0	79	2	2	2	LS
cord-321267-ihd30qi0	79	3	)	)	-RRB-
cord-321267-ihd30qi0	79	4	For	for	IN
cord-321267-ihd30qi0	79	5	each	each	DT
cord-321267-ihd30qi0	79	6	of	of	IN
cord-321267-ihd30qi0	79	7	the	the	DT
cord-321267-ihd30qi0	79	8	three	three	CD
cord-321267-ihd30qi0	79	9	test	test	NN
cord-321267-ihd30qi0	79	10	groups	group	NNS
cord-321267-ihd30qi0	79	11	,	,	,
cord-321267-ihd30qi0	79	12	the	the	DT
cord-321267-ihd30qi0	79	13	collective	collective	JJ
cord-321267-ihd30qi0	79	14	percent	percent	NN
cord-321267-ihd30qi0	79	15	-	-	HYPH
cord-321267-ihd30qi0	79	16	usage	usage	NN
cord-321267-ihd30qi0	79	17	rate	rate	NN
cord-321267-ihd30qi0	79	18	of	of	IN
cord-321267-ihd30qi0	79	19	each	each	DT
cord-321267-ihd30qi0	79	20	drug	drug	NN
cord-321267-ihd30qi0	79	21	(	(	-LRB-
cord-321267-ihd30qi0	79	22	D	D	NNP
cord-321267-ihd30qi0	79	23	x	x	SYM
cord-321267-ihd30qi0	79	24	UR	UR	NNP
cord-321267-ihd30qi0	79	25	)	)	-RRB-
cord-321267-ihd30qi0	79	26	would	would	MD
cord-321267-ihd30qi0	79	27	be	be	VB
cord-321267-ihd30qi0	79	28	continually	continually	RB
cord-321267-ihd30qi0	79	29	updated	update	VBN
cord-321267-ihd30qi0	79	30	in	in	IN
cord-321267-ihd30qi0	79	31	real	real	JJ
cord-321267-ihd30qi0	79	32	-	-	HYPH
cord-321267-ihd30qi0	79	33	time	time	NN
cord-321267-ihd30qi0	79	34	.	.	.
cord-321267-ihd30qi0	80	1	Percentages	percentage	NNS
cord-321267-ihd30qi0	80	2	could	could	MD
cord-321267-ihd30qi0	80	3	also	also	RB
cord-321267-ihd30qi0	80	4	be	be	VB
cord-321267-ihd30qi0	80	5	calculated	calculate	VBN
cord-321267-ihd30qi0	80	6	for	for	IN
cord-321267-ihd30qi0	80	7	sub	sub	NN
cord-321267-ihd30qi0	80	8	-	-	NNS
cord-321267-ihd30qi0	80	9	groups	group	NNS
cord-321267-ihd30qi0	80	10	,	,	,
cord-321267-ihd30qi0	80	11	determined	determine	VBN
cord-321267-ihd30qi0	80	12	by	by	IN
cord-321267-ihd30qi0	80	13	the	the	DT
cord-321267-ihd30qi0	80	14	spectrum	spectrum	NN
cord-321267-ihd30qi0	80	15	of	of	IN
cord-321267-ihd30qi0	80	16	severity	severity	NN
cord-321267-ihd30qi0	80	17	of	of	IN
cord-321267-ihd30qi0	80	18	clinical	clinical	JJ
cord-321267-ihd30qi0	80	19	status	status	NN
cord-321267-ihd30qi0	80	20	or	or	CC
cord-321267-ihd30qi0	80	21	outcomes	outcome	NNS
cord-321267-ihd30qi0	80	22	-ranging	-range	VBG
cord-321267-ihd30qi0	80	23	,	,	,
cord-321267-ihd30qi0	80	24	for	for	IN
cord-321267-ihd30qi0	80	25	example	example	NN
cord-321267-ihd30qi0	80	26	,	,	,
cord-321267-ihd30qi0	80	27	from	from	IN
cord-321267-ihd30qi0	80	28	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	80	29	,	,	,
cord-321267-ihd30qi0	80	30	mild	mild	JJ
cord-321267-ihd30qi0	80	31	,	,	,
cord-321267-ihd30qi0	80	32	moderate	moderate	JJ
cord-321267-ihd30qi0	80	33	,	,	,
cord-321267-ihd30qi0	80	34	severe	severe	JJ
cord-321267-ihd30qi0	80	35	,	,	,
cord-321267-ihd30qi0	80	36	critical	critical	JJ
cord-321267-ihd30qi0	80	37	,	,	,
cord-321267-ihd30qi0	80	38	and	and	CC
cord-321267-ihd30qi0	80	39	death	death	NN
cord-321267-ihd30qi0	80	40	.	.	.
cord-321267-ihd30qi0	81	1	Note	note	VB
cord-321267-ihd30qi0	81	2	that	that	IN
cord-321267-ihd30qi0	81	3	the	the	DT
cord-321267-ihd30qi0	81	4	population	population	NN
cord-321267-ihd30qi0	81	5	-	-	HYPH
cord-321267-ihd30qi0	81	6	wide	wide	JJ
cord-321267-ihd30qi0	81	7	incidence	incidence	NN
cord-321267-ihd30qi0	81	8	of	of	IN
cord-321267-ihd30qi0	81	9	"	"	``
cord-321267-ihd30qi0	81	10	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	81	11	"	"	''
cord-321267-ihd30qi0	81	12	Covid-19	covid-19	NN
cord-321267-ihd30qi0	81	13	cases	case	NNS
cord-321267-ihd30qi0	81	14	(	(	-LRB-
cord-321267-ihd30qi0	81	15	where	where	WRB
cord-321267-ihd30qi0	81	16	no	no	DT
cord-321267-ihd30qi0	81	17	symptoms	symptom	NNS
cord-321267-ihd30qi0	81	18	are	be	VBP
cord-321267-ihd30qi0	81	19	noted	note	VBN
cord-321267-ihd30qi0	81	20	over	over	IN
cord-321267-ihd30qi0	81	21	the	the	DT
cord-321267-ihd30qi0	81	22	entire	entire	JJ
cord-321267-ihd30qi0	81	23	course	course	NN
cord-321267-ihd30qi0	81	24	of	of	IN
cord-321267-ihd30qi0	81	25	the	the	DT
cord-321267-ihd30qi0	81	26	disease	disease	NN
cord-321267-ihd30qi0	81	27	)	)	-RRB-
cord-321267-ihd30qi0	81	28	has	have	VBZ
cord-321267-ihd30qi0	81	29	yet	yet	RB
cord-321267-ihd30qi0	81	30	to	to	TO
cord-321267-ihd30qi0	81	31	be	be	VB
cord-321267-ihd30qi0	81	32	determined	determine	VBN
cord-321267-ihd30qi0	82	1	(	(	-LRB-
cord-321267-ihd30qi0	82	2	e.g.	e.g.	RB
cord-321267-ihd30qi0	82	3	,	,	,
cord-321267-ihd30qi0	82	4	see	see	VB
cord-321267-ihd30qi0	82	5	:	:	:
cord-321267-ihd30qi0	83	1	Lippi	Lippi	NNP
cord-321267-ihd30qi0	83	2	et	et	NNP
cord-321267-ihd30qi0	83	3	al	al	NNP
cord-321267-ihd30qi0	83	4	.	.	NNP
cord-321267-ihd30qi0	83	5	2020	2020	CD
cord-321267-ihd30qi0	83	6	)	)	-RRB-
cord-321267-ihd30qi0	83	7	;	;	:
cord-321267-ihd30qi0	83	8	also	also	RB
cord-321267-ihd30qi0	83	9	note	note	VB
cord-321267-ihd30qi0	83	10	that	that	IN
cord-321267-ihd30qi0	83	11	"	"	``
cord-321267-ihd30qi0	83	12	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	83	13	"	"	''
cord-321267-ihd30qi0	83	14	is	be	VBZ
cord-321267-ihd30qi0	83	15	used	use	VBN
cord-321267-ihd30qi0	83	16	in	in	IN
cord-321267-ihd30qi0	83	17	this	this	DT
cord-321267-ihd30qi0	83	18	presentation	presentation	NN
cord-321267-ihd30qi0	83	19	to	to	TO
cord-321267-ihd30qi0	83	20	encompass	encompass	VB
cord-321267-ihd30qi0	83	21	those	those	DT
cord-321267-ihd30qi0	83	22	who	who	WP
cord-321267-ihd30qi0	83	23	have	have	VBP
cord-321267-ihd30qi0	83	24	never	never	RB
cord-321267-ihd30qi0	83	25	been	be	VBN
cord-321267-ihd30qi0	83	26	infected	infect	VBN
cord-321267-ihd30qi0	83	27	as	as	RB
cord-321267-ihd30qi0	83	28	well	well	RB
cord-321267-ihd30qi0	83	29	as	as	IN
cord-321267-ihd30qi0	83	30	those	those	DT
cord-321267-ihd30qi0	83	31	with	with	IN
cord-321267-ihd30qi0	83	32	undetectable	undetectable	JJ
cord-321267-ihd30qi0	83	33	subclinical	subclinical	JJ
cord-321267-ihd30qi0	83	34	infections	infection	NNS
cord-321267-ihd30qi0	83	35	.	.	.
cord-321267-ihd30qi0	84	1	But	but	CC
cord-321267-ihd30qi0	84	2	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	84	3	cases	case	NNS
cord-321267-ihd30qi0	84	4	often	often	RB
cord-321267-ihd30qi0	84	5	progress	progress	VBP
cord-321267-ihd30qi0	84	6	to	to	IN
cord-321267-ihd30qi0	84	7	being	be	VBG
cord-321267-ihd30qi0	84	8	pre	pre	JJ
cord-321267-ihd30qi0	84	9	-	-	JJ
cord-321267-ihd30qi0	84	10	symptomatic	symptomatic	JJ
cord-321267-ihd30qi0	84	11	,	,	,
cord-321267-ihd30qi0	84	12	where	where	WRB
cord-321267-ihd30qi0	84	13	symptoms	symptom	NNS
cord-321267-ihd30qi0	84	14	become	become	VBP
cord-321267-ihd30qi0	84	15	evident	evident	JJ
cord-321267-ihd30qi0	84	16	days	day	NNS
cord-321267-ihd30qi0	84	17	after	after	IN
cord-321267-ihd30qi0	84	18	testing	test	VBG
cord-321267-ihd30qi0	84	19	positive	positive	JJ
cord-321267-ihd30qi0	84	20	.	.	.
cord-321267-ihd30qi0	85	1	This	this	DT
cord-321267-ihd30qi0	85	2	distinction	distinction	NN
cord-321267-ihd30qi0	85	3	,	,	,
cord-321267-ihd30qi0	85	4	however	however	RB
cord-321267-ihd30qi0	85	5	,	,	,
cord-321267-ihd30qi0	85	6	does	do	VBZ
cord-321267-ihd30qi0	85	7	not	not	RB
cord-321267-ihd30qi0	85	8	matter	matter	VB
cord-321267-ihd30qi0	85	9	for	for	IN
cord-321267-ihd30qi0	85	10	NERD	NERD	NNP
cord-321267-ihd30qi0	85	11	,	,	,
cord-321267-ihd30qi0	85	12	as	as	IN
cord-321267-ihd30qi0	85	13	all	all	DT
cord-321267-ihd30qi0	85	14	of	of	IN
cord-321267-ihd30qi0	85	15	J	J	NNP
cord-321267-ihd30qi0	85	16	o	o	NNP
cord-321267-ihd30qi0	85	17	u	u	NN
cord-321267-ihd30qi0	85	18	r	r	NNP
cord-321267-ihd30qi0	85	19	n	n	NN
cord-321267-ihd30qi0	85	20	a	a	DT
cord-321267-ihd30qi0	85	21	l	l	NN
cord-321267-ihd30qi0	85	22	P	p	NN
cord-321267-ihd30qi0	85	23	r	r	NN
cord-321267-ihd30qi0	85	24	e	e	NN
cord-321267-ihd30qi0	85	25	-p	-p	NN
cord-321267-ihd30qi0	86	1	r	r	NN
cord-321267-ihd30qi0	86	2	o	o	NN
cord-321267-ihd30qi0	86	3	o	o	NN
cord-321267-ihd30qi0	87	1	f	f	LS
cord-321267-ihd30qi0	87	2	page	page	NN
cord-321267-ihd30qi0	87	3	5	5	CD
cord-321267-ihd30qi0	87	4	of	of	IN
cord-321267-ihd30qi0	87	5	16	16	CD
cord-321267-ihd30qi0	87	6	10	10	CD
cord-321267-ihd30qi0	87	7	April	April	NNP
cord-321267-ihd30qi0	87	8	2020	2020	CD
cord-321267-ihd30qi0	87	9	(	(	-LRB-
cord-321267-ihd30qi0	87	10	revised	revise	VBN
cord-321267-ihd30qi0	87	11	11	11	CD
cord-321267-ihd30qi0	87	12	May	May	NNP
cord-321267-ihd30qi0	87	13	)	)	-RRB-
cord-321267-ihd30qi0	87	14	draft	draft	VB
cord-321267-ihd30qi0	87	15	for	for	IN
cord-321267-ihd30qi0	87	16	Global	Global	NNP
cord-321267-ihd30qi0	87	17	Epidemiology	Epidemiology	NNP
cord-321267-ihd30qi0	87	18	Christian	Christian	NNP
cord-321267-ihd30qi0	87	19	G.	G.	NNP
cord-321267-ihd30qi0	87	20	Daughton	Daughton	NNP
cord-321267-ihd30qi0	87	21	these	these	DT
cord-321267-ihd30qi0	87	22	cases	case	NNS
cord-321267-ihd30qi0	87	23	can	can	MD
cord-321267-ihd30qi0	87	24	be	be	VB
cord-321267-ihd30qi0	87	25	considered	consider	VBN
cord-321267-ihd30qi0	87	26	positive	positive	JJ
cord-321267-ihd30qi0	87	27	for	for	IN
cord-321267-ihd30qi0	87	28	infection	infection	NN
cord-321267-ihd30qi0	87	29	.	.	.
cord-321267-ihd30qi0	88	1	So	so	RB
cord-321267-ihd30qi0	88	2	the	the	DT
cord-321267-ihd30qi0	88	3	term	term	NN
cord-321267-ihd30qi0	88	4	"	"	``
cord-321267-ihd30qi0	88	5	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	88	6	"	"	''
cord-321267-ihd30qi0	88	7	will	will	MD
cord-321267-ihd30qi0	88	8	be	be	VB
cord-321267-ihd30qi0	88	9	used	use	VBN
cord-321267-ihd30qi0	88	10	here	here	RB
cord-321267-ihd30qi0	88	11	.	.	.
cord-321267-ihd30qi0	89	1	(	(	-LRB-
cord-321267-ihd30qi0	89	2	3	3	LS
cord-321267-ihd30qi0	89	3	)	)	-RRB-
cord-321267-ihd30qi0	90	1	The	the	DT
cord-321267-ihd30qi0	90	2	D	d	NN
cord-321267-ihd30qi0	90	3	x	x	NN
cord-321267-ihd30qi0	90	4	UR	ur	NN
cord-321267-ihd30qi0	90	5	for	for	IN
cord-321267-ihd30qi0	90	6	each	each	DT
cord-321267-ihd30qi0	90	7	group	group	NN
cord-321267-ihd30qi0	90	8	(	(	-LRB-
cord-321267-ihd30qi0	90	9	and	and	CC
cord-321267-ihd30qi0	90	10	subgroups	subgroup	NNS
cord-321267-ihd30qi0	90	11	)	)	-RRB-
cord-321267-ihd30qi0	90	12	would	would	MD
cord-321267-ihd30qi0	90	13	then	then	RB
cord-321267-ihd30qi0	90	14	be	be	VB
cord-321267-ihd30qi0	90	15	statistically	statistically	RB
cord-321267-ihd30qi0	90	16	compared	compare	VBN
cord-321267-ihd30qi0	90	17	with	with	IN
cord-321267-ihd30qi0	90	18	each	each	DT
cord-321267-ihd30qi0	90	19	other	other	JJ
cord-321267-ihd30qi0	90	20	;	;	:
cord-321267-ihd30qi0	90	21	alternative	alternative	JJ
cord-321267-ihd30qi0	90	22	comparisons	comparison	NNS
cord-321267-ihd30qi0	90	23	might	may	MD
cord-321267-ihd30qi0	90	24	be	be	VB
cord-321267-ihd30qi0	90	25	with	with	IN
cord-321267-ihd30qi0	90	26	the	the	DT
cord-321267-ihd30qi0	90	27	known	know	VBN
cord-321267-ihd30qi0	90	28	rates	rate	NNS
cord-321267-ihd30qi0	90	29	of	of	IN
cord-321267-ihd30qi0	90	30	general	general	JJ
cord-321267-ihd30qi0	90	31	population	population	NN
cord-321267-ihd30qi0	90	32	use	use	NN
cord-321267-ihd30qi0	90	33	of	of	IN
cord-321267-ihd30qi0	90	34	each	each	DT
cord-321267-ihd30qi0	90	35	legend	legend	NN
cord-321267-ihd30qi0	90	36	drug	drug	NN
cord-321267-ihd30qi0	90	37	,	,	,
cord-321267-ihd30qi0	90	38	or	or	CC
cord-321267-ihd30qi0	90	39	the	the	DT
cord-321267-ihd30qi0	90	40	estimated	estimate	VBN
cord-321267-ihd30qi0	90	41	population	population	NN
cord-321267-ihd30qi0	90	42	-	-	HYPH
cord-321267-ihd30qi0	90	43	wide	wide	JJ
cord-321267-ihd30qi0	90	44	use	use	NN
cord-321267-ihd30qi0	90	45	of	of	IN
cord-321267-ihd30qi0	90	46	each	each	DT
cord-321267-ihd30qi0	90	47	non	non	JJ
cord-321267-ihd30qi0	90	48	-	-	JJ
cord-321267-ihd30qi0	90	49	legend	legend	JJ
cord-321267-ihd30qi0	90	50	drug	drug	NN
cord-321267-ihd30qi0	90	51	.	.	.
cord-321267-ihd30qi0	91	1	(	(	-LRB-
cord-321267-ihd30qi0	91	2	4	4	LS
cord-321267-ihd30qi0	91	3	)	)	-RRB-
cord-321267-ihd30qi0	91	4	Potential	potential	JJ
cord-321267-ihd30qi0	91	5	drug	drug	NN
cord-321267-ihd30qi0	91	6	candidates	candidate	NNS
cord-321267-ihd30qi0	91	7	would	would	MD
cord-321267-ihd30qi0	91	8	be	be	VB
cord-321267-ihd30qi0	91	9	revealed	reveal	VBN
cord-321267-ihd30qi0	91	10	by	by	IN
cord-321267-ihd30qi0	91	11	whether	whether	IN
cord-321267-ihd30qi0	91	12	D	D	NNP
cord-321267-ihd30qi0	91	13	x	x	SYM
cord-321267-ihd30qi0	91	14	UR	UR	NNP
cord-321267-ihd30qi0	91	15	distributions	distribution	NNS
cord-321267-ihd30qi0	91	16	are	be	VBP
cord-321267-ihd30qi0	91	17	significantly	significantly	RB
cord-321267-ihd30qi0	91	18	skewed	skewed	JJ
cord-321267-ihd30qi0	91	19	within	within	IN
cord-321267-ihd30qi0	91	20	the	the	DT
cord-321267-ihd30qi0	91	21	major	major	JJ
cord-321267-ihd30qi0	91	22	case	case	NN
cord-321267-ihd30qi0	91	23	test	test	NN
cord-321267-ihd30qi0	91	24	groups	group	NNS
cord-321267-ihd30qi0	91	25	(	(	-LRB-
cord-321267-ihd30qi0	91	26	see	see	VB
cord-321267-ihd30qi0	91	27	"	"	``
cord-321267-ihd30qi0	91	28	Options	option	NNS
cord-321267-ihd30qi0	91	29	"	"	''
cord-321267-ihd30qi0	91	30	in	in	IN
cord-321267-ihd30qi0	91	31	Table	Table	NNP
cord-321267-ihd30qi0	91	32	1	1	CD
cord-321267-ihd30qi0	91	33	)	)	-RRB-
cord-321267-ihd30qi0	91	34	.	.	.
cord-321267-ihd30qi0	92	1	Normalized	normalized	JJ
cord-321267-ihd30qi0	92	2	usage	usage	NN
cord-321267-ihd30qi0	92	3	rates	rate	NNS
cord-321267-ihd30qi0	92	4	that	that	WDT
cord-321267-ihd30qi0	92	5	have	have	VBP
cord-321267-ihd30qi0	92	6	significant	significant	JJ
cord-321267-ihd30qi0	92	7	associations	association	NNS
cord-321267-ihd30qi0	92	8	with	with	IN
cord-321267-ihd30qi0	92	9	a	a	DT
cord-321267-ihd30qi0	92	10	particular	particular	JJ
cord-321267-ihd30qi0	92	11	group	group	NN
cord-321267-ihd30qi0	92	12	may	may	MD
cord-321267-ihd30qi0	92	13	have	have	VB
cord-321267-ihd30qi0	92	14	potential	potential	NN
cord-321267-ihd30qi0	92	15	for	for	IN
cord-321267-ihd30qi0	92	16	enhancing	enhance	VBG
cord-321267-ihd30qi0	92	17	protection	protection	NN
cord-321267-ihd30qi0	92	18	or	or	CC
cord-321267-ihd30qi0	92	19	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	92	20	outcomes	outcome	NNS
cord-321267-ihd30qi0	92	21	or	or	CC
cord-321267-ihd30qi0	92	22	,	,	,
cord-321267-ihd30qi0	92	23	alternatively	alternatively	RB
cord-321267-ihd30qi0	92	24	,	,	,
cord-321267-ihd30qi0	92	25	the	the	DT
cord-321267-ihd30qi0	92	26	potential	potential	NN
cord-321267-ihd30qi0	92	27	for	for	IN
cord-321267-ihd30qi0	92	28	increasing	increase	VBG
cord-321267-ihd30qi0	92	29	the	the	DT
cord-321267-ihd30qi0	92	30	risk	risk	NN
cord-321267-ihd30qi0	92	31	for	for	IN
cord-321267-ihd30qi0	92	32	developing	develop	VBG
cord-321267-ihd30qi0	92	33	overt	overt	JJ
cord-321267-ihd30qi0	92	34	signs	sign	NNS
cord-321267-ihd30qi0	92	35	of	of	IN
cord-321267-ihd30qi0	92	36	infection	infection	NN
cord-321267-ihd30qi0	92	37	or	or	CC
cord-321267-ihd30qi0	92	38	exacerbating	exacerbate	VBG
cord-321267-ihd30qi0	92	39	clinical	clinical	JJ
cord-321267-ihd30qi0	92	40	outcomes	outcome	NNS
cord-321267-ihd30qi0	92	41	.	.	.
cord-321267-ihd30qi0	93	1	The	the	DT
cord-321267-ihd30qi0	93	2	database	database	NN
cord-321267-ihd30qi0	93	3	would	would	MD
cord-321267-ihd30qi0	93	4	have	have	VB
cord-321267-ihd30qi0	93	5	to	to	TO
cord-321267-ihd30qi0	93	6	be	be	VB
cord-321267-ihd30qi0	93	7	coded	code	VBN
cord-321267-ihd30qi0	93	8	to	to	TO
cord-321267-ihd30qi0	93	9	account	account	VB
cord-321267-ihd30qi0	93	10	for	for	IN
cord-321267-ihd30qi0	93	11	patients	patient	NNS
cord-321267-ihd30qi0	93	12	who	who	WP
cord-321267-ihd30qi0	93	13	receive	receive	VBP
cord-321267-ihd30qi0	93	14	multiple	multiple	JJ
cord-321267-ihd30qi0	93	15	tests	test	NNS
cord-321267-ihd30qi0	93	16	.	.	.
cord-321267-ihd30qi0	94	1	Because	because	IN
cord-321267-ihd30qi0	94	2	of	of	IN
cord-321267-ihd30qi0	94	3	the	the	DT
cord-321267-ihd30qi0	94	4	natural	natural	JJ
cord-321267-ihd30qi0	94	5	heightened	heightened	JJ
cord-321267-ihd30qi0	94	6	rate	rate	NN
cord-321267-ihd30qi0	94	7	of	of	IN
cord-321267-ihd30qi0	94	8	mutation	mutation	NN
cord-321267-ihd30qi0	94	9	with	with	IN
cord-321267-ihd30qi0	94	10	RNA	RNA	NNP
cord-321267-ihd30qi0	94	11	viruses	virus	NNS
cord-321267-ihd30qi0	94	12	,	,	,
cord-321267-ihd30qi0	94	13	it	-PRON-	PRP
cord-321267-ihd30qi0	94	14	would	would	MD
cord-321267-ihd30qi0	94	15	be	be	VB
cord-321267-ihd30qi0	94	16	prove	prove	VB
cord-321267-ihd30qi0	94	17	important	important	JJ
cord-321267-ihd30qi0	94	18	to	to	TO
cord-321267-ihd30qi0	94	19	constantly	constantly	RB
cord-321267-ihd30qi0	94	20	re	re	VB
cord-321267-ihd30qi0	94	21	-	-	NN
cord-321267-ihd30qi0	94	22	screen	screen	VB
cord-321267-ihd30qi0	94	23	the	the	DT
cord-321267-ihd30qi0	94	24	same	same	JJ
cord-321267-ihd30qi0	94	25	universe	universe	NN
cord-321267-ihd30qi0	94	26	of	of	IN
cord-321267-ihd30qi0	94	27	existing	exist	VBG
cord-321267-ihd30qi0	94	28	drugs	drug	NNS
cord-321267-ihd30qi0	94	29	for	for	IN
cord-321267-ihd30qi0	94	30	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	94	31	efficacy	efficacy	NN
cord-321267-ihd30qi0	94	32	.	.	.
cord-321267-ihd30qi0	95	1	This	this	DT
cord-321267-ihd30qi0	95	2	would	would	MD
cord-321267-ihd30qi0	95	3	occur	occur	VB
cord-321267-ihd30qi0	95	4	automatically	automatically	RB
cord-321267-ihd30qi0	95	5	as	as	IN
cord-321267-ihd30qi0	95	6	the	the	DT
cord-321267-ihd30qi0	95	7	database	database	NN
cord-321267-ihd30qi0	95	8	is	be	VBZ
cord-321267-ihd30qi0	95	9	updated	update	VBN
cord-321267-ihd30qi0	95	10	in	in	IN
cord-321267-ihd30qi0	95	11	real	real	JJ
cord-321267-ihd30qi0	95	12	time	time	NN
cord-321267-ihd30qi0	95	13	.	.	.
cord-321267-ihd30qi0	96	1	(	(	-LRB-
cord-321267-ihd30qi0	96	2	5	5	LS
cord-321267-ihd30qi0	96	3	)	)	-RRB-
cord-321267-ihd30qi0	96	4	Interpretation	interpretation	NN
cord-321267-ihd30qi0	96	5	of	of	IN
cord-321267-ihd30qi0	96	6	NERD	NERD	NNP
cord-321267-ihd30qi0	96	7	data	datum	NNS
cord-321267-ihd30qi0	96	8	and	and	CC
cord-321267-ihd30qi0	96	9	defining	define	VBG
cord-321267-ihd30qi0	96	10	the	the	DT
cord-321267-ihd30qi0	96	11	Covid-19	covid-19	NN
cord-321267-ihd30qi0	96	12	test	test	NN
cord-321267-ihd30qi0	96	13	groups	group	NNS
cord-321267-ihd30qi0	96	14	of	of	IN
cord-321267-ihd30qi0	96	15	most	most	JJS
cord-321267-ihd30qi0	96	16	use	use	NN
cord-321267-ihd30qi0	96	17	to	to	IN
cord-321267-ihd30qi0	96	18	NERD	NERD	NNP
cord-321267-ihd30qi0	96	19	.	.	.
cord-321267-ihd30qi0	97	1	There	there	EX
cord-321267-ihd30qi0	97	2	are	be	VBP
cord-321267-ihd30qi0	97	3	currently	currently	RB
cord-321267-ihd30qi0	97	4	two	two	CD
cord-321267-ihd30qi0	97	5	general	general	JJ
cord-321267-ihd30qi0	97	6	categories	category	NNS
cord-321267-ihd30qi0	97	7	of	of	IN
cord-321267-ihd30qi0	97	8	tests	test	NNS
cord-321267-ihd30qi0	97	9	for	for	IN
cord-321267-ihd30qi0	97	10	Covid-19	covid-19	NN
cord-321267-ihd30qi0	97	11	:	:	:
cord-321267-ihd30qi0	97	12	tests	test	NNS
cord-321267-ihd30qi0	97	13	that	that	WDT
cord-321267-ihd30qi0	97	14	indicate	indicate	VBP
cord-321267-ihd30qi0	97	15	active	active	JJ
cord-321267-ihd30qi0	97	16	infection	infection	NN
cord-321267-ihd30qi0	97	17	and	and	CC
cord-321267-ihd30qi0	97	18	tests	test	NNS
cord-321267-ihd30qi0	97	19	that	that	WDT
cord-321267-ihd30qi0	97	20	primarily	primarily	RB
cord-321267-ihd30qi0	97	21	indicate	indicate	VBP
cord-321267-ihd30qi0	97	22	past	past	IN
cord-321267-ihd30qi0	97	23	infection	infection	NN
cord-321267-ihd30qi0	97	24	that	that	WDT
cord-321267-ihd30qi0	97	25	has	have	VBZ
cord-321267-ihd30qi0	97	26	resolved	resolve	VBN
cord-321267-ihd30qi0	97	27	.	.	.
cord-321267-ihd30qi0	98	1	The	the	DT
cord-321267-ihd30qi0	98	2	former	former	JJ
cord-321267-ihd30qi0	98	3	currently	currently	RB
cord-321267-ihd30qi0	98	4	relies	rely	VBZ
cord-321267-ihd30qi0	98	5	on	on	IN
cord-321267-ihd30qi0	98	6	RT	RT	NNP
cord-321267-ihd30qi0	98	7	-	-	HYPH
cord-321267-ihd30qi0	98	8	PCR	PCR	NNP
cord-321267-ihd30qi0	98	9	or	or	CC
cord-321267-ihd30qi0	98	10	antigen	antigen	NN
cord-321267-ihd30qi0	98	11	testing	testing	NN
cord-321267-ihd30qi0	98	12	,	,	,
cord-321267-ihd30qi0	98	13	and	and	CC
cord-321267-ihd30qi0	98	14	the	the	DT
cord-321267-ihd30qi0	98	15	latter	latter	JJ
cord-321267-ihd30qi0	98	16	relies	rely	VBZ
cord-321267-ihd30qi0	98	17	on	on	IN
cord-321267-ihd30qi0	98	18	serum	serum	NN
cord-321267-ihd30qi0	98	19	testing	testing	NN
cord-321267-ihd30qi0	98	20	for	for	IN
cord-321267-ihd30qi0	98	21	antibodies	antibody	NNS
cord-321267-ihd30qi0	98	22	to	to	IN
cord-321267-ihd30qi0	98	23	SARS	SARS	NNP
cord-321267-ihd30qi0	98	24	-	-	HYPH
cord-321267-ihd30qi0	98	25	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	98	26	;	;	:
cord-321267-ihd30qi0	98	27	conceivable	conceivable	JJ
cord-321267-ihd30qi0	98	28	future	future	JJ
cord-321267-ihd30qi0	98	29	tests	test	NNS
cord-321267-ihd30qi0	98	30	would	would	MD
cord-321267-ihd30qi0	98	31	be	be	VB
cord-321267-ihd30qi0	98	32	those	those	DT
cord-321267-ihd30qi0	98	33	predicting	predict	VBG
cord-321267-ihd30qi0	98	34	vulnerability	vulnerability	NN
cord-321267-ihd30qi0	98	35	to	to	IN
cord-321267-ihd30qi0	98	36	disease	disease	NN
cord-321267-ihd30qi0	98	37	progression	progression	NN
cord-321267-ihd30qi0	98	38	.	.	.
cord-321267-ihd30qi0	99	1	These	these	DT
cord-321267-ihd30qi0	99	2	two	two	CD
cord-321267-ihd30qi0	99	3	groups	group	NNS
cord-321267-ihd30qi0	99	4	provide	provide	VBP
cord-321267-ihd30qi0	99	5	complementary	complementary	JJ
cord-321267-ihd30qi0	99	6	information	information	NN
cord-321267-ihd30qi0	99	7	for	for	IN
cord-321267-ihd30qi0	99	8	clinical	clinical	JJ
cord-321267-ihd30qi0	99	9	,	,	,
cord-321267-ihd30qi0	99	10	epidemiological	epidemiological	JJ
cord-321267-ihd30qi0	99	11	,	,	,
cord-321267-ihd30qi0	99	12	and	and	CC
cord-321267-ihd30qi0	99	13	public	public	JJ
cord-321267-ihd30qi0	99	14	health	health	NN
cord-321267-ihd30qi0	99	15	purposes	purpose	NNS
cord-321267-ihd30qi0	99	16	.	.	.
cord-321267-ihd30qi0	100	1	For	for	IN
cord-321267-ihd30qi0	100	2	NERD	nerd	NN
cord-321267-ihd30qi0	100	3	,	,	,
cord-321267-ihd30qi0	100	4	however	however	RB
cord-321267-ihd30qi0	100	5	,	,	,
cord-321267-ihd30qi0	100	6	the	the	DT
cord-321267-ihd30qi0	100	7	drug	drug	NN
cord-321267-ihd30qi0	100	8	usage	usage	NN
cord-321267-ihd30qi0	100	9	data	datum	NNS
cord-321267-ihd30qi0	100	10	collected	collect	VBN
cord-321267-ihd30qi0	100	11	from	from	IN
cord-321267-ihd30qi0	100	12	these	these	DT
cord-321267-ihd30qi0	100	13	two	two	CD
cord-321267-ihd30qi0	100	14	approaches	approach	NNS
cord-321267-ihd30qi0	100	15	would	would	MD
cord-321267-ihd30qi0	100	16	yield	yield	VB
cord-321267-ihd30qi0	100	17	insights	insight	NNS
cord-321267-ihd30qi0	100	18	for	for	IN
cord-321267-ihd30qi0	100	19	the	the	DT
cord-321267-ihd30qi0	100	20	screening	screening	NN
cord-321267-ihd30qi0	100	21	of	of	IN
cord-321267-ihd30qi0	100	22	drugs	drug	NNS
cord-321267-ihd30qi0	100	23	with	with	IN
cord-321267-ihd30qi0	100	24	a	a	DT
cord-321267-ihd30qi0	100	25	higher	high	JJR
cord-321267-ihd30qi0	100	26	probability	probability	NN
cord-321267-ihd30qi0	100	27	of	of	IN
cord-321267-ihd30qi0	100	28	success	success	NN
cord-321267-ihd30qi0	100	29	in	in	IN
cord-321267-ihd30qi0	100	30	repurposing	repurposing	NN
cord-321267-ihd30qi0	100	31	.	.	.
cord-321267-ihd30qi0	101	1	A	a	DT
cord-321267-ihd30qi0	101	2	very	very	RB
cord-321267-ihd30qi0	101	3	limited	limited	JJ
cord-321267-ihd30qi0	101	4	number	number	NN
cord-321267-ihd30qi0	101	5	of	of	IN
cord-321267-ihd30qi0	101	6	possible	possible	JJ
cord-321267-ihd30qi0	101	7	combinations	combination	NNS
cord-321267-ihd30qi0	101	8	exist	exist	VBP
cord-321267-ihd30qi0	101	9	for	for	IN
cord-321267-ihd30qi0	101	10	how	how	WRB
cord-321267-ihd30qi0	101	11	case	case	NN
cord-321267-ihd30qi0	101	12	groups	group	NNS
cord-321267-ihd30qi0	101	13	can	can	MD
cord-321267-ihd30qi0	101	14	be	be	VB
cord-321267-ihd30qi0	101	15	defined	define	VBN
cord-321267-ihd30qi0	101	16	for	for	IN
cord-321267-ihd30qi0	101	17	use	use	NN
cord-321267-ihd30qi0	101	18	in	in	IN
cord-321267-ihd30qi0	101	19	NERD	nerd	NN
cord-321267-ihd30qi0	101	20	.	.	.
cord-321267-ihd30qi0	102	1	These	these	DT
cord-321267-ihd30qi0	102	2	groups	group	NNS
cord-321267-ihd30qi0	102	3	are	be	VBP
cord-321267-ihd30qi0	102	4	determined	determine	VBN
cord-321267-ihd30qi0	102	5	by	by	IN
cord-321267-ihd30qi0	102	6	the	the	DT
cord-321267-ihd30qi0	102	7	results	result	NNS
cord-321267-ihd30qi0	102	8	for	for	IN
cord-321267-ihd30qi0	102	9	each	each	DT
cord-321267-ihd30qi0	102	10	clinical	clinical	JJ
cord-321267-ihd30qi0	102	11	case	case	NN
cord-321267-ihd30qi0	102	12	and	and	CC
cord-321267-ihd30qi0	102	13	the	the	DT
cord-321267-ihd30qi0	102	14	type	type	NN
cord-321267-ihd30qi0	102	15	of	of	IN
cord-321267-ihd30qi0	102	16	testing	testing	NN
cord-321267-ihd30qi0	102	17	used	use	VBN
cord-321267-ihd30qi0	102	18	:	:	:
cord-321267-ihd30qi0	102	19	(	(	-LRB-
cord-321267-ihd30qi0	102	20	1	1	LS
cord-321267-ihd30qi0	102	21	)	)	-RRB-
cord-321267-ihd30qi0	102	22	positive	positive	JJ
cord-321267-ihd30qi0	102	23	or	or	CC
cord-321267-ihd30qi0	102	24	negative	negative	JJ
cord-321267-ihd30qi0	102	25	for	for	IN
cord-321267-ihd30qi0	102	26	active	active	JJ
cord-321267-ihd30qi0	102	27	infection	infection	NN
cord-321267-ihd30qi0	102	28	,	,	,
cord-321267-ihd30qi0	102	29	(	(	-LRB-
cord-321267-ihd30qi0	102	30	2	2	LS
cord-321267-ihd30qi0	102	31	)	)	-RRB-
cord-321267-ihd30qi0	102	32	positive	positive	JJ
cord-321267-ihd30qi0	102	33	or	or	CC
cord-321267-ihd30qi0	102	34	negative	negative	JJ
cord-321267-ihd30qi0	102	35	for	for	IN
cord-321267-ihd30qi0	102	36	past	past	JJ
cord-321267-ihd30qi0	102	37	infection	infection	NN
cord-321267-ihd30qi0	102	38	(	(	-LRB-
cord-321267-ihd30qi0	102	39	i.e.	i.e.	FW
cord-321267-ihd30qi0	102	40	,	,	,
cord-321267-ihd30qi0	102	41	past	past	JJ
cord-321267-ihd30qi0	102	42	infections	infection	NNS
cord-321267-ihd30qi0	102	43	that	that	WDT
cord-321267-ihd30qi0	102	44	resolved	resolve	VBD
cord-321267-ihd30qi0	102	45	via	via	IN
cord-321267-ihd30qi0	102	46	immune	immune	JJ
cord-321267-ihd30qi0	102	47	response	response	NN
cord-321267-ihd30qi0	102	48	with	with	IN
cord-321267-ihd30qi0	102	49	display	display	NN
cord-321267-ihd30qi0	102	50	of	of	IN
cord-321267-ihd30qi0	102	51	little	little	JJ
cord-321267-ihd30qi0	102	52	symptomology	symptomology	NN
cord-321267-ihd30qi0	102	53	)	)	-RRB-
cord-321267-ihd30qi0	102	54	,	,	,
cord-321267-ihd30qi0	102	55	and	and	CC
cord-321267-ihd30qi0	102	56	(	(	-LRB-
cord-321267-ihd30qi0	102	57	3	3	LS
cord-321267-ihd30qi0	102	58	)	)	-RRB-
cord-321267-ihd30qi0	102	59	where	where	WRB
cord-321267-ihd30qi0	102	60	the	the	DT
cord-321267-ihd30qi0	102	61	case	case	NN
cord-321267-ihd30qi0	102	62	resides	reside	VBZ
cord-321267-ihd30qi0	102	63	on	on	IN
cord-321267-ihd30qi0	102	64	a	a	DT
cord-321267-ihd30qi0	102	65	morbidity	morbidity	NN
cord-321267-ihd30qi0	102	66	spectrum	spectrum	NN
cord-321267-ihd30qi0	102	67	ranging	range	VBG
cord-321267-ihd30qi0	102	68	from	from	IN
cord-321267-ihd30qi0	102	69	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	102	70	,	,	,
cord-321267-ihd30qi0	102	71	to	to	TO
cord-321267-ihd30qi0	102	72	mild	mild	JJ
cord-321267-ihd30qi0	102	73	signs	sign	NNS
cord-321267-ihd30qi0	102	74	and	and	CC
cord-321267-ihd30qi0	102	75	symptoms	symptom	NNS
cord-321267-ihd30qi0	102	76	,	,	,
cord-321267-ihd30qi0	102	77	to	to	IN
cord-321267-ihd30qi0	102	78	severe	severe	JJ
cord-321267-ihd30qi0	102	79	complications	complication	NNS
cord-321267-ihd30qi0	102	80	,	,	,
cord-321267-ihd30qi0	102	81	to	to	IN
cord-321267-ihd30qi0	102	82	death	death	NN
cord-321267-ihd30qi0	102	83	(	(	-LRB-
cord-321267-ihd30qi0	102	84	refer	refer	NN
cord-321267-ihd30qi0	102	85	to	to	IN
cord-321267-ihd30qi0	102	86	Table	table	NN
cord-321267-ihd30qi0	102	87	1	1	CD
cord-321267-ihd30qi0	102	88	)	)	-RRB-
cord-321267-ihd30qi0	102	89	.	.	.
cord-321267-ihd30qi0	103	1	While	while	IN
cord-321267-ihd30qi0	103	2	there	there	EX
cord-321267-ihd30qi0	103	3	are	be	VBP
cord-321267-ihd30qi0	103	4	two	two	CD
cord-321267-ihd30qi0	103	5	overarching	overarching	JJ
cord-321267-ihd30qi0	103	6	test	test	NN
cord-321267-ihd30qi0	103	7	groups	group	NNS
cord-321267-ihd30qi0	103	8	with	with	IN
cord-321267-ihd30qi0	103	9	respect	respect	NN
cord-321267-ihd30qi0	103	10	to	to	IN
cord-321267-ihd30qi0	103	11	all	all	DT
cord-321267-ihd30qi0	103	12	suspected	suspect	VBN
cord-321267-ihd30qi0	103	13	cases	case	NNS
cord-321267-ihd30qi0	103	14	(	(	-LRB-
cord-321267-ihd30qi0	103	15	positive	positive	JJ
cord-321267-ihd30qi0	103	16	and	and	CC
cord-321267-ihd30qi0	103	17	negative	negative	JJ
cord-321267-ihd30qi0	103	18	)	)	-RRB-
cord-321267-ihd30qi0	103	19	,	,	,
cord-321267-ihd30qi0	103	20	there	there	EX
cord-321267-ihd30qi0	103	21	are	be	VBP
cord-321267-ihd30qi0	103	22	three	three	CD
cord-321267-ihd30qi0	103	23	major	major	JJ
cord-321267-ihd30qi0	103	24	types	type	NNS
cord-321267-ihd30qi0	103	25	of	of	IN
cord-321267-ihd30qi0	103	26	tests	test	NNS
cord-321267-ihd30qi0	103	27	:	:	:
cord-321267-ihd30qi0	103	28	molecular	molecular	JJ
cord-321267-ihd30qi0	103	29	nucleic	nucleic	JJ
cord-321267-ihd30qi0	103	30	acid	acid	NN
cord-321267-ihd30qi0	103	31	(	(	-LRB-
cord-321267-ihd30qi0	103	32	e.g.	e.g.	RB
cord-321267-ihd30qi0	103	33	,	,	,
cord-321267-ihd30qi0	103	34	RT	RT	NNP
cord-321267-ihd30qi0	103	35	-	-	HYPH
cord-321267-ihd30qi0	103	36	PCR	PCR	NNP
cord-321267-ihd30qi0	103	37	)	)	-RRB-
cord-321267-ihd30qi0	103	38	,	,	,
cord-321267-ihd30qi0	103	39	antigen	antigen	NN
cord-321267-ihd30qi0	103	40	,	,	,
cord-321267-ihd30qi0	103	41	and	and	CC
cord-321267-ihd30qi0	103	42	serologic	serologic	NNP
cord-321267-ihd30qi0	103	43	antibody	antibody	NNP
cord-321267-ihd30qi0	103	44	(	(	-LRB-
cord-321267-ihd30qi0	103	45	isotypes	isotypes	NNP
cord-321267-ihd30qi0	103	46	IgM	IgM	NNP
cord-321267-ihd30qi0	103	47	and/or	and/or	CC
cord-321267-ihd30qi0	103	48	especially	especially	RB
cord-321267-ihd30qi0	103	49	IgG	IgG	NNP
cord-321267-ihd30qi0	103	50	)	)	-RRB-
cord-321267-ihd30qi0	104	1	(	(	-LRB-
cord-321267-ihd30qi0	104	2	see	see	VB
cord-321267-ihd30qi0	104	3	:	:	:
cord-321267-ihd30qi0	104	4	FIND	find	VB
cord-321267-ihd30qi0	104	5	2020	2020	CD
cord-321267-ihd30qi0	104	6	;	;	:
cord-321267-ihd30qi0	104	7	Sheridan	Sheridan	NNP
cord-321267-ihd30qi0	104	8	2020	2020	CD
cord-321267-ihd30qi0	104	9	;	;	:
cord-321267-ihd30qi0	104	10	NAS	NAS	NNP
cord-321267-ihd30qi0	104	11	2020a	2020a	NNS
cord-321267-ihd30qi0	104	12	)	)	-RRB-
cord-321267-ihd30qi0	104	13	.	.	.
cord-321267-ihd30qi0	105	1	RT	RT	NNP
cord-321267-ihd30qi0	105	2	-	-	HYPH
cord-321267-ihd30qi0	105	3	PCR	PCR	NNP
cord-321267-ihd30qi0	105	4	is	be	VBZ
cord-321267-ihd30qi0	105	5	the	the	DT
cord-321267-ihd30qi0	105	6	current	current	JJ
cord-321267-ihd30qi0	105	7	gold	gold	NN
cord-321267-ihd30qi0	105	8	standard	standard	NN
cord-321267-ihd30qi0	105	9	for	for	IN
cord-321267-ihd30qi0	105	10	revealing	reveal	VBG
cord-321267-ihd30qi0	105	11	whether	whether	IN
cord-321267-ihd30qi0	105	12	an	an	DT
cord-321267-ihd30qi0	105	13	active	active	JJ
cord-321267-ihd30qi0	105	14	infection	infection	NN
cord-321267-ihd30qi0	105	15	is	be	VBZ
cord-321267-ihd30qi0	105	16	underway	underway	JJ
cord-321267-ihd30qi0	105	17	,	,	,
cord-321267-ihd30qi0	105	18	as	as	IN
cord-321267-ihd30qi0	105	19	it	-PRON-	PRP
cord-321267-ihd30qi0	105	20	reveals	reveal	VBZ
cord-321267-ihd30qi0	105	21	viable	viable	JJ
cord-321267-ihd30qi0	105	22	,	,	,
cord-321267-ihd30qi0	105	23	replicating	replicate	VBG
cord-321267-ihd30qi0	105	24	virus	virus	NN
cord-321267-ihd30qi0	105	25	;	;	:
cord-321267-ihd30qi0	105	26	less	less	RBR
cord-321267-ihd30qi0	105	27	costly	costly	JJ
cord-321267-ihd30qi0	105	28	nucleic	nucleic	JJ
cord-321267-ihd30qi0	105	29	acid	acid	NN
cord-321267-ihd30qi0	105	30	tests	test	NNS
cord-321267-ihd30qi0	105	31	with	with	IN
cord-321267-ihd30qi0	105	32	higher	high	JJR
cord-321267-ihd30qi0	105	33	throughput	throughput	NN
cord-321267-ihd30qi0	105	34	are	be	VBP
cord-321267-ihd30qi0	105	35	emerging	emerge	VBG
cord-321267-ihd30qi0	106	1	(	(	-LRB-
cord-321267-ihd30qi0	106	2	Broughton	Broughton	NNP
cord-321267-ihd30qi0	106	3	et	et	NNP
cord-321267-ihd30qi0	106	4	al	al	NNP
cord-321267-ihd30qi0	106	5	.	.	.
cord-321267-ihd30qi0	107	1	2020	2020	CD
cord-321267-ihd30qi0	107	2	;	;	:
cord-321267-ihd30qi0	107	3	Suo	Suo	NNP
cord-321267-ihd30qi0	107	4	et	et	FW
cord-321267-ihd30qi0	107	5	al	al	NNP
cord-321267-ihd30qi0	107	6	.	.	.
cord-321267-ihd30qi0	108	1	2020	2020	CD
cord-321267-ihd30qi0	109	1	In	in	IN
cord-321267-ihd30qi0	109	2	contrast	contrast	NN
cord-321267-ihd30qi0	109	3	,	,	,
cord-321267-ihd30qi0	109	4	antibody	antibody	NN
cord-321267-ihd30qi0	109	5	tests	test	NNS
cord-321267-ihd30qi0	109	6	(	(	-LRB-
cord-321267-ihd30qi0	109	7	in	in	IN
cord-321267-ihd30qi0	109	8	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	109	9	and	and	CC
cord-321267-ihd30qi0	109	10	mild	mild	JJ
cord-321267-ihd30qi0	109	11	cases	case	NNS
cord-321267-ihd30qi0	109	12	)	)	-RRB-
cord-321267-ihd30qi0	109	13	can	can	MD
cord-321267-ihd30qi0	109	14	indicate	indicate	VB
cord-321267-ihd30qi0	109	15	a	a	DT
cord-321267-ihd30qi0	109	16	graduated	graduate	VBN
cord-321267-ihd30qi0	109	17	spectrum	spectrum	NN
cord-321267-ihd30qi0	109	18	of	of	IN
cord-321267-ihd30qi0	109	19	possibilities	possibility	NNS
cord-321267-ihd30qi0	109	20	,	,	,
cord-321267-ihd30qi0	109	21	including	include	VBG
cord-321267-ihd30qi0	109	22	whether	whether	IN
cord-321267-ihd30qi0	109	23	an	an	DT
cord-321267-ihd30qi0	109	24	infection	infection	NN
cord-321267-ihd30qi0	109	25	had	have	VBD
cord-321267-ihd30qi0	109	26	been	be	VBN
cord-321267-ihd30qi0	109	27	cleared	clear	VBN
cord-321267-ihd30qi0	109	28	sometime	sometime	RB
cord-321267-ihd30qi0	109	29	in	in	IN
cord-321267-ihd30qi0	109	30	the	the	DT
cord-321267-ihd30qi0	109	31	past	past	NN
cord-321267-ihd30qi0	109	32	or	or	CC
cord-321267-ihd30qi0	109	33	that	that	IN
cord-321267-ihd30qi0	109	34	an	an	DT
cord-321267-ihd30qi0	109	35	active	active	JJ
cord-321267-ihd30qi0	109	36	infection	infection	NN
cord-321267-ihd30qi0	109	37	is	be	VBZ
cord-321267-ihd30qi0	109	38	currently	currently	RB
cord-321267-ihd30qi0	109	39	being	be	VBG
cord-321267-ihd30qi0	109	40	resolved	resolve	VBN
cord-321267-ihd30qi0	109	41	(	(	-LRB-
cord-321267-ihd30qi0	109	42	assuming	assume	VBG
cord-321267-ihd30qi0	109	43	that	that	IN
cord-321267-ihd30qi0	109	44	more	more	RBR
cord-321267-ihd30qi0	109	45	serious	serious	JJ
cord-321267-ihd30qi0	109	46	morbidities	morbidity	NNS
cord-321267-ihd30qi0	109	47	do	do	VBP
cord-321267-ihd30qi0	109	48	not	not	RB
cord-321267-ihd30qi0	109	49	develop	develop	VB
cord-321267-ihd30qi0	109	50	)	)	-RRB-
cord-321267-ihd30qi0	109	51	.	.	.
cord-321267-ihd30qi0	110	1	Important	important	JJ
cord-321267-ihd30qi0	110	2	to	to	TO
cord-321267-ihd30qi0	110	3	recognize	recognize	VB
cord-321267-ihd30qi0	110	4	,	,	,
cord-321267-ihd30qi0	110	5	however	however	RB
cord-321267-ihd30qi0	110	6	,	,	,
cord-321267-ihd30qi0	110	7	is	be	VBZ
cord-321267-ihd30qi0	110	8	that	that	DT
cord-321267-ihd30qi0	110	9	NERD	nerd	NN
cord-321267-ihd30qi0	110	10	can	can	MD
cord-321267-ihd30qi0	110	11	not	not	RB
cord-321267-ihd30qi0	110	12	be	be	VB
cord-321267-ihd30qi0	110	13	fully	fully	RB
cord-321267-ihd30qi0	110	14	implemented	implement	VBN
cord-321267-ihd30qi0	110	15	until	until	IN
cord-321267-ihd30qi0	110	16	reliable	reliable	JJ
cord-321267-ihd30qi0	110	17	(	(	-LRB-
cord-321267-ihd30qi0	110	18	low	low	JJ
cord-321267-ihd30qi0	110	19	rates	rate	NNS
cord-321267-ihd30qi0	110	20	of	of	IN
cord-321267-ihd30qi0	110	21	false	false	JJ
cord-321267-ihd30qi0	110	22	-	-	HYPH
cord-321267-ihd30qi0	110	23	negative	negative	JJ
cord-321267-ihd30qi0	110	24	and	and	CC
cord-321267-ihd30qi0	110	25	false	false	JJ
cord-321267-ihd30qi0	110	26	-	-	HYPH
cord-321267-ihd30qi0	110	27	positive	positive	JJ
cord-321267-ihd30qi0	110	28	)	)	-RRB-
cord-321267-ihd30qi0	110	29	,	,	,
cord-321267-ihd30qi0	110	30	accurate	accurate	JJ
cord-321267-ihd30qi0	110	31	,	,	,
cord-321267-ihd30qi0	110	32	standardized	standardized	JJ
cord-321267-ihd30qi0	110	33	,	,	,
cord-321267-ihd30qi0	110	34	and	and	CC
cord-321267-ihd30qi0	110	35	inexpensive	inexpensive	JJ
cord-321267-ihd30qi0	110	36	antibody	antibody	NN
cord-321267-ihd30qi0	110	37	testing	testing	NN
cord-321267-ihd30qi0	110	38	becomes	become	VBZ
cord-321267-ihd30qi0	110	39	widely	widely	RB
cord-321267-ihd30qi0	110	40	available	available	JJ
cord-321267-ihd30qi0	110	41	in	in	IN
cord-321267-ihd30qi0	110	42	order	order	NN
cord-321267-ihd30qi0	110	43	to	to	TO
cord-321267-ihd30qi0	110	44	perform	perform	VB
cord-321267-ihd30qi0	110	45	random	random	JJ
cord-321267-ihd30qi0	110	46	serological	serological	JJ
cord-321267-ihd30qi0	110	47	surveys	survey	NNS
cord-321267-ihd30qi0	110	48	.	.	.
cord-321267-ihd30qi0	111	1	Not	not	RB
cord-321267-ihd30qi0	111	2	until	until	IN
cord-321267-ihd30qi0	111	3	1	1	CD
cord-321267-ihd30qi0	111	4	April	April	NNP
cord-321267-ihd30qi0	111	5	2020	2020	CD
cord-321267-ihd30qi0	111	6	was	be	VBD
cord-321267-ihd30qi0	111	7	the	the	DT
cord-321267-ihd30qi0	111	8	first	first	JJ
cord-321267-ihd30qi0	111	9	Emergency	Emergency	NNP
cord-321267-ihd30qi0	111	10	Use	Use	NNP
cord-321267-ihd30qi0	111	11	Authorization	Authorization	NNP
cord-321267-ihd30qi0	111	12	(	(	-LRB-
cord-321267-ihd30qi0	111	13	EUA	EUA	NNP
cord-321267-ihd30qi0	111	14	)	)	-RRB-
cord-321267-ihd30qi0	111	15	for	for	IN
cord-321267-ihd30qi0	111	16	a	a	DT
cord-321267-ihd30qi0	111	17	Covid-19	covid-19	JJ
cord-321267-ihd30qi0	111	18	serological	serological	JJ
cord-321267-ihd30qi0	111	19	test	test	NN
cord-321267-ihd30qi0	111	20	(	(	-LRB-
cord-321267-ihd30qi0	111	21	for	for	IN
cord-321267-ihd30qi0	111	22	use	use	NN
cord-321267-ihd30qi0	111	23	in	in	IN
cord-321267-ihd30qi0	111	24	clinical	clinical	JJ
cord-321267-ihd30qi0	111	25	laboratories	laboratory	NNS
cord-321267-ihd30qi0	111	26	)	)	-RRB-
cord-321267-ihd30qi0	111	27	issued	issue	VBN
cord-321267-ihd30qi0	111	28	by	by	IN
cord-321267-ihd30qi0	111	29	the	the	DT
cord-321267-ihd30qi0	111	30	US	US	NNP
cord-321267-ihd30qi0	111	31	FDA	FDA	NNP
cord-321267-ihd30qi0	111	32	(	(	-LRB-
cord-321267-ihd30qi0	111	33	https://www.fda.gov/media/136622/download	https://www.fda.gov/media/136622/download	UH
cord-321267-ihd30qi0	111	34	)	)	-RRB-
cord-321267-ihd30qi0	111	35	;	;	,
cord-321267-ihd30qi0	111	36	unknown	unknown	JJ
cord-321267-ihd30qi0	111	37	is	be	VBZ
cord-321267-ihd30qi0	111	38	when	when	WRB
cord-321267-ihd30qi0	111	39	any	any	DT
cord-321267-ihd30qi0	111	40	serological	serological	JJ
cord-321267-ihd30qi0	111	41	test	test	NN
cord-321267-ihd30qi0	111	42	will	will	MD
cord-321267-ihd30qi0	111	43	receive	receive	VB
cord-321267-ihd30qi0	111	44	full	full	JJ
cord-321267-ihd30qi0	111	45	approval	approval	NN
cord-321267-ihd30qi0	111	46	in	in	IN
cord-321267-ihd30qi0	111	47	the	the	DT
cord-321267-ihd30qi0	111	48	US	US	NNP
cord-321267-ihd30qi0	111	49	,	,	,
cord-321267-ihd30qi0	111	50	where	where	WRB
cord-321267-ihd30qi0	111	51	validation	validation	NN
cord-321267-ihd30qi0	111	52	for	for	IN
cord-321267-ihd30qi0	111	53	specificity	specificity	NN
cord-321267-ihd30qi0	111	54	and	and	CC
cord-321267-ihd30qi0	111	55	sensitivity	sensitivity	NN
cord-321267-ihd30qi0	111	56	are	be	VBP
cord-321267-ihd30qi0	111	57	critical	critical	JJ
cord-321267-ihd30qi0	111	58	.	.	.
cord-321267-ihd30qi0	112	1	Antibody	antibody	NN
cord-321267-ihd30qi0	112	2	testing	testing	NN
cord-321267-ihd30qi0	112	3	would	would	MD
cord-321267-ihd30qi0	112	4	also	also	RB
cord-321267-ihd30qi0	112	5	have	have	VB
cord-321267-ihd30qi0	112	6	to	to	TO
cord-321267-ihd30qi0	112	7	assume	assume	VB
cord-321267-ihd30qi0	112	8	that	that	IN
cord-321267-ihd30qi0	112	9	pre	pre	JJ
cord-321267-ihd30qi0	112	10	-	-	NN
cord-321267-ihd30qi0	112	11	immunity	immunity	NN
cord-321267-ihd30qi0	112	12	was	be	VBD
cord-321267-ihd30qi0	112	13	not	not	RB
cord-321267-ihd30qi0	112	14	possible	possible	JJ
cord-321267-ihd30qi0	112	15	(	(	-LRB-
cord-321267-ihd30qi0	112	16	e.g.	e.g.	RB
cord-321267-ihd30qi0	112	17	,	,	,
cord-321267-ihd30qi0	112	18	from	from	IN
cord-321267-ihd30qi0	112	19	exposure	exposure	NN
cord-321267-ihd30qi0	112	20	to	to	IN
cord-321267-ihd30qi0	112	21	other	other	JJ
cord-321267-ihd30qi0	112	22	coronaviruses	coronaviruse	NNS
cord-321267-ihd30qi0	112	23	)	)	-RRB-
cord-321267-ihd30qi0	112	24	.	.	.
cord-321267-ihd30qi0	113	1	There	there	EX
cord-321267-ihd30qi0	113	2	are	be	VBP
cord-321267-ihd30qi0	113	3	many	many	JJ
cord-321267-ihd30qi0	113	4	unknowns	unknown	NNS
cord-321267-ihd30qi0	113	5	and	and	CC
cord-321267-ihd30qi0	113	6	problems	problem	NNS
cord-321267-ihd30qi0	113	7	surrounding	surround	VBG
cord-321267-ihd30qi0	113	8	serologic	serologic	NNP
cord-321267-ihd30qi0	113	9	tests	test	NNS
cord-321267-ihd30qi0	113	10	for	for	IN
cord-321267-ihd30qi0	113	11	Covid-19	covid-19	NN
cord-321267-ihd30qi0	113	12	(	(	-LRB-
cord-321267-ihd30qi0	113	13	Gronvall	Gronvall	NNP
cord-321267-ihd30qi0	113	14	et	et	FW
cord-321267-ihd30qi0	113	15	al	al	NNP
cord-321267-ihd30qi0	113	16	.	.	.
cord-321267-ihd30qi0	114	1	2020	2020	CD
cord-321267-ihd30qi0	114	2	;	;	:
cord-321267-ihd30qi0	114	3	NAS	NAS	NNP
cord-321267-ihd30qi0	114	4	2020b	2020b	CD
cord-321267-ihd30qi0	114	5	)	)	-RRB-
cord-321267-ihd30qi0	114	6	.	.	.
cord-321267-ihd30qi0	115	1	A	a	DT
cord-321267-ihd30qi0	115	2	positive	positive	JJ
cord-321267-ihd30qi0	115	3	test	test	NN
cord-321267-ihd30qi0	115	4	using	use	VBG
cord-321267-ihd30qi0	115	5	RT	RT	NNP
cord-321267-ihd30qi0	115	6	-	-	HYPH
cord-321267-ihd30qi0	115	7	PCR	PCR	NNP
cord-321267-ihd30qi0	115	8	or	or	CC
cord-321267-ihd30qi0	115	9	antigen	antigen	NN
cord-321267-ihd30qi0	115	10	testing	testing	NN
cord-321267-ihd30qi0	115	11	would	would	MD
cord-321267-ihd30qi0	115	12	yield	yield	VB
cord-321267-ihd30qi0	115	13	a	a	DT
cord-321267-ihd30qi0	115	14	relatively	relatively	RB
cord-321267-ihd30qi0	115	15	definitive	definitive	JJ
cord-321267-ihd30qi0	115	16	indication	indication	NN
cord-321267-ihd30qi0	115	17	for	for	IN
cord-321267-ihd30qi0	115	18	an	an	DT
cord-321267-ihd30qi0	115	19	active	active	JJ
cord-321267-ihd30qi0	115	20	infection	infection	NN
cord-321267-ihd30qi0	115	21	(	(	-LRB-
cord-321267-ihd30qi0	115	22	especially	especially	RB
cord-321267-ihd30qi0	115	23	with	with	IN
cord-321267-ihd30qi0	115	24	the	the	DT
cord-321267-ihd30qi0	115	25	presence	presence	NN
cord-321267-ihd30qi0	115	26	of	of	IN
cord-321267-ihd30qi0	115	27	key	key	JJ
cord-321267-ihd30qi0	115	28	signs	sign	NNS
cord-321267-ihd30qi0	115	29	or	or	CC
cord-321267-ihd30qi0	115	30	symptoms	symptom	NNS
cord-321267-ihd30qi0	115	31	)	)	-RRB-
cord-321267-ihd30qi0	115	32	.	.	.
cord-321267-ihd30qi0	116	1	In	in	IN
cord-321267-ihd30qi0	116	2	contrast	contrast	NN
cord-321267-ihd30qi0	116	3	,	,	,
cord-321267-ihd30qi0	116	4	a	a	DT
cord-321267-ihd30qi0	116	5	negative	negative	JJ
cord-321267-ihd30qi0	116	6	test	test	NN
cord-321267-ihd30qi0	116	7	for	for	IN
cord-321267-ihd30qi0	116	8	active	active	JJ
cord-321267-ihd30qi0	116	9	disease	disease	NN
cord-321267-ihd30qi0	116	10	(	(	-LRB-
cord-321267-ihd30qi0	116	11	without	without	IN
cord-321267-ihd30qi0	116	12	any	any	DT
cord-321267-ihd30qi0	116	13	other	other	JJ
cord-321267-ihd30qi0	116	14	complementary	complementary	JJ
cord-321267-ihd30qi0	116	15	test	test	NN
cord-321267-ihd30qi0	116	16	)	)	-RRB-
cord-321267-ihd30qi0	116	17	would	would	MD
cord-321267-ihd30qi0	116	18	not	not	RB
cord-321267-ihd30qi0	116	19	be	be	VB
cord-321267-ihd30qi0	116	20	useful	useful	JJ
cord-321267-ihd30qi0	116	21	for	for	IN
cord-321267-ihd30qi0	116	22	NERD	nerd	NN
cord-321267-ihd30qi0	116	23	.	.	.
cord-321267-ihd30qi0	117	1	This	this	DT
cord-321267-ihd30qi0	117	2	is	be	VBZ
cord-321267-ihd30qi0	117	3	because	because	IN
cord-321267-ihd30qi0	117	4	negative	negative	JJ
cord-321267-ihd30qi0	117	5	-	-	HYPH
cord-321267-ihd30qi0	117	6	test	test	NN
cord-321267-ihd30qi0	117	7	cases	case	NNS
cord-321267-ihd30qi0	117	8	would	would	MD
cord-321267-ihd30qi0	117	9	aggregate	aggregate	VB
cord-321267-ihd30qi0	117	10	two	two	CD
cord-321267-ihd30qi0	117	11	primary	primary	JJ
cord-321267-ihd30qi0	117	12	subgroups	subgroup	NNS
cord-321267-ihd30qi0	117	13	:	:	:
cord-321267-ihd30qi0	117	14	(	(	-LRB-
cord-321267-ihd30qi0	117	15	i	i	NN
cord-321267-ihd30qi0	117	16	)	)	-RRB-
cord-321267-ihd30qi0	117	17	those	those	DT
cord-321267-ihd30qi0	117	18	who	who	WP
cord-321267-ihd30qi0	117	19	have	have	VBP
cord-321267-ihd30qi0	117	20	never	never	RB
cord-321267-ihd30qi0	117	21	been	be	VBN
cord-321267-ihd30qi0	117	22	exposed	expose	VBN
cord-321267-ihd30qi0	117	23	to	to	IN
cord-321267-ihd30qi0	117	24	SARS	SARS	NNP
cord-321267-ihd30qi0	117	25	-	-	HYPH
cord-321267-ihd30qi0	117	26	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	117	27	and	and	CC
cord-321267-ihd30qi0	117	28	(	(	-LRB-
cord-321267-ihd30qi0	117	29	ii	ii	NN
cord-321267-ihd30qi0	117	30	)	)	-RRB-
cord-321267-ihd30qi0	117	31	those	those	DT
cord-321267-ihd30qi0	117	32	who	who	WP
cord-321267-ihd30qi0	117	33	were	be	VBD
cord-321267-ihd30qi0	117	34	infected	infect	VBN
cord-321267-ihd30qi0	117	35	but	but	CC
cord-321267-ihd30qi0	117	36	who	who	WP
cord-321267-ihd30qi0	117	37	resolved	resolve	VBD
cord-321267-ihd30qi0	117	38	the	the	DT
cord-321267-ihd30qi0	117	39	infection	infection	NN
cord-321267-ihd30qi0	117	40	via	via	IN
cord-321267-ihd30qi0	117	41	a	a	DT
cord-321267-ihd30qi0	117	42	successful	successful	JJ
cord-321267-ihd30qi0	117	43	immune	immune	JJ
cord-321267-ihd30qi0	117	44	response	response	NN
cord-321267-ihd30qi0	117	45	(	(	-LRB-
cord-321267-ihd30qi0	117	46	being	be	VBG
cord-321267-ihd30qi0	117	47	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	117	48	or	or	CC
cord-321267-ihd30qi0	117	49	experiencing	experience	VBG
cord-321267-ihd30qi0	117	50	only	only	RB
cord-321267-ihd30qi0	117	51	mild	mild	JJ
cord-321267-ihd30qi0	117	52	infection	infection	NN
cord-321267-ihd30qi0	117	53	)	)	-RRB-
cord-321267-ihd30qi0	117	54	.	.	.
cord-321267-ihd30qi0	118	1	Both	both	DT
cord-321267-ihd30qi0	118	2	of	of	IN
cord-321267-ihd30qi0	118	3	these	these	DT
cord-321267-ihd30qi0	118	4	subgroups	subgroup	NNS
cord-321267-ihd30qi0	118	5	can	can	MD
cord-321267-ihd30qi0	118	6	be	be	VB
cord-321267-ihd30qi0	118	7	disaggregated	disaggregate	VBN
cord-321267-ihd30qi0	118	8	only	only	RB
cord-321267-ihd30qi0	118	9	by	by	IN
cord-321267-ihd30qi0	118	10	IgM	IgM	NNP
cord-321267-ihd30qi0	118	11	/	/	SYM
cord-321267-ihd30qi0	118	12	IgG	IgG	NNP
cord-321267-ihd30qi0	118	13	antibody	antibody	NNP
cord-321267-ihd30qi0	118	14	testing	testing	NN
cord-321267-ihd30qi0	118	15	(	(	-LRB-
cord-321267-ihd30qi0	118	16	option	option	NN
cord-321267-ihd30qi0	118	17	#	#	$
cord-321267-ihd30qi0	118	18	1	1	CD
cord-321267-ihd30qi0	118	19	or	or	CC
cord-321267-ihd30qi0	118	20	#	#	$
cord-321267-ihd30qi0	118	21	3	3	CD
cord-321267-ihd30qi0	118	22	)	)	-RRB-
cord-321267-ihd30qi0	118	23	;	;	:
cord-321267-ihd30qi0	118	24	the	the	DT
cord-321267-ihd30qi0	118	25	course	course	NN
cord-321267-ihd30qi0	118	26	of	of	IN
cord-321267-ihd30qi0	118	27	the	the	DT
cord-321267-ihd30qi0	118	28	disease	disease	NN
cord-321267-ihd30qi0	118	29	can	can	MD
cord-321267-ihd30qi0	118	30	transition	transition	VB
cord-321267-ihd30qi0	118	31	from	from	IN
cord-321267-ihd30qi0	118	32	infection	infection	NN
cord-321267-ihd30qi0	118	33	-	-	HYPH
cord-321267-ihd30qi0	118	34	positive	positive	JJ
cord-321267-ihd30qi0	118	35	to	to	IN
cord-321267-ihd30qi0	118	36	infection	infection	NN
cord-321267-ihd30qi0	118	37	-	-	HYPH
cord-321267-ihd30qi0	118	38	negative	negative	JJ
cord-321267-ihd30qi0	118	39	after	after	IN
cord-321267-ihd30qi0	118	40	testing	test	VBG
cord-321267-ihd30qi0	118	41	immune	immune	NN
cord-321267-ihd30qi0	118	42	-	-	HYPH
cord-321267-ihd30qi0	118	43	positive	positive	JJ
cord-321267-ihd30qi0	118	44	.	.	.
cord-321267-ihd30qi0	119	1	It	-PRON-	PRP
cord-321267-ihd30qi0	119	2	is	be	VBZ
cord-321267-ihd30qi0	119	3	only	only	RB
cord-321267-ihd30qi0	119	4	this	this	DT
cord-321267-ihd30qi0	119	5	second	second	JJ
cord-321267-ihd30qi0	119	6	negative	negative	JJ
cord-321267-ihd30qi0	119	7	-	-	HYPH
cord-321267-ihd30qi0	119	8	test	test	NN
cord-321267-ihd30qi0	119	9	subgroup	subgroup	NN
cord-321267-ihd30qi0	119	10	(	(	-LRB-
cord-321267-ihd30qi0	119	11	i.e.	i.e.	FW
cord-321267-ihd30qi0	119	12	,	,	,
cord-321267-ihd30qi0	119	13	positive	positive	JJ
cord-321267-ihd30qi0	119	14	serum	serum	NN
cord-321267-ihd30qi0	119	15	antibody	antibody	NN
cord-321267-ihd30qi0	119	16	test	test	NN
cord-321267-ihd30qi0	119	17	)	)	-RRB-
cord-321267-ihd30qi0	119	18	that	that	WDT
cord-321267-ihd30qi0	119	19	would	would	MD
cord-321267-ihd30qi0	119	20	be	be	VB
cord-321267-ihd30qi0	119	21	useful	useful	JJ
cord-321267-ihd30qi0	119	22	to	to	IN
cord-321267-ihd30qi0	119	23	NERD	NERD	NNP
cord-321267-ihd30qi0	119	24	.	.	.
cord-321267-ihd30qi0	120	1	Antibody	antibody	NN
cord-321267-ihd30qi0	120	2	tests	test	NNS
cord-321267-ihd30qi0	120	3	provide	provide	VBP
cord-321267-ihd30qi0	120	4	additional	additional	JJ
cord-321267-ihd30qi0	120	5	opportunity	opportunity	NN
cord-321267-ihd30qi0	120	6	for	for	IN
cord-321267-ihd30qi0	120	7	interpretation	interpretation	NN
cord-321267-ihd30qi0	120	8	in	in	IN
cord-321267-ihd30qi0	120	9	NERD	NERD	NNP
cord-321267-ihd30qi0	120	10	,	,	,
cord-321267-ihd30qi0	120	11	as	as	IN
cord-321267-ihd30qi0	120	12	they	-PRON-	PRP
cord-321267-ihd30qi0	120	13	would	would	MD
cord-321267-ihd30qi0	120	14	represent	represent	VB
cord-321267-ihd30qi0	120	15	a	a	DT
cord-321267-ihd30qi0	120	16	portion	portion	NN
cord-321267-ihd30qi0	120	17	of	of	IN
cord-321267-ihd30qi0	120	18	the	the	DT
cord-321267-ihd30qi0	120	19	population	population	NN
cord-321267-ihd30qi0	120	20	that	that	WDT
cord-321267-ihd30qi0	120	21	was	be	VBD
cord-321267-ihd30qi0	120	22	most	most	RBS
cord-321267-ihd30qi0	120	23	successful	successful	JJ
cord-321267-ihd30qi0	120	24	in	in	IN
cord-321267-ihd30qi0	120	25	recovering	recover	VBG
cord-321267-ihd30qi0	120	26	from	from	IN
cord-321267-ihd30qi0	120	27	self	self	NN
cord-321267-ihd30qi0	120	28	-	-	HYPH
cord-321267-ihd30qi0	120	29	limited	limit	VBN
cord-321267-ihd30qi0	120	30	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	120	31	or	or	CC
cord-321267-ihd30qi0	120	32	mild	mild	JJ
cord-321267-ihd30qi0	120	33	infection	infection	NN
cord-321267-ihd30qi0	120	34	.	.	.
cord-321267-ihd30qi0	121	1	But	but	CC
cord-321267-ihd30qi0	121	2	antibody	antibody	NN
cord-321267-ihd30qi0	121	3	testing	testing	NN
cord-321267-ihd30qi0	121	4	could	could	MD
cord-321267-ihd30qi0	121	5	also	also	RB
cord-321267-ihd30qi0	121	6	prove	prove	VB
cord-321267-ihd30qi0	121	7	problematic	problematic	JJ
cord-321267-ihd30qi0	121	8	for	for	IN
cord-321267-ihd30qi0	121	9	interpretation	interpretation	NN
cord-321267-ihd30qi0	121	10	because	because	IN
cord-321267-ihd30qi0	121	11	the	the	DT
cord-321267-ihd30qi0	121	12	patient	patient	NN
cord-321267-ihd30qi0	121	13	would	would	MD
cord-321267-ihd30qi0	121	14	need	need	VB
cord-321267-ihd30qi0	121	15	to	to	TO
cord-321267-ihd30qi0	121	16	know	know	VB
cord-321267-ihd30qi0	121	17	when	when	WRB
cord-321267-ihd30qi0	121	18	they	-PRON-	PRP
cord-321267-ihd30qi0	121	19	had	have	VBD
cord-321267-ihd30qi0	121	20	probably	probably	RB
cord-321267-ihd30qi0	121	21	become	become	VBN
cord-321267-ihd30qi0	121	22	infected	infected	JJ
cord-321267-ihd30qi0	121	23	.	.	.
cord-321267-ihd30qi0	122	1	If	if	IN
cord-321267-ihd30qi0	122	2	this	this	DT
cord-321267-ihd30qi0	122	3	is	be	VBZ
cord-321267-ihd30qi0	122	4	not	not	RB
cord-321267-ihd30qi0	122	5	known	know	VBN
cord-321267-ihd30qi0	122	6	,	,	,
cord-321267-ihd30qi0	122	7	then	then	RB
cord-321267-ihd30qi0	122	8	the	the	DT
cord-321267-ihd30qi0	122	9	patient	patient	NN
cord-321267-ihd30qi0	122	10	may	may	MD
cord-321267-ihd30qi0	122	11	not	not	RB
cord-321267-ihd30qi0	122	12	know	know	VB
cord-321267-ihd30qi0	122	13	what	what	WP
cord-321267-ihd30qi0	122	14	drug	drug	NN
cord-321267-ihd30qi0	122	15	usage	usage	NN
cord-321267-ihd30qi0	122	16	they	-PRON-	PRP
cord-321267-ihd30qi0	122	17	had	have	VBD
cord-321267-ihd30qi0	122	18	experienced	experience	VBN
cord-321267-ihd30qi0	122	19	over	over	IN
cord-321267-ihd30qi0	122	20	the	the	DT
cord-321267-ihd30qi0	122	21	time	time	NN
cord-321267-ihd30qi0	122	22	period	period	NN
cord-321267-ihd30qi0	122	23	encompasses	encompass	VBZ
cord-321267-ihd30qi0	122	24	pre	pre	JJ
cord-321267-ihd30qi0	122	25	-	-	NN
cord-321267-ihd30qi0	122	26	exposure	exposure	NN
cord-321267-ihd30qi0	122	27	and	and	CC
cord-321267-ihd30qi0	122	28	infection	infection	NN
cord-321267-ihd30qi0	122	29	.	.	.
cord-321267-ihd30qi0	123	1	In	in	IN
cord-321267-ihd30qi0	123	2	Table	Table	NNP
cord-321267-ihd30qi0	123	3	1	1	CD
cord-321267-ihd30qi0	123	4	,	,	,
cord-321267-ihd30qi0	123	5	the	the	DT
cord-321267-ihd30qi0	123	6	group	group	NN
cord-321267-ihd30qi0	123	7	"	"	``
cord-321267-ihd30qi0	123	8	Negative	negative	JJ
cord-321267-ihd30qi0	123	9	test	test	NN
cord-321267-ihd30qi0	123	10	for	for	IN
cord-321267-ihd30qi0	123	11	past	past	JJ
cord-321267-ihd30qi0	123	12	infection	infection	NN
cord-321267-ihd30qi0	123	13	"	"	''
cord-321267-ihd30qi0	123	14	(	(	-LRB-
cord-321267-ihd30qi0	123	15	absence	absence	NN
cord-321267-ihd30qi0	123	16	of	of	IN
cord-321267-ihd30qi0	123	17	any	any	DT
cord-321267-ihd30qi0	123	18	immune	immune	JJ
cord-321267-ihd30qi0	123	19	response	response	NN
cord-321267-ihd30qi0	123	20	)	)	-RRB-
cord-321267-ihd30qi0	123	21	,	,	,
cord-321267-ihd30qi0	123	22	whether	whether	IN
cord-321267-ihd30qi0	123	23	used	use	VBN
cord-321267-ihd30qi0	123	24	alone	alone	RB
cord-321267-ihd30qi0	123	25	(	(	-LRB-
cord-321267-ihd30qi0	123	26	option	option	NN
cord-321267-ihd30qi0	123	27	#	#	$
cord-321267-ihd30qi0	123	28	4	4	CD
cord-321267-ihd30qi0	123	29	)	)	-RRB-
cord-321267-ihd30qi0	123	30	or	or	CC
cord-321267-ihd30qi0	123	31	even	even	RB
cord-321267-ihd30qi0	123	32	if	if	IN
cord-321267-ihd30qi0	123	33	it	-PRON-	PRP
cord-321267-ihd30qi0	123	34	were	be	VBD
cord-321267-ihd30qi0	123	35	used	use	VBN
cord-321267-ihd30qi0	123	36	in	in	IN
cord-321267-ihd30qi0	123	37	concert	concert	NN
cord-321267-ihd30qi0	123	38	with	with	IN
cord-321267-ihd30qi0	123	39	a	a	DT
cord-321267-ihd30qi0	123	40	test	test	NN
cord-321267-ihd30qi0	123	41	of	of	IN
cord-321267-ihd30qi0	123	42	active	active	JJ
cord-321267-ihd30qi0	123	43	infection	infection	NN
cord-321267-ihd30qi0	123	44	(	(	-LRB-
cord-321267-ihd30qi0	123	45	option	option	NN
cord-321267-ihd30qi0	123	46	#	#	$
cord-321267-ihd30qi0	123	47	2	2	CD
cord-321267-ihd30qi0	123	48	)	)	-RRB-
cord-321267-ihd30qi0	123	49	,	,	,
cord-321267-ihd30qi0	123	50	would	would	MD
cord-321267-ihd30qi0	123	51	not	not	RB
cord-321267-ihd30qi0	123	52	provide	provide	VB
cord-321267-ihd30qi0	123	53	any	any	DT
cord-321267-ihd30qi0	123	54	useful	useful	JJ
cord-321267-ihd30qi0	123	55	information	information	NN
cord-321267-ihd30qi0	123	56	for	for	IN
cord-321267-ihd30qi0	123	57	NERD	NERD	NNP
cord-321267-ihd30qi0	123	58	.	.	.
cord-321267-ihd30qi0	124	1	Note	note	VB
cord-321267-ihd30qi0	124	2	,	,	,
cord-321267-ihd30qi0	124	3	however	however	RB
cord-321267-ihd30qi0	124	4	that	that	IN
cord-321267-ihd30qi0	124	5	there	there	EX
cord-321267-ihd30qi0	124	6	are	be	VBP
cord-321267-ihd30qi0	124	7	two	two	CD
cord-321267-ihd30qi0	124	8	additional	additional	JJ
cord-321267-ihd30qi0	124	9	sub	sub	NN
cord-321267-ihd30qi0	124	10	-	-	NNS
cord-321267-ihd30qi0	124	11	groups	group	NNS
cord-321267-ihd30qi0	124	12	among	among	IN
cord-321267-ihd30qi0	124	13	the	the	DT
cord-321267-ihd30qi0	124	14	negative	negative	JJ
cord-321267-ihd30qi0	124	15	test	test	NN
cord-321267-ihd30qi0	124	16	group	group	NN
cord-321267-ihd30qi0	124	17	,	,	,
cord-321267-ihd30qi0	124	18	which	which	WDT
cord-321267-ihd30qi0	124	19	creates	create	VBZ
cord-321267-ihd30qi0	124	20	two	two	CD
cord-321267-ihd30qi0	124	21	more	more	JJR
cord-321267-ihd30qi0	124	22	groups	group	NNS
cord-321267-ihd30qi0	124	23	:	:	:
cord-321267-ihd30qi0	124	24	(	(	-LRB-
cord-321267-ihd30qi0	124	25	iii	iii	NN
cord-321267-ihd30qi0	124	26	)	)	-RRB-
cord-321267-ihd30qi0	125	1	those	those	DT
cord-321267-ihd30qi0	125	2	who	who	WP
cord-321267-ihd30qi0	125	3	are	be	VBP
cord-321267-ihd30qi0	125	4	infected	infect	VBN
cord-321267-ihd30qi0	125	5	but	but	CC
cord-321267-ihd30qi0	125	6	their	-PRON-	PRP$
cord-321267-ihd30qi0	125	7	virus	virus	NN
cord-321267-ihd30qi0	125	8	titers	titer	NNS
cord-321267-ihd30qi0	125	9	are	be	VBP
cord-321267-ihd30qi0	125	10	too	too	RB
cord-321267-ihd30qi0	125	11	low	low	JJ
cord-321267-ihd30qi0	125	12	to	to	TO
cord-321267-ihd30qi0	125	13	yet	yet	RB
cord-321267-ihd30qi0	125	14	detect	detect	VB
cord-321267-ihd30qi0	125	15	(	(	-LRB-
cord-321267-ihd30qi0	125	16	these	these	DT
cord-321267-ihd30qi0	125	17	could	could	MD
cord-321267-ihd30qi0	125	18	become	become	VB
cord-321267-ihd30qi0	125	19	positive	positive	JJ
cord-321267-ihd30qi0	125	20	with	with	IN
cord-321267-ihd30qi0	125	21	subsequent	subsequent	JJ
cord-321267-ihd30qi0	125	22	testing	testing	NN
cord-321267-ihd30qi0	125	23	)	)	-RRB-
cord-321267-ihd30qi0	125	24	,	,	,
cord-321267-ihd30qi0	125	25	and	and	CC
cord-321267-ihd30qi0	125	26	(	(	-LRB-
cord-321267-ihd30qi0	125	27	iv	iv	LS
cord-321267-ihd30qi0	125	28	)	)	-RRB-
cord-321267-ihd30qi0	125	29	those	those	DT
cord-321267-ihd30qi0	125	30	with	with	IN
cord-321267-ihd30qi0	125	31	an	an	DT
cord-321267-ihd30qi0	125	32	active	active	JJ
cord-321267-ihd30qi0	125	33	infection	infection	NN
cord-321267-ihd30qi0	125	34	but	but	CC
cord-321267-ihd30qi0	125	35	the	the	DT
cord-321267-ihd30qi0	125	36	test	test	NN
cord-321267-ihd30qi0	125	37	yielded	yield	VBD
cord-321267-ihd30qi0	125	38	a	a	DT
cord-321267-ihd30qi0	125	39	false	false	JJ
cord-321267-ihd30qi0	125	40	negative	negative	NN
cord-321267-ihd30qi0	125	41	(	(	-LRB-
cord-321267-ihd30qi0	125	42	because	because	IN
cord-321267-ihd30qi0	125	43	of	of	IN
cord-321267-ihd30qi0	125	44	sampling	sampling	NN
cord-321267-ihd30qi0	125	45	errors	error	NNS
cord-321267-ihd30qi0	125	46	or	or	CC
cord-321267-ihd30qi0	125	47	test	test	NN
cord-321267-ihd30qi0	125	48	problems	problem	NNS
cord-321267-ihd30qi0	125	49	)	)	-RRB-
cord-321267-ihd30qi0	125	50	.	.	.
cord-321267-ihd30qi0	126	1	These	these	DT
cord-321267-ihd30qi0	126	2	two	two	CD
cord-321267-ihd30qi0	126	3	groups	group	NNS
cord-321267-ihd30qi0	126	4	would	would	MD
cord-321267-ihd30qi0	126	5	serve	serve	VB
cord-321267-ihd30qi0	126	6	as	as	IN
cord-321267-ihd30qi0	126	7	confounders	confounder	NNS
cord-321267-ihd30qi0	126	8	for	for	IN
cord-321267-ihd30qi0	126	9	interpreting	interpret	VBG
cord-321267-ihd30qi0	126	10	negative	negative	JJ
cord-321267-ihd30qi0	126	11	-	-	HYPH
cord-321267-ihd30qi0	126	12	test	test	NN
cord-321267-ihd30qi0	126	13	data	datum	NNS
cord-321267-ihd30qi0	126	14	.	.	.
cord-321267-ihd30qi0	127	1	could	could	MD
cord-321267-ihd30qi0	127	2	point	point	VB
cord-321267-ihd30qi0	127	3	to	to	IN
cord-321267-ihd30qi0	127	4	:	:	:
cord-321267-ihd30qi0	127	5	(	(	-LRB-
cord-321267-ihd30qi0	127	6	I	i	NN
cord-321267-ihd30qi0	127	7	)	)	-RRB-
cord-321267-ihd30qi0	127	8	potential	potential	JJ
cord-321267-ihd30qi0	127	9	contraindications	contraindication	NNS
cord-321267-ihd30qi0	127	10	and	and	CC
cord-321267-ihd30qi0	127	11	warn	warn	VBP
cord-321267-ihd30qi0	127	12	of	of	IN
cord-321267-ihd30qi0	127	13	those	those	DT
cord-321267-ihd30qi0	127	14	drugs	drug	NNS
cord-321267-ihd30qi0	127	15	to	to	TO
cord-321267-ihd30qi0	127	16	AVOID	avoid	VB
cord-321267-ihd30qi0	127	17	for	for	IN
cord-321267-ihd30qi0	127	18	Covid-19	covid-19	NN
cord-321267-ihd30qi0	127	19	treatment	treatment	NN
cord-321267-ihd30qi0	128	1	,	,	,
cord-321267-ihd30qi0	128	2	(	(	-LRB-
cord-321267-ihd30qi0	128	3	ii	ii	NN
cord-321267-ihd30qi0	128	4	)	)	-RRB-
cord-321267-ihd30qi0	128	5	potential	potential	NN
cord-321267-ihd30qi0	128	6	for	for	IN
cord-321267-ihd30qi0	128	7	increasing	increase	VBG
cord-321267-ihd30qi0	128	8	the	the	DT
cord-321267-ihd30qi0	128	9	risk	risk	NN
cord-321267-ihd30qi0	128	10	of	of	IN
cord-321267-ihd30qi0	128	11	developing	develop	VBG
cord-321267-ihd30qi0	128	12	more	more	RBR
cord-321267-ihd30qi0	128	13	serious	serious	JJ
cord-321267-ihd30qi0	128	14	infection	infection	NN
cord-321267-ihd30qi0	128	15	or	or	CC
cord-321267-ihd30qi0	128	16	exacerbating	exacerbate	VBG
cord-321267-ihd30qi0	128	17	clinical	clinical	JJ
cord-321267-ihd30qi0	128	18	outcomes	outcome	NNS
cord-321267-ihd30qi0	128	19	,	,	,
cord-321267-ihd30qi0	128	20	and	and	CC
cord-321267-ihd30qi0	128	21	(	(	-LRB-
cord-321267-ihd30qi0	128	22	iii	iii	NN
cord-321267-ihd30qi0	128	23	)	)	-RRB-
cord-321267-ihd30qi0	128	24	drugs	drug	NNS
cord-321267-ihd30qi0	128	25	that	that	WDT
cord-321267-ihd30qi0	128	26	might	may	MD
cord-321267-ihd30qi0	128	27	also	also	RB
cord-321267-ihd30qi0	128	28	make	make	VB
cord-321267-ihd30qi0	128	29	exposed	expose	VBN
cord-321267-ihd30qi0	128	30	individuals	individual	NNS
cord-321267-ihd30qi0	128	31	more	more	RBR
cord-321267-ihd30qi0	128	32	susceptible	susceptible	JJ
cord-321267-ihd30qi0	128	33	to	to	IN
cord-321267-ihd30qi0	128	34	developing	develop	VBG
cord-321267-ihd30qi0	128	35	serious	serious	JJ
cord-321267-ihd30qi0	128	36	disease	disease	NN
cord-321267-ihd30qi0	128	37	(	(	-LRB-
cord-321267-ihd30qi0	128	38	thereby	thereby	RB
cord-321267-ihd30qi0	128	39	allowing	allow	VBG
cord-321267-ihd30qi0	128	40	for	for	IN
cord-321267-ihd30qi0	128	41	more	more	JJR
cord-321267-ihd30qi0	128	42	vigilance	vigilance	NN
cord-321267-ihd30qi0	128	43	in	in	IN
cord-321267-ihd30qi0	128	44	avoiding	avoid	VBG
cord-321267-ihd30qi0	128	45	exposure	exposure	NN
cord-321267-ihd30qi0	128	46	)	)	-RRB-
cord-321267-ihd30qi0	128	47	.	.	.
cord-321267-ihd30qi0	129	1	A	a	DT
cord-321267-ihd30qi0	129	2	positive	positive	JJ
cord-321267-ihd30qi0	129	3	correlation	correlation	NN
cord-321267-ihd30qi0	129	4	with	with	IN
cord-321267-ihd30qi0	129	5	severe	severe	JJ
cord-321267-ihd30qi0	129	6	,	,	,
cord-321267-ihd30qi0	129	7	critical	critical	JJ
cord-321267-ihd30qi0	129	8	,	,	,
cord-321267-ihd30qi0	129	9	or	or	CC
cord-321267-ihd30qi0	129	10	especially	especially	RB
cord-321267-ihd30qi0	129	11	fatal	fatal	JJ
cord-321267-ihd30qi0	129	12	outcomes	outcome	NNS
cord-321267-ihd30qi0	129	13	could	could	MD
cord-321267-ihd30qi0	129	14	point	point	VB
cord-321267-ihd30qi0	129	15	to	to	IN
cord-321267-ihd30qi0	129	16	negative	negative	JJ
cord-321267-ihd30qi0	129	17	interactions	interaction	NNS
cord-321267-ihd30qi0	129	18	of	of	IN
cord-321267-ihd30qi0	129	19	a	a	DT
cord-321267-ihd30qi0	129	20	drug	drug	NN
cord-321267-ihd30qi0	129	21	with	with	IN
cord-321267-ihd30qi0	129	22	the	the	DT
cord-321267-ihd30qi0	129	23	disease	disease	NN
cord-321267-ihd30qi0	129	24	,	,	,
cord-321267-ihd30qi0	129	25	and	and	CC
cord-321267-ihd30qi0	129	26	thereby	thereby	RB
cord-321267-ihd30qi0	129	27	inform	inform	VB
cord-321267-ihd30qi0	129	28	recommendations	recommendation	NNS
cord-321267-ihd30qi0	129	29	to	to	TO
cord-321267-ihd30qi0	129	30	avoid	avoid	VB
cord-321267-ihd30qi0	129	31	taking	take	VBG
cord-321267-ihd30qi0	129	32	the	the	DT
cord-321267-ihd30qi0	129	33	drug	drug	NN
cord-321267-ihd30qi0	129	34	during	during	IN
cord-321267-ihd30qi0	129	35	an	an	DT
cord-321267-ihd30qi0	129	36	epidemic	epidemic	NN
cord-321267-ihd30qi0	129	37	(	(	-LRB-
cord-321267-ihd30qi0	129	38	possible	possible	JJ
cord-321267-ihd30qi0	129	39	examples	example	NNS
cord-321267-ihd30qi0	129	40	being	be	VBG
cord-321267-ihd30qi0	129	41	the	the	DT
cord-321267-ihd30qi0	129	42	use	use	NN
cord-321267-ihd30qi0	129	43	of	of	IN
cord-321267-ihd30qi0	129	44	IL-6	IL-6	NNP
cord-321267-ihd30qi0	129	45	inhibitors	inhibitor	NNS
cord-321267-ihd30qi0	129	46	and	and	CC
cord-321267-ihd30qi0	129	47	steroids	steroid	NNS
cord-321267-ihd30qi0	129	48	;	;	:
cord-321267-ihd30qi0	129	49	see	see	VB
cord-321267-ihd30qi0	129	50	:	:	:
cord-321267-ihd30qi0	129	51	Kalil	Kalil	NNP
cord-321267-ihd30qi0	129	52	2020	2020	CD
cord-321267-ihd30qi0	129	53	)	)	-RRB-
cord-321267-ihd30qi0	129	54	.	.	.
cord-321267-ihd30qi0	130	1	Conversely	conversely	RB
cord-321267-ihd30qi0	130	2	,	,	,
cord-321267-ihd30qi0	130	3	also	also	RB
cord-321267-ihd30qi0	130	4	for	for	IN
cord-321267-ihd30qi0	130	5	the	the	DT
cord-321267-ihd30qi0	130	6	positive	positive	JJ
cord-321267-ihd30qi0	130	7	-	-	HYPH
cord-321267-ihd30qi0	130	8	test	test	NN
cord-321267-ihd30qi0	130	9	group	group	NN
cord-321267-ihd30qi0	130	10	,	,	,
cord-321267-ihd30qi0	130	11	a	a	DT
cord-321267-ihd30qi0	130	12	lower	low	JJR
cord-321267-ihd30qi0	130	13	D	d	NN
cord-321267-ihd30qi0	130	14	x	x	NN
cord-321267-ihd30qi0	130	15	UR	ur	NN
cord-321267-ihd30qi0	130	16	for	for	IN
cord-321267-ihd30qi0	130	17	a	a	DT
cord-321267-ihd30qi0	130	18	particular	particular	JJ
cord-321267-ihd30qi0	130	19	drug	drug	NN
cord-321267-ihd30qi0	130	20	among	among	IN
cord-321267-ihd30qi0	130	21	severe	severe	JJ
cord-321267-ihd30qi0	130	22	and	and	CC
cord-321267-ihd30qi0	130	23	critical	critical	JJ
cord-321267-ihd30qi0	130	24	cases	case	NNS
cord-321267-ihd30qi0	130	25	(	(	-LRB-
cord-321267-ihd30qi0	130	26	or	or	CC
cord-321267-ihd30qi0	130	27	higher	high	JJR
cord-321267-ihd30qi0	130	28	D	d	NN
cord-321267-ihd30qi0	131	1	x	x	SYM
cord-321267-ihd30qi0	131	2	UR	ur	NN
cord-321267-ihd30qi0	131	3	among	among	IN
cord-321267-ihd30qi0	131	4	negative	negative	JJ
cord-321267-ihd30qi0	131	5	cases	case	NNS
cord-321267-ihd30qi0	131	6	)	)	-RRB-
cord-321267-ihd30qi0	131	7	could	could	MD
cord-321267-ihd30qi0	131	8	also	also	RB
cord-321267-ihd30qi0	131	9	indicate	indicate	VB
cord-321267-ihd30qi0	131	10	a	a	DT
cord-321267-ihd30qi0	131	11	protective	protective	JJ
cord-321267-ihd30qi0	131	12	or	or	CC
cord-321267-ihd30qi0	131	13	prophylactic	prophylactic	JJ
cord-321267-ihd30qi0	131	14	effect	effect	NN
cord-321267-ihd30qi0	131	15	of	of	IN
cord-321267-ihd30qi0	131	16	the	the	DT
cord-321267-ihd30qi0	131	17	drug	drug	NN
cord-321267-ihd30qi0	131	18	.	.	.
cord-321267-ihd30qi0	132	1	While	while	IN
cord-321267-ihd30qi0	132	2	the	the	DT
cord-321267-ihd30qi0	132	3	usefulness	usefulness	NN
cord-321267-ihd30qi0	132	4	of	of	IN
cord-321267-ihd30qi0	132	5	positive	positive	JJ
cord-321267-ihd30qi0	132	6	cases	case	NNS
cord-321267-ihd30qi0	132	7	for	for	IN
cord-321267-ihd30qi0	132	8	NERD	nerd	NN
cord-321267-ihd30qi0	132	9	is	be	VBZ
cord-321267-ihd30qi0	132	10	straightforward	straightforward	JJ
cord-321267-ihd30qi0	132	11	(	(	-LRB-
cord-321267-ihd30qi0	132	12	indicating	indicate	VBG
cord-321267-ihd30qi0	132	13	drugs	drug	NNS
cord-321267-ihd30qi0	132	14	to	to	TO
cord-321267-ihd30qi0	132	15	possibly	possibly	RB
cord-321267-ihd30qi0	132	16	avoid	avoid	VB
cord-321267-ihd30qi0	132	17	)	)	-RRB-
cord-321267-ihd30qi0	132	18	,	,	,
cord-321267-ihd30qi0	132	19	the	the	DT
cord-321267-ihd30qi0	132	20	predictive	predictive	JJ
cord-321267-ihd30qi0	132	21	power	power	NN
cord-321267-ihd30qi0	132	22	of	of	IN
cord-321267-ihd30qi0	132	23	NERD	nerd	NN
cord-321267-ihd30qi0	132	24	would	would	MD
cord-321267-ihd30qi0	132	25	be	be	VB
cord-321267-ihd30qi0	132	26	maximized	maximize	VBN
cord-321267-ihd30qi0	132	27	by	by	IN
cord-321267-ihd30qi0	132	28	actively	actively	RB
cord-321267-ihd30qi0	132	29	seeking	seek	VBG
cord-321267-ihd30qi0	132	30	out	out	RP
cord-321267-ihd30qi0	132	31	and	and	CC
cord-321267-ihd30qi0	132	32	testing	test	VBG
cord-321267-ihd30qi0	132	33	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	132	34	cases	case	NNS
cord-321267-ihd30qi0	132	35	from	from	IN
cord-321267-ihd30qi0	132	36	the	the	DT
cord-321267-ihd30qi0	132	37	general	general	JJ
cord-321267-ihd30qi0	132	38	population	population	NN
cord-321267-ihd30qi0	132	39	that	that	WDT
cord-321267-ihd30qi0	132	40	never	never	RB
cord-321267-ihd30qi0	132	41	displayed	display	VBD
cord-321267-ihd30qi0	132	42	signs	sign	NNS
cord-321267-ihd30qi0	132	43	and	and	CC
cord-321267-ihd30qi0	132	44	symptoms	symptom	NNS
cord-321267-ihd30qi0	132	45	and	and	CC
cord-321267-ihd30qi0	132	46	therefore	therefore	RB
cord-321267-ihd30qi0	132	47	would	would	MD
cord-321267-ihd30qi0	132	48	have	have	VB
cord-321267-ihd30qi0	132	49	otherwise	otherwise	RB
cord-321267-ihd30qi0	132	50	possibly	possibly	RB
cord-321267-ihd30qi0	132	51	escaped	escape	VBN
cord-321267-ihd30qi0	132	52	diagnostic	diagnostic	JJ
cord-321267-ihd30qi0	132	53	testing	testing	NN
cord-321267-ihd30qi0	132	54	.	.	.
cord-321267-ihd30qi0	133	1	It	-PRON-	PRP
cord-321267-ihd30qi0	133	2	is	be	VBZ
cord-321267-ihd30qi0	133	3	these	these	DT
cord-321267-ihd30qi0	133	4	very	very	JJ
cord-321267-ihd30qi0	133	5	cases	case	NNS
cord-321267-ihd30qi0	133	6	(	(	-LRB-
cord-321267-ihd30qi0	133	7	along	along	IN
cord-321267-ihd30qi0	133	8	with	with	IN
cord-321267-ihd30qi0	133	9	a	a	DT
cord-321267-ihd30qi0	133	10	subgroup	subgroup	NN
cord-321267-ihd30qi0	133	11	of	of	IN
cord-321267-ihd30qi0	133	12	the	the	DT
cord-321267-ihd30qi0	133	13	clinical	clinical	JJ
cord-321267-ihd30qi0	133	14	diagnostic	diagnostic	JJ
cord-321267-ihd30qi0	133	15	negatives	negative	NNS
cord-321267-ihd30qi0	133	16	(	(	-LRB-
cord-321267-ihd30qi0	133	17	see	see	VB
cord-321267-ihd30qi0	133	18	Option	option	NN
cord-321267-ihd30qi0	133	19	#	#	$
cord-321267-ihd30qi0	133	20	1	1	CD
cord-321267-ihd30qi0	133	21	or	or	CC
cord-321267-ihd30qi0	133	22	#	#	$
cord-321267-ihd30qi0	133	23	3	3	CD
cord-321267-ihd30qi0	133	24	in	in	IN
cord-321267-ihd30qi0	133	25	Table	Table	NNP
cord-321267-ihd30qi0	133	26	1	1	CD
cord-321267-ihd30qi0	133	27	)	)	-RRB-
cord-321267-ihd30qi0	133	28	that	that	WDT
cord-321267-ihd30qi0	133	29	could	could	MD
cord-321267-ihd30qi0	133	30	most	most	RBS
cord-321267-ihd30qi0	133	31	likely	likely	RB
cord-321267-ihd30qi0	133	32	reveal	reveal	VB
cord-321267-ihd30qi0	133	33	potential	potential	JJ
cord-321267-ihd30qi0	133	34	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	133	35	drug	drug	NN
cord-321267-ihd30qi0	133	36	candidates	candidate	NNS
cord-321267-ihd30qi0	133	37	.	.	.
cord-321267-ihd30qi0	134	1	Indeed	indeed	RB
cord-321267-ihd30qi0	134	2	,	,	,
cord-321267-ihd30qi0	134	3	widespread	widespread	JJ
cord-321267-ihd30qi0	134	4	epidemiologic	epidemiologic	JJ
cord-321267-ihd30qi0	134	5	surveillance	surveillance	NN
cord-321267-ihd30qi0	134	6	screening	screening	NN
cord-321267-ihd30qi0	134	7	of	of	IN
cord-321267-ihd30qi0	134	8	the	the	DT
cord-321267-ihd30qi0	134	9	general	general	JJ
cord-321267-ihd30qi0	134	10	population	population	NN
cord-321267-ihd30qi0	134	11	for	for	IN
cord-321267-ihd30qi0	134	12	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	134	13	Covid-19	covid-19	NN
cord-321267-ihd30qi0	134	14	has	have	VBZ
cord-321267-ihd30qi0	134	15	been	be	VBN
cord-321267-ihd30qi0	134	16	done	do	VBN
cord-321267-ihd30qi0	134	17	in	in	IN
cord-321267-ihd30qi0	134	18	very	very	RB
cord-321267-ihd30qi0	134	19	few	few	JJ
cord-321267-ihd30qi0	134	20	countries	country	NNS
cord-321267-ihd30qi0	134	21	-Iceland	-iceland	VBP
cord-321267-ihd30qi0	134	22	being	be	VBG
cord-321267-ihd30qi0	134	23	one	one	CD
cord-321267-ihd30qi0	134	24	example	example	NN
cord-321267-ihd30qi0	135	1	(	(	-LRB-
cord-321267-ihd30qi0	135	2	Iceland	Iceland	NNP
cord-321267-ihd30qi0	135	3	,	,	,
cord-321267-ihd30qi0	135	4	Minister	Minister	NNP
cord-321267-ihd30qi0	135	5	of	of	IN
cord-321267-ihd30qi0	135	6	Health	Health	NNP
cord-321267-ihd30qi0	135	7	2020	2020	CD
cord-321267-ihd30qi0	135	8	)	)	-RRB-
cord-321267-ihd30qi0	135	9	.	.	.
cord-321267-ihd30qi0	136	1	A	a	DT
cord-321267-ihd30qi0	136	2	major	major	JJ
cord-321267-ihd30qi0	136	3	limitation	limitation	NN
cord-321267-ihd30qi0	136	4	is	be	VBZ
cord-321267-ihd30qi0	136	5	inherent	inherent	JJ
cord-321267-ihd30qi0	136	6	with	with	IN
cord-321267-ihd30qi0	136	7	NERD	nerd	NN
cord-321267-ihd30qi0	136	8	with	with	IN
cord-321267-ihd30qi0	136	9	its	-PRON-	PRP$
cord-321267-ihd30qi0	136	10	reliance	reliance	NN
cord-321267-ihd30qi0	136	11	on	on	IN
cord-321267-ihd30qi0	136	12	the	the	DT
cord-321267-ihd30qi0	136	13	binary	binary	JJ
cord-321267-ihd30qi0	136	14	choice	choice	NN
cord-321267-ihd30qi0	136	15	of	of	IN
cord-321267-ihd30qi0	136	16	infected	infected	JJ
cord-321267-ihd30qi0	136	17	cases	case	NNS
cord-321267-ihd30qi0	136	18	versus	versus	IN
cord-321267-ihd30qi0	136	19	uninfected	uninfected	JJ
cord-321267-ihd30qi0	136	20	.	.	.
cord-321267-ihd30qi0	137	1	The	the	DT
cord-321267-ihd30qi0	137	2	limitation	limitation	NN
cord-321267-ihd30qi0	137	3	results	result	VBZ
cord-321267-ihd30qi0	137	4	from	from	IN
cord-321267-ihd30qi0	137	5	oversimplifying	oversimplify	VBG
cord-321267-ihd30qi0	137	6	the	the	DT
cord-321267-ihd30qi0	137	7	actual	actual	JJ
cord-321267-ihd30qi0	137	8	process	process	NN
cord-321267-ihd30qi0	137	9	of	of	IN
cord-321267-ihd30qi0	137	10	transmission	transmission	NN
cord-321267-ihd30qi0	137	11	,	,	,
cord-321267-ihd30qi0	137	12	which	which	WDT
cord-321267-ihd30qi0	137	13	is	be	VBZ
cord-321267-ihd30qi0	137	14	undoubtedly	undoubtedly	RB
cord-321267-ihd30qi0	137	15	a	a	DT
cord-321267-ihd30qi0	137	16	function	function	NN
cord-321267-ihd30qi0	137	17	of	of	IN
cord-321267-ihd30qi0	137	18	the	the	DT
cord-321267-ihd30qi0	137	19	magnitude	magnitude	NN
cord-321267-ihd30qi0	137	20	of	of	IN
cord-321267-ihd30qi0	137	21	the	the	DT
cord-321267-ihd30qi0	137	22	delivered	deliver	VBN
cord-321267-ihd30qi0	137	23	dose	dose	NN
cord-321267-ihd30qi0	137	24	of	of	IN
cord-321267-ihd30qi0	137	25	viral	viral	JJ
cord-321267-ihd30qi0	137	26	particles	particle	NNS
cord-321267-ihd30qi0	137	27	.	.	.
cord-321267-ihd30qi0	138	1	This	this	DT
cord-321267-ihd30qi0	138	2	exposure	exposure	NN
cord-321267-ihd30qi0	138	3	"	"	``
cord-321267-ihd30qi0	138	4	intensity	intensity	NN
cord-321267-ihd30qi0	138	5	"	"	''
cord-321267-ihd30qi0	138	6	likely	likely	JJ
cord-321267-ihd30qi0	138	7	results	result	NNS
cord-321267-ihd30qi0	138	8	in	in	IN
cord-321267-ihd30qi0	138	9	a	a	DT
cord-321267-ihd30qi0	138	10	continuum	continuum	NN
cord-321267-ihd30qi0	138	11	of	of	IN
cord-321267-ihd30qi0	138	12	severity	severity	NN
cord-321267-ihd30qi0	138	13	of	of	IN
cord-321267-ihd30qi0	138	14	symptoms	symptom	NNS
cord-321267-ihd30qi0	138	15	,	,	,
cord-321267-ihd30qi0	138	16	rate	rate	NN
cord-321267-ihd30qi0	138	17	of	of	IN
cord-321267-ihd30qi0	138	18	disease	disease	NN
cord-321267-ihd30qi0	138	19	progression	progression	NN
cord-321267-ihd30qi0	138	20	,	,	,
cord-321267-ihd30qi0	138	21	and	and	CC
cord-321267-ihd30qi0	138	22	modulation	modulation	NN
cord-321267-ihd30qi0	138	23	of	of	IN
cord-321267-ihd30qi0	138	24	disease	disease	NN
cord-321267-ihd30qi0	138	25	outcomes	outcome	NNS
cord-321267-ihd30qi0	138	26	.	.	.
cord-321267-ihd30qi0	139	1	But	but	CC
cord-321267-ihd30qi0	139	2	this	this	DT
cord-321267-ihd30qi0	139	3	important	important	JJ
cord-321267-ihd30qi0	139	4	aspect	aspect	NN
cord-321267-ihd30qi0	139	5	of	of	IN
cord-321267-ihd30qi0	139	6	Covid-19	covid-19	NN
cord-321267-ihd30qi0	139	7	is	be	VBZ
cord-321267-ihd30qi0	139	8	ignored	ignore	VBN
cord-321267-ihd30qi0	139	9	in	in	IN
cord-321267-ihd30qi0	139	10	the	the	DT
cord-321267-ihd30qi0	139	11	concept	concept	NN
cord-321267-ihd30qi0	139	12	of	of	IN
cord-321267-ihd30qi0	139	13	NERD	nerd	NN
cord-321267-ihd30qi0	139	14	developed	develop	VBN
cord-321267-ihd30qi0	139	15	here	here	RB
cord-321267-ihd30qi0	139	16	simply	simply	RB
cord-321267-ihd30qi0	139	17	because	because	IN
cord-321267-ihd30qi0	139	18	there	there	EX
cord-321267-ihd30qi0	139	19	is	be	VBZ
cord-321267-ihd30qi0	139	20	no	no	DT
cord-321267-ihd30qi0	139	21	current	current	JJ
cord-321267-ihd30qi0	139	22	way	way	NN
cord-321267-ihd30qi0	139	23	to	to	TO
cord-321267-ihd30qi0	139	24	easily	easily	RB
cord-321267-ihd30qi0	139	25	determine	determine	VB
cord-321267-ihd30qi0	139	26	exposure	exposure	NN
cord-321267-ihd30qi0	139	27	intensity	intensity	NN
cord-321267-ihd30qi0	139	28	.	.	.
cord-321267-ihd30qi0	140	1	It	-PRON-	PRP
cord-321267-ihd30qi0	140	2	is	be	VBZ
cord-321267-ihd30qi0	140	3	important	important	JJ
cord-321267-ihd30qi0	140	4	to	to	TO
cord-321267-ihd30qi0	140	5	recognize	recognize	VB
cord-321267-ihd30qi0	140	6	that	that	IN
cord-321267-ihd30qi0	140	7	it	-PRON-	PRP
cord-321267-ihd30qi0	140	8	is	be	VBZ
cord-321267-ihd30qi0	140	9	within	within	IN
cord-321267-ihd30qi0	140	10	the	the	DT
cord-321267-ihd30qi0	140	11	actual	actual	JJ
cord-321267-ihd30qi0	140	12	complexities	complexity	NNS
cord-321267-ihd30qi0	140	13	of	of	IN
cord-321267-ihd30qi0	140	14	the	the	DT
cord-321267-ihd30qi0	140	15	disease	disease	NN
cord-321267-ihd30qi0	140	16	,	,	,
cord-321267-ihd30qi0	140	17	such	such	JJ
cord-321267-ihd30qi0	140	18	as	as	IN
cord-321267-ihd30qi0	140	19	exposure	exposure	NN
cord-321267-ihd30qi0	140	20	intensity	intensity	NN
cord-321267-ihd30qi0	140	21	,	,	,
cord-321267-ihd30qi0	140	22	that	that	IN
cord-321267-ihd30qi0	140	23	NERD	nerd	NN
cord-321267-ihd30qi0	140	24	attempts	attempt	VBZ
cord-321267-ihd30qi0	140	25	to	to	TO
cord-321267-ihd30qi0	140	26	reveal	reveal	VB
cord-321267-ihd30qi0	140	27	drugs	drug	NNS
cord-321267-ihd30qi0	140	28	that	that	WDT
cord-321267-ihd30qi0	140	29	impact	impact	VBP
cord-321267-ihd30qi0	140	30	the	the	DT
cord-321267-ihd30qi0	140	31	disease	disease	NN
cord-321267-ihd30qi0	140	32	.	.	.
cord-321267-ihd30qi0	141	1	So	so	RB
cord-321267-ihd30qi0	141	2	any	any	DT
cord-321267-ihd30qi0	141	3	apparent	apparent	JJ
cord-321267-ihd30qi0	141	4	indication	indication	NN
cord-321267-ihd30qi0	141	5	that	that	IN
cord-321267-ihd30qi0	141	6	a	a	DT
cord-321267-ihd30qi0	141	7	drug	drug	NN
cord-321267-ihd30qi0	141	8	might	may	MD
cord-321267-ihd30qi0	141	9	correlate	correlate	VB
cord-321267-ihd30qi0	141	10	with	with	IN
cord-321267-ihd30qi0	141	11	positive	positive	JJ
cord-321267-ihd30qi0	141	12	or	or	CC
cord-321267-ihd30qi0	141	13	negative	negative	JJ
cord-321267-ihd30qi0	141	14	disease	disease	NN
cord-321267-ihd30qi0	141	15	outcomes	outcome	NNS
cord-321267-ihd30qi0	141	16	might	may	MD
cord-321267-ihd30qi0	141	17	instead	instead	RB
cord-321267-ihd30qi0	141	18	simply	simply	RB
cord-321267-ihd30qi0	141	19	be	be	VB
cord-321267-ihd30qi0	141	20	a	a	DT
cord-321267-ihd30qi0	141	21	confounding	confounding	JJ
cord-321267-ihd30qi0	141	22	reflection	reflection	NN
cord-321267-ihd30qi0	141	23	of	of	IN
cord-321267-ihd30qi0	141	24	the	the	DT
cord-321267-ihd30qi0	141	25	type	type	NN
cord-321267-ihd30qi0	141	26	of	of	IN
cord-321267-ihd30qi0	141	27	exposure	exposure	NN
cord-321267-ihd30qi0	141	28	and	and	CC
cord-321267-ihd30qi0	141	29	not	not	RB
cord-321267-ihd30qi0	141	30	the	the	DT
cord-321267-ihd30qi0	141	31	drug	drug	NN
cord-321267-ihd30qi0	141	32	itself	-PRON-	PRP
cord-321267-ihd30qi0	141	33	.	.	.
cord-321267-ihd30qi0	142	1	Additional	additional	JJ
cord-321267-ihd30qi0	142	2	attributes	attribute	NNS
cord-321267-ihd30qi0	142	3	,	,	,
cord-321267-ihd30qi0	142	4	advantages	advantage	NNS
cord-321267-ihd30qi0	142	5	,	,	,
cord-321267-ihd30qi0	142	6	and	and	CC
cord-321267-ihd30qi0	142	7	limitations	limitation	NNS
cord-321267-ihd30qi0	142	8	of	of	IN
cord-321267-ihd30qi0	142	9	the	the	DT
cord-321267-ihd30qi0	142	10	NERD	nerd	NN
cord-321267-ihd30qi0	142	11	concept	concept	NN
cord-321267-ihd30qi0	142	12	are	be	VBP
cord-321267-ihd30qi0	142	13	compiled	compile	VBN
cord-321267-ihd30qi0	142	14	in	in	IN
cord-321267-ihd30qi0	142	15	Table	Table	NNP
cord-321267-ihd30qi0	142	16	2	2	CD
cord-321267-ihd30qi0	142	17	.	.	.
cord-321267-ihd30qi0	143	1	Worth	worth	JJ
cord-321267-ihd30qi0	143	2	noting	note	VBG
cord-321267-ihd30qi0	143	3	is	be	VBZ
cord-321267-ihd30qi0	143	4	that	that	IN
cord-321267-ihd30qi0	143	5	additional	additional	JJ
cord-321267-ihd30qi0	143	6	opportunities	opportunity	NNS
cord-321267-ihd30qi0	143	7	with	with	IN
cord-321267-ihd30qi0	143	8	the	the	DT
cord-321267-ihd30qi0	143	9	natural	natural	JJ
cord-321267-ihd30qi0	143	10	experiment	experiment	NN
cord-321267-ihd30qi0	143	11	presented	present	VBN
cord-321267-ihd30qi0	143	12	by	by	IN
cord-321267-ihd30qi0	143	13	the	the	DT
cord-321267-ihd30qi0	143	14	Covid-19	covid-19	NN
cord-321267-ihd30qi0	143	15	epidemic	epidemic	NN
cord-321267-ihd30qi0	143	16	(	(	-LRB-
cord-321267-ihd30qi0	143	17	as	as	RB
cord-321267-ihd30qi0	143	18	well	well	RB
cord-321267-ihd30qi0	143	19	as	as	IN
cord-321267-ihd30qi0	143	20	any	any	DT
cord-321267-ihd30qi0	143	21	future	future	JJ
cord-321267-ihd30qi0	143	22	epidemic	epidemic	NN
cord-321267-ihd30qi0	143	23	)	)	-RRB-
cord-321267-ihd30qi0	143	24	include	include	VBP
cord-321267-ihd30qi0	143	25	epidemiologic	epidemiologic	JJ
cord-321267-ihd30qi0	143	26	surveys	survey	NNS
cord-321267-ihd30qi0	143	27	regarding	regard	VBG
cord-321267-ihd30qi0	143	28	not	not	RB
cord-321267-ihd30qi0	143	29	just	just	RB
cord-321267-ihd30qi0	143	30	common	common	JJ
cord-321267-ihd30qi0	143	31	risk	risk	NN
cord-321267-ihd30qi0	143	32	factors	factor	NNS
cord-321267-ihd30qi0	143	33	such	such	JJ
cord-321267-ihd30qi0	143	34	as	as	IN
cord-321267-ihd30qi0	143	35	smoking	smoking	NN
cord-321267-ihd30qi0	143	36	,	,	,
cord-321267-ihd30qi0	143	37	but	but	CC
cord-321267-ihd30qi0	143	38	also	also	RB
cord-321267-ihd30qi0	143	39	occupational	occupational	JJ
cord-321267-ihd30qi0	143	40	exposures	exposure	NNS
cord-321267-ihd30qi0	143	41	and	and	CC
cord-321267-ihd30qi0	143	42	real	real	JJ
cord-321267-ihd30qi0	143	43	-	-	HYPH
cord-321267-ihd30qi0	143	44	world	world	NN
cord-321267-ihd30qi0	143	45	inadvertent	inadvertent	JJ
cord-321267-ihd30qi0	143	46	human	human	JJ
cord-321267-ihd30qi0	143	47	exposures	exposure	NNS
cord-321267-ihd30qi0	143	48	to	to	IN
cord-321267-ihd30qi0	143	49	known	know	VBN
cord-321267-ihd30qi0	143	50	environmental	environmental	JJ
cord-321267-ihd30qi0	143	51	hazards	hazard	NNS
cord-321267-ihd30qi0	143	52	(	(	-LRB-
cord-321267-ihd30qi0	143	53	e.g.	e.g.	RB
cord-321267-ihd30qi0	143	54	,	,	,
cord-321267-ihd30qi0	143	55	volatile	volatile	JJ
cord-321267-ihd30qi0	143	56	algal	algal	JJ
cord-321267-ihd30qi0	143	57	toxins	toxin	NNS
cord-321267-ihd30qi0	143	58	and	and	CC
cord-321267-ihd30qi0	143	59	pulmonary	pulmonary	JJ
cord-321267-ihd30qi0	143	60	toxicants	toxicant	NNS
cord-321267-ihd30qi0	143	61	such	such	JJ
cord-321267-ihd30qi0	143	62	as	as	IN
cord-321267-ihd30qi0	143	63	atmospheric	atmospheric	JJ
cord-321267-ihd30qi0	143	64	particulate	particulate	NN
cord-321267-ihd30qi0	143	65	matter	matter	NN
cord-321267-ihd30qi0	143	66	and	and	CC
cord-321267-ihd30qi0	143	67	synthetic	synthetic	JJ
cord-321267-ihd30qi0	143	68	chemicals	chemical	NNS
cord-321267-ihd30qi0	143	69	,	,	,
cord-321267-ihd30qi0	143	70	asbestos	asbestos	NN
cord-321267-ihd30qi0	143	71	,	,	,
cord-321267-ihd30qi0	143	72	silica	silica	NN
cord-321267-ihd30qi0	143	73	,	,	,
cord-321267-ihd30qi0	143	74	and	and	CC
cord-321267-ihd30qi0	143	75	beryllium	beryllium	NN
cord-321267-ihd30qi0	143	76	)	)	-RRB-
cord-321267-ihd30qi0	143	77	.	.	.
cord-321267-ihd30qi0	144	1	In	in	IN
cord-321267-ihd30qi0	144	2	particular	particular	JJ
cord-321267-ihd30qi0	144	3	,	,	,
cord-321267-ihd30qi0	144	4	the	the	DT
cord-321267-ihd30qi0	144	5	possibility	possibility	NN
cord-321267-ihd30qi0	144	6	exists	exist	VBZ
cord-321267-ihd30qi0	144	7	for	for	IN
cord-321267-ihd30qi0	144	8	discovering	discover	VBG
cord-321267-ihd30qi0	144	9	whether	whether	IN
cord-321267-ihd30qi0	144	10	such	such	JJ
cord-321267-ihd30qi0	144	11	non	non	JJ
cord-321267-ihd30qi0	144	12	-	-	JJ
cord-321267-ihd30qi0	144	13	drug	drug	JJ
cord-321267-ihd30qi0	144	14	exposures	exposure	NNS
cord-321267-ihd30qi0	144	15	increase	increase	VBP
cord-321267-ihd30qi0	144	16	the	the	DT
cord-321267-ihd30qi0	144	17	susceptibility	susceptibility	NN
cord-321267-ihd30qi0	144	18	or	or	CC
cord-321267-ihd30qi0	144	19	vulnerability	vulnerability	NN
cord-321267-ihd30qi0	144	20	to	to	IN
cord-321267-ihd30qi0	144	21	more	more	RBR
cord-321267-ihd30qi0	144	22	serious	serious	JJ
cord-321267-ihd30qi0	144	23	Covid-19	covid-19	JJ
cord-321267-ihd30qi0	144	24	outcomes	outcome	NNS
cord-321267-ihd30qi0	144	25	.	.	.
cord-321267-ihd30qi0	145	1	This	this	DT
cord-321267-ihd30qi0	145	2	might	may	MD
cord-321267-ihd30qi0	145	3	be	be	VB
cord-321267-ihd30qi0	145	4	especially	especially	RB
cord-321267-ihd30qi0	145	5	germane	germane	JJ
cord-321267-ihd30qi0	145	6	to	to	IN
cord-321267-ihd30qi0	145	7	explaining	explain	VBG
cord-321267-ihd30qi0	145	8	cases	case	NNS
cord-321267-ihd30qi0	145	9	of	of	IN
cord-321267-ihd30qi0	145	10	serious	serious	JJ
cord-321267-ihd30qi0	145	11	Covid-19	covid-19	NN
cord-321267-ihd30qi0	145	12	disease	disease	NN
cord-321267-ihd30qi0	145	13	among	among	IN
cord-321267-ihd30qi0	145	14	healthy	healthy	JJ
cord-321267-ihd30qi0	145	15	younger	young	JJR
cord-321267-ihd30qi0	145	16	adults	adult	NNS
cord-321267-ihd30qi0	145	17	and	and	CC
cord-321267-ihd30qi0	145	18	reported	report	VBN
cord-321267-ihd30qi0	145	19	gender	gender	NN
cord-321267-ihd30qi0	145	20	and	and	CC
cord-321267-ihd30qi0	145	21	racial	racial	JJ
cord-321267-ihd30qi0	145	22	disparities	disparity	NNS
cord-321267-ihd30qi0	145	23	.	.	.
cord-321267-ihd30qi0	146	1	This	this	DT
cord-321267-ihd30qi0	146	2	would	would	MD
cord-321267-ihd30qi0	146	3	entail	entail	VB
cord-321267-ihd30qi0	146	4	a	a	DT
cord-321267-ihd30qi0	146	5	more	more	RBR
cord-321267-ihd30qi0	146	6	ambitious	ambitious	JJ
cord-321267-ihd30qi0	146	7	data	datum	NNS
cord-321267-ihd30qi0	146	8	collection	collection	NN
cord-321267-ihd30qi0	146	9	effort	effort	NN
cord-321267-ihd30qi0	146	10	involving	involve	VBG
cord-321267-ihd30qi0	146	11	collaboration	collaboration	NN
cord-321267-ihd30qi0	146	12	with	with	IN
cord-321267-ihd30qi0	146	13	industrial	industrial	JJ
cord-321267-ihd30qi0	146	14	and	and	CC
cord-321267-ihd30qi0	146	15	environmental	environmental	JJ
cord-321267-ihd30qi0	146	16	toxicologists	toxicologist	NNS
cord-321267-ihd30qi0	146	17	to	to	TO
cord-321267-ihd30qi0	146	18	extend	extend	VB
cord-321267-ihd30qi0	146	19	the	the	DT
cord-321267-ihd30qi0	146	20	utility	utility	NN
cord-321267-ihd30qi0	146	21	beyond	beyond	IN
cord-321267-ihd30qi0	146	22	drug	drug	NN
cord-321267-ihd30qi0	146	23	usage	usage	NN
cord-321267-ihd30qi0	146	24	by	by	IN
cord-321267-ihd30qi0	146	25	broadening	broaden	VBG
cord-321267-ihd30qi0	146	26	the	the	DT
cord-321267-ihd30qi0	146	27	exposome	exposome	NN
cord-321267-ihd30qi0	146	28	and	and	CC
cord-321267-ihd30qi0	146	29	incorporating	incorporate	VBG
cord-321267-ihd30qi0	146	30	known	know	VBN
cord-321267-ihd30qi0	146	31	occupational	occupational	JJ
cord-321267-ihd30qi0	146	32	and	and	CC
cord-321267-ihd30qi0	146	33	environmental	environmental	JJ
cord-321267-ihd30qi0	146	34	hazards	hazard	NNS
cord-321267-ihd30qi0	146	35	.	.	.
cord-321267-ihd30qi0	147	1	Finally	finally	RB
cord-321267-ihd30qi0	147	2	,	,	,
cord-321267-ihd30qi0	147	3	another	another	DT
cord-321267-ihd30qi0	147	4	unique	unique	JJ
cord-321267-ihd30qi0	147	5	possibility	possibility	NN
cord-321267-ihd30qi0	147	6	may	may	MD
cord-321267-ihd30qi0	147	7	exist	exist	VB
cord-321267-ihd30qi0	147	8	for	for	IN
cord-321267-ihd30qi0	147	9	verifying	verify	VBG
cord-321267-ihd30qi0	147	10	the	the	DT
cord-321267-ihd30qi0	147	11	findings	finding	NNS
cord-321267-ihd30qi0	147	12	of	of	IN
cord-321267-ihd30qi0	147	13	NERD	NERD	NNP
cord-321267-ihd30qi0	147	14	.	.	.
cord-321267-ihd30qi0	148	1	The	the	DT
cord-321267-ihd30qi0	148	2	relatively	relatively	RB
cord-321267-ihd30qi0	148	3	new	new	JJ
cord-321267-ihd30qi0	148	4	monitoring	monitoring	NN
cord-321267-ihd30qi0	148	5	approach	approach	NN
cord-321267-ihd30qi0	148	6	called	call	VBN
cord-321267-ihd30qi0	148	7	wastewater	wastewater	NN
cord-321267-ihd30qi0	148	8	-	-	HYPH
cord-321267-ihd30qi0	148	9	based	base	VBN
cord-321267-ihd30qi0	148	10	epidemiology	epidemiology	NN
cord-321267-ihd30qi0	148	11	(	(	-LRB-
cord-321267-ihd30qi0	148	12	WBE	WBE	NNP
cord-321267-ihd30qi0	148	13	)	)	-RRB-
cord-321267-ihd30qi0	148	14	has	have	VBZ
cord-321267-ihd30qi0	148	15	been	be	VBN
cord-321267-ihd30qi0	148	16	in	in	IN
cord-321267-ihd30qi0	148	17	use	use	NN
cord-321267-ihd30qi0	148	18	for	for	IN
cord-321267-ihd30qi0	148	19	identifying	identify	VBG
cord-321267-ihd30qi0	148	20	drugs	drug	NNS
cord-321267-ihd30qi0	148	21	that	that	WDT
cord-321267-ihd30qi0	148	22	are	be	VBP
cord-321267-ihd30qi0	148	23	collectively	collectively	RB
cord-321267-ihd30qi0	148	24	consumed	consume	VBN
cord-321267-ihd30qi0	148	25	across	across	IN
cord-321267-ihd30qi0	148	26	entire	entire	JJ
cord-321267-ihd30qi0	148	27	communities	community	NNS
cord-321267-ihd30qi0	148	28	.	.	.
cord-321267-ihd30qi0	149	1	One	one	CD
cord-321267-ihd30qi0	149	2	of	of	IN
cord-321267-ihd30qi0	149	3	the	the	DT
cord-321267-ihd30qi0	149	4	primary	primary	JJ
cord-321267-ihd30qi0	149	5	applications	application	NNS
cord-321267-ihd30qi0	149	6	of	of	IN
cord-321267-ihd30qi0	149	7	WBE	WBE	NNP
cord-321267-ihd30qi0	149	8	has	have	VBZ
cord-321267-ihd30qi0	149	9	been	be	VBN
cord-321267-ihd30qi0	149	10	the	the	DT
cord-321267-ihd30qi0	149	11	monitoring	monitoring	NN
cord-321267-ihd30qi0	149	12	of	of	IN
cord-321267-ihd30qi0	149	13	sewage	sewage	NN
cord-321267-ihd30qi0	149	14	for	for	IN
cord-321267-ihd30qi0	149	15	drugs	drug	NNS
cord-321267-ihd30qi0	149	16	(	(	-LRB-
cord-321267-ihd30qi0	149	17	or	or	CC
cord-321267-ihd30qi0	149	18	their	-PRON-	PRP$
cord-321267-ihd30qi0	149	19	metabolites	metabolite	NNS
cord-321267-ihd30qi0	149	20	)	)	-RRB-
cord-321267-ihd30qi0	149	21	and	and	CC
cord-321267-ihd30qi0	149	22	back	back	RB
cord-321267-ihd30qi0	149	23	-	-	HYPH
cord-321267-ihd30qi0	149	24	calculating	calculate	VBG
cord-321267-ihd30qi0	149	25	per	per	IN
cord-321267-ihd30qi0	149	26	capita	capita	FW
cord-321267-ihd30qi0	149	27	consumption	consumption	NN
cord-321267-ihd30qi0	149	28	(	(	-LRB-
cord-321267-ihd30qi0	149	29	Sims	Sims	NNP
cord-321267-ihd30qi0	149	30	and	and	CC
cord-321267-ihd30qi0	149	31	Kasprzyk	Kasprzyk	NNP
cord-321267-ihd30qi0	149	32	-	-	HYPH
cord-321267-ihd30qi0	149	33	Hordern	Hordern	NNP
cord-321267-ihd30qi0	149	34	2020	2020	CD
cord-321267-ihd30qi0	149	35	)	)	-RRB-
cord-321267-ihd30qi0	149	36	.	.	.
cord-321267-ihd30qi0	150	1	WBE	WBE	NNP
cord-321267-ihd30qi0	150	2	has	have	VBZ
cord-321267-ihd30qi0	150	3	also	also	RB
cord-321267-ihd30qi0	150	4	been	be	VBN
cord-321267-ihd30qi0	150	5	used	use	VBN
cord-321267-ihd30qi0	150	6	for	for	IN
cord-321267-ihd30qi0	150	7	monitoring	monitor	VBG
cord-321267-ihd30qi0	150	8	the	the	DT
cord-321267-ihd30qi0	150	9	presence	presence	NN
cord-321267-ihd30qi0	150	10	of	of	IN
cord-321267-ihd30qi0	150	11	pathogens	pathogen	NNS
cord-321267-ihd30qi0	150	12	such	such	JJ
cord-321267-ihd30qi0	150	13	as	as	IN
cord-321267-ihd30qi0	150	14	viruses	virus	NNS
cord-321267-ihd30qi0	150	15	(	(	-LRB-
cord-321267-ihd30qi0	150	16	to	to	TO
cord-321267-ihd30qi0	150	17	provide	provide	VB
cord-321267-ihd30qi0	150	18	early	early	JJ
cord-321267-ihd30qi0	150	19	warnings	warning	NNS
cord-321267-ihd30qi0	150	20	for	for	IN
cord-321267-ihd30qi0	150	21	emerging	emerge	VBG
cord-321267-ihd30qi0	150	22	outbreaks	outbreak	NNS
cord-321267-ihd30qi0	150	23	)	)	-RRB-
cord-321267-ihd30qi0	150	24	and	and	CC
cord-321267-ihd30qi0	150	25	more	more	RBR
cord-321267-ihd30qi0	150	26	recently	recently	RB
cord-321267-ihd30qi0	150	27	proposed	propose	VBN
cord-321267-ihd30qi0	150	28	for	for	IN
cord-321267-ihd30qi0	150	29	gauging	gauge	VBG
cord-321267-ihd30qi0	150	30	community	community	NN
cord-321267-ihd30qi0	150	31	-	-	HYPH
cord-321267-ihd30qi0	150	32	wide	wide	JJ
cord-321267-ihd30qi0	150	33	overall	overall	JJ
cord-321267-ihd30qi0	150	34	health	health	NN
cord-321267-ihd30qi0	150	35	(	(	-LRB-
cord-321267-ihd30qi0	150	36	Daughton	Daughton	NNP
cord-321267-ihd30qi0	150	37	2018	2018	CD
cord-321267-ihd30qi0	150	38	;	;	:
cord-321267-ihd30qi0	150	39	Choi	Choi	NNP
cord-321267-ihd30qi0	150	40	2018	2018	CD
cord-321267-ihd30qi0	150	41	)	)	-RRB-
cord-321267-ihd30qi0	150	42	or	or	CC
cord-321267-ihd30qi0	150	43	for	for	IN
cord-321267-ihd30qi0	150	44	gauging	gauge	VBG
cord-321267-ihd30qi0	150	45	community	community	NN
cord-321267-ihd30qi0	150	46	-	-	HYPH
cord-321267-ihd30qi0	150	47	wide	wide	JJ
cord-321267-ihd30qi0	150	48	status	status	NN
cord-321267-ihd30qi0	150	49	and	and	CC
cord-321267-ihd30qi0	150	50	trends	trend	NNS
cord-321267-ihd30qi0	150	51	of	of	IN
cord-321267-ihd30qi0	150	52	infection	infection	NN
cord-321267-ihd30qi0	150	53	(	(	-LRB-
cord-321267-ihd30qi0	150	54	Daughton	Daughton	NNP
cord-321267-ihd30qi0	150	55	2020	2020	CD
cord-321267-ihd30qi0	150	56	)	)	-RRB-
cord-321267-ihd30qi0	150	57	.	.	.
cord-321267-ihd30qi0	151	1	WBE	WBE	NNP
cord-321267-ihd30qi0	151	2	could	could	MD
cord-321267-ihd30qi0	151	3	therefore	therefore	RB
cord-321267-ihd30qi0	151	4	possibly	possibly	RB
cord-321267-ihd30qi0	151	5	be	be	VB
cord-321267-ihd30qi0	151	6	used	use	VBN
cord-321267-ihd30qi0	151	7	to	to	TO
cord-321267-ihd30qi0	151	8	complement	complement	VB
cord-321267-ihd30qi0	151	9	and	and	CC
cord-321267-ihd30qi0	151	10	verify	verify	VB
cord-321267-ihd30qi0	151	11	the	the	DT
cord-321267-ihd30qi0	151	12	findings	finding	NNS
cord-321267-ihd30qi0	151	13	of	of	IN
cord-321267-ihd30qi0	151	14	NERD	NERD	NNP
cord-321267-ihd30qi0	151	15	.	.	.
cord-321267-ihd30qi0	152	1	For	for	IN
cord-321267-ihd30qi0	152	2	example	example	NN
cord-321267-ihd30qi0	152	3	,	,	,
cord-321267-ihd30qi0	152	4	drugs	drug	NNS
cord-321267-ihd30qi0	152	5	found	find	VBN
cord-321267-ihd30qi0	152	6	by	by	IN
cord-321267-ihd30qi0	152	7	NERD	NERD	NNP
cord-321267-ihd30qi0	152	8	to	to	TO
cord-321267-ihd30qi0	152	9	be	be	VB
cord-321267-ihd30qi0	152	10	predominantly	predominantly	RB
cord-321267-ihd30qi0	152	11	associated	associate	VBN
cord-321267-ihd30qi0	152	12	with	with	IN
cord-321267-ihd30qi0	152	13	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	152	14	or	or	CC
cord-321267-ihd30qi0	152	15	mild	mild	JJ
cord-321267-ihd30qi0	152	16	cases	case	NNS
cord-321267-ihd30qi0	152	17	of	of	IN
cord-321267-ihd30qi0	152	18	Covid-19	covid-19	NN
cord-321267-ihd30qi0	152	19	could	could	MD
cord-321267-ihd30qi0	152	20	be	be	VB
cord-321267-ihd30qi0	152	21	targeted	target	VBN
cord-321267-ihd30qi0	152	22	for	for	IN
cord-321267-ihd30qi0	152	23	WBE	WBE	NNP
cord-321267-ihd30qi0	152	24	monitoring	monitoring	NN
cord-321267-ihd30qi0	152	25	in	in	IN
cord-321267-ihd30qi0	152	26	communities	community	NNS
cord-321267-ihd30qi0	152	27	suspected	suspect	VBN
cord-321267-ihd30qi0	152	28	as	as	IN
cord-321267-ihd30qi0	152	29	having	have	VBG
cord-321267-ihd30qi0	152	30	low	low	JJ
cord-321267-ihd30qi0	152	31	infection	infection	NN
cord-321267-ihd30qi0	152	32	rates	rate	NNS
cord-321267-ihd30qi0	152	33	;	;	:
cord-321267-ihd30qi0	152	34	note	note	VBP
cord-321267-ihd30qi0	152	35	that	that	IN
cord-321267-ihd30qi0	152	36	the	the	DT
cord-321267-ihd30qi0	152	37	overall	overall	JJ
cord-321267-ihd30qi0	152	38	rates	rate	NNS
cord-321267-ihd30qi0	152	39	of	of	IN
cord-321267-ihd30qi0	152	40	community	community	NN
cord-321267-ihd30qi0	152	41	infection	infection	NN
cord-321267-ihd30qi0	152	42	could	could	MD
cord-321267-ihd30qi0	152	43	also	also	RB
cord-321267-ihd30qi0	152	44	be	be	VB
cord-321267-ihd30qi0	152	45	gauged	gauge	VBN
cord-321267-ihd30qi0	152	46	by	by	IN
cord-321267-ihd30qi0	152	47	WBE	WBE	NNP
cord-321267-ihd30qi0	152	48	(	(	-LRB-
cord-321267-ihd30qi0	152	49	e.g.	e.g.	RB
cord-321267-ihd30qi0	152	50	,	,	,
cord-321267-ihd30qi0	152	51	see	see	VB
cord-321267-ihd30qi0	152	52	:	:	:
cord-321267-ihd30qi0	152	53	Medema	Medema	NNP
cord-321267-ihd30qi0	152	54	et	et	NNP
cord-321267-ihd30qi0	152	55	al	al	NNP
cord-321267-ihd30qi0	152	56	2020	2020	CD
cord-321267-ihd30qi0	152	57	;	;	:
cord-321267-ihd30qi0	152	58	Wu	Wu	NNP
cord-321267-ihd30qi0	152	59	et	et	NNP
cord-321267-ihd30qi0	152	60	al	al	NNP
cord-321267-ihd30qi0	152	61	.	.	NNP
cord-321267-ihd30qi0	152	62	2020	2020	CD
cord-321267-ihd30qi0	152	63	)	)	-RRB-
cord-321267-ihd30qi0	152	64	.	.	.
cord-321267-ihd30qi0	153	1	Conversely	conversely	RB
cord-321267-ihd30qi0	153	2	,	,	,
cord-321267-ihd30qi0	153	3	drugs	drug	NNS
cord-321267-ihd30qi0	153	4	found	find	VBD
cord-321267-ihd30qi0	153	5	to	to	TO
cord-321267-ihd30qi0	153	6	be	be	VB
cord-321267-ihd30qi0	153	7	predominantly	predominantly	RB
cord-321267-ihd30qi0	153	8	associated	associate	VBN
cord-321267-ihd30qi0	153	9	with	with	IN
cord-321267-ihd30qi0	153	10	severe	severe	JJ
cord-321267-ihd30qi0	153	11	or	or	CC
cord-321267-ihd30qi0	153	12	critical	critical	JJ
cord-321267-ihd30qi0	153	13	cases	case	NNS
cord-321267-ihd30qi0	153	14	of	of	IN
cord-321267-ihd30qi0	153	15	Covid-19	covid-19	NN
cord-321267-ihd30qi0	153	16	could	could	MD
cord-321267-ihd30qi0	153	17	be	be	VB
cord-321267-ihd30qi0	153	18	targeted	target	VBN
cord-321267-ihd30qi0	153	19	for	for	IN
cord-321267-ihd30qi0	153	20	WBE	WBE	NNP
cord-321267-ihd30qi0	153	21	monitoring	monitoring	NN
cord-321267-ihd30qi0	153	22	in	in	IN
cord-321267-ihd30qi0	153	23	communities	community	NNS
cord-321267-ihd30qi0	153	24	suspected	suspect	VBN
cord-321267-ihd30qi0	153	25	as	as	IN
cord-321267-ihd30qi0	153	26	having	have	VBG
cord-321267-ihd30qi0	153	27	high	high	JJ
cord-321267-ihd30qi0	153	28	infection	infection	NN
cord-321267-ihd30qi0	153	29	rates	rate	NNS
cord-321267-ihd30qi0	153	30	.	.	.
cord-321267-ihd30qi0	154	1	Likewise	likewise	RB
cord-321267-ihd30qi0	154	2	,	,	,
cord-321267-ihd30qi0	154	3	WBE	WBE	NNP
cord-321267-ihd30qi0	154	4	could	could	MD
cord-321267-ihd30qi0	154	5	be	be	VB
cord-321267-ihd30qi0	154	6	used	use	VBN
cord-321267-ihd30qi0	154	7	to	to	TO
cord-321267-ihd30qi0	154	8	quickly	quickly	RB
cord-321267-ihd30qi0	154	9	assess	assess	VB
cord-321267-ihd30qi0	154	10	which	which	WDT
cord-321267-ihd30qi0	154	11	communities	community	NNS
cord-321267-ihd30qi0	154	12	may	may	MD
cord-321267-ihd30qi0	154	13	have	have	VB
cord-321267-ihd30qi0	154	14	high	high	JJ
cord-321267-ihd30qi0	154	15	infection	infection	NN
cord-321267-ihd30qi0	154	16	rates	rate	NNS
cord-321267-ihd30qi0	154	17	,	,	,
cord-321267-ihd30qi0	154	18	and	and	CC
cord-321267-ihd30qi0	154	19	then	then	RB
cord-321267-ihd30qi0	154	20	target	target	VB
cord-321267-ihd30qi0	154	21	these	these	DT
cord-321267-ihd30qi0	154	22	communities	community	NNS
cord-321267-ihd30qi0	154	23	for	for	IN
cord-321267-ihd30qi0	154	24	testing	testing	NN
cord-321267-ihd30qi0	154	25	of	of	IN
cord-321267-ihd30qi0	154	26	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	154	27	individuals	individual	NNS
cord-321267-ihd30qi0	154	28	.	.	.
cord-321267-ihd30qi0	155	1	Surveillance	surveillance	NN
cord-321267-ihd30qi0	155	2	testing	testing	NN
cord-321267-ihd30qi0	155	3	and	and	CC
cord-321267-ihd30qi0	155	4	diagnostic	diagnostic	JJ
cord-321267-ihd30qi0	155	5	testing	testing	NN
cord-321267-ihd30qi0	155	6	are	be	VBP
cord-321267-ihd30qi0	155	7	critical	critical	JJ
cord-321267-ihd30qi0	155	8	tools	tool	NNS
cord-321267-ihd30qi0	155	9	for	for	IN
cord-321267-ihd30qi0	155	10	timely	timely	JJ
cord-321267-ihd30qi0	155	11	detection	detection	NN
cord-321267-ihd30qi0	155	12	,	,	,
cord-321267-ihd30qi0	155	13	control	control	NN
cord-321267-ihd30qi0	155	14	,	,	,
cord-321267-ihd30qi0	155	15	and	and	CC
cord-321267-ihd30qi0	155	16	mitigation	mitigation	NN
cord-321267-ihd30qi0	155	17	of	of	IN
cord-321267-ihd30qi0	155	18	any	any	DT
cord-321267-ihd30qi0	155	19	disease	disease	NN
cord-321267-ihd30qi0	155	20	epidemic	epidemic	NN
cord-321267-ihd30qi0	155	21	.	.	.
cord-321267-ihd30qi0	156	1	Testing	testing	NN
cord-321267-ihd30qi0	156	2	during	during	IN
cord-321267-ihd30qi0	156	3	epidemics	epidemic	NNS
cord-321267-ihd30qi0	156	4	provides	provide	VBZ
cord-321267-ihd30qi0	156	5	rare	rare	JJ
cord-321267-ihd30qi0	156	6	opportunities	opportunity	NNS
cord-321267-ihd30qi0	156	7	to	to	TO
cord-321267-ihd30qi0	156	8	capitalize	capitalize	VB
cord-321267-ihd30qi0	156	9	on	on	IN
cord-321267-ihd30qi0	156	10	natural	natural	JJ
cord-321267-ihd30qi0	156	11	experiments	experiment	NNS
cord-321267-ihd30qi0	156	12	for	for	IN
cord-321267-ihd30qi0	156	13	expanding	expand	VBG
cord-321267-ihd30qi0	156	14	what	what	WP
cord-321267-ihd30qi0	156	15	is	be	VBZ
cord-321267-ihd30qi0	156	16	known	know	VBN
cord-321267-ihd30qi0	156	17	about	about	IN
cord-321267-ihd30qi0	156	18	exposure	exposure	NN
cord-321267-ihd30qi0	156	19	,	,	,
cord-321267-ihd30qi0	156	20	transmission	transmission	NN
cord-321267-ihd30qi0	156	21	,	,	,
cord-321267-ihd30qi0	156	22	disease	disease	NN
cord-321267-ihd30qi0	156	23	progression	progression	NN
cord-321267-ihd30qi0	156	24	,	,	,
cord-321267-ihd30qi0	156	25	and	and	CC
cord-321267-ihd30qi0	156	26	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	156	27	treatment	treatment	NN
cord-321267-ihd30qi0	156	28	.	.	.
cord-321267-ihd30qi0	157	1	Presented	present	VBN
cord-321267-ihd30qi0	157	2	here	here	RB
cord-321267-ihd30qi0	157	3	is	be	VBZ
cord-321267-ihd30qi0	157	4	a	a	DT
cord-321267-ihd30qi0	157	5	concept	concept	NN
cord-321267-ihd30qi0	157	6	for	for	IN
cord-321267-ihd30qi0	157	7	a	a	DT
cord-321267-ihd30qi0	157	8	potential	potential	JJ
cord-321267-ihd30qi0	157	9	natural	natural	JJ
cord-321267-ihd30qi0	157	10	experiment	experiment	NN
cord-321267-ihd30qi0	157	11	that	that	WDT
cord-321267-ihd30qi0	157	12	could	could	MD
cord-321267-ihd30qi0	157	13	reveal	reveal	VB
cord-321267-ihd30qi0	157	14	existing	exist	VBG
cord-321267-ihd30qi0	157	15	drugs	drug	NNS
cord-321267-ihd30qi0	157	16	(	(	-LRB-
cord-321267-ihd30qi0	157	17	or	or	CC
cord-321267-ihd30qi0	157	18	multi	multi	JJ
cord-321267-ihd30qi0	157	19	-	-	JJ
cord-321267-ihd30qi0	157	20	drug	drug	JJ
cord-321267-ihd30qi0	157	21	combinations	combination	NNS
cord-321267-ihd30qi0	157	22	)	)	-RRB-
cord-321267-ihd30qi0	157	23	that	that	WDT
cord-321267-ihd30qi0	157	24	may	may	MD
cord-321267-ihd30qi0	157	25	have	have	VB
cord-321267-ihd30qi0	157	26	higher	high	JJR
cord-321267-ihd30qi0	157	27	probabilities	probability	NNS
cord-321267-ihd30qi0	157	28	of	of	IN
cord-321267-ihd30qi0	157	29	success	success	NN
cord-321267-ihd30qi0	157	30	in	in	IN
cord-321267-ihd30qi0	157	31	their	-PRON-	PRP$
cord-321267-ihd30qi0	157	32	re	re	NN
cord-321267-ihd30qi0	157	33	-	-	JJ
cord-321267-ihd30qi0	157	34	purposing	purposing	JJ
cord-321267-ihd30qi0	157	35	(	(	-LRB-
cord-321267-ihd30qi0	157	36	re	re	IN
cord-321267-ihd30qi0	157	37	-	-	JJ
cord-321267-ihd30qi0	157	38	positioning	positioning	NN
cord-321267-ihd30qi0	157	39	)	)	-RRB-
cord-321267-ihd30qi0	157	40	for	for	IN
cord-321267-ihd30qi0	157	41	disease	disease	NN
cord-321267-ihd30qi0	157	42	prevention	prevention	NN
cord-321267-ihd30qi0	157	43	or	or	CC
cord-321267-ihd30qi0	157	44	clinical	clinical	JJ
cord-321267-ihd30qi0	157	45	therapy	therapy	NN
cord-321267-ihd30qi0	157	46	-or	-or	:
cord-321267-ihd30qi0	157	47	conversely	conversely	RB
cord-321267-ihd30qi0	157	48	those	those	DT
cord-321267-ihd30qi0	157	49	drugs	drug	NNS
cord-321267-ihd30qi0	157	50	whose	whose	WP$
cord-321267-ihd30qi0	157	51	use	use	NN
cord-321267-ihd30qi0	157	52	should	should	MD
cord-321267-ihd30qi0	157	53	be	be	VB
cord-321267-ihd30qi0	157	54	avoided	avoid	VBN
cord-321267-ihd30qi0	157	55	during	during	IN
cord-321267-ihd30qi0	157	56	infection	infection	NN
cord-321267-ihd30qi0	157	57	.	.	.
cord-321267-ihd30qi0	158	1	This	this	DT
cord-321267-ihd30qi0	158	2	concept	concept	NN
cord-321267-ihd30qi0	158	3	(	(	-LRB-
cord-321267-ihd30qi0	158	4	Natural	Natural	NNP
cord-321267-ihd30qi0	158	5	Experiment	Experiment	NNP
cord-321267-ihd30qi0	158	6	for	for	IN
cord-321267-ihd30qi0	158	7	Re	re	NN
cord-321267-ihd30qi0	158	8	-	-	NN
cord-321267-ihd30qi0	158	9	purposing	purposing	NN
cord-321267-ihd30qi0	158	10	of	of	IN
cord-321267-ihd30qi0	158	11	Drugs	drug	NNS
cord-321267-ihd30qi0	158	12	-NERD	-NERD	,
cord-321267-ihd30qi0	158	13	)	)	-RRB-
cord-321267-ihd30qi0	158	14	would	would	MD
cord-321267-ihd30qi0	158	15	require	require	VB
cord-321267-ihd30qi0	158	16	considerable	considerable	JJ
cord-321267-ihd30qi0	158	17	additional	additional	JJ
cord-321267-ihd30qi0	158	18	discussion	discussion	NN
cord-321267-ihd30qi0	158	19	and	and	CC
cord-321267-ihd30qi0	158	20	examination	examination	NN
cord-321267-ihd30qi0	158	21	before	before	IN
cord-321267-ihd30qi0	158	22	reaching	reach	VBG
cord-321267-ihd30qi0	158	23	any	any	DT
cord-321267-ihd30qi0	158	24	decision	decision	NN
cord-321267-ihd30qi0	158	25	to	to	TO
cord-321267-ihd30qi0	158	26	develop	develop	VB
cord-321267-ihd30qi0	158	27	pilot	pilot	NN
cord-321267-ihd30qi0	158	28	studies	study	NNS
cord-321267-ihd30qi0	158	29	to	to	TO
cord-321267-ihd30qi0	158	30	assess	assess	VB
cord-321267-ihd30qi0	158	31	its	-PRON-	PRP$
cord-321267-ihd30qi0	158	32	potential	potential	JJ
cord-321267-ihd30qi0	158	33	viability	viability	NN
cord-321267-ihd30qi0	158	34	or	or	CC
cord-321267-ihd30qi0	158	35	usefulness	usefulness	NN
cord-321267-ihd30qi0	158	36	.	.	.
cord-321267-ihd30qi0	159	1	If	if	IN
cord-321267-ihd30qi0	159	2	successful	successful	JJ
cord-321267-ihd30qi0	159	3	,	,	,
cord-321267-ihd30qi0	159	4	however	however	RB
cord-321267-ihd30qi0	159	5	,	,	,
cord-321267-ihd30qi0	159	6	the	the	DT
cord-321267-ihd30qi0	159	7	concept	concept	NN
cord-321267-ihd30qi0	159	8	could	could	MD
cord-321267-ihd30qi0	159	9	prove	prove	VB
cord-321267-ihd30qi0	159	10	invaluable	invaluable	JJ
cord-321267-ihd30qi0	159	11	in	in	IN
cord-321267-ihd30qi0	159	12	fighting	fight	VBG
cord-321267-ihd30qi0	159	13	future	future	JJ
cord-321267-ihd30qi0	159	14	epidemics	epidemic	NNS
cord-321267-ihd30qi0	159	15	involving	involve	VBG
cord-321267-ihd30qi0	159	16	novel	novel	NN
cord-321267-ihd30qi0	159	17	pathogens	pathogen	NNS
cord-321267-ihd30qi0	159	18	or	or	CC
cord-321267-ihd30qi0	159	19	mutated	mutate	VBN
cord-321267-ihd30qi0	159	20	strains	strain	NNS
cord-321267-ihd30qi0	159	21	of	of	IN
cord-321267-ihd30qi0	159	22	prior	prior	JJ
cord-321267-ihd30qi0	159	23	pathogens	pathogen	NNS
cord-321267-ihd30qi0	160	1	for	for	IN
cord-321267-ihd30qi0	160	2	which	which	WDT
cord-321267-ihd30qi0	160	3	past	past	NN
cord-321267-ihd30qi0	160	4	immunity	immunity	NN
cord-321267-ihd30qi0	160	5	or	or	CC
cord-321267-ihd30qi0	160	6	previously	previously	RB
cord-321267-ihd30qi0	160	7	effective	effective	JJ
cord-321267-ihd30qi0	160	8	therapies	therapy	NNS
cord-321267-ihd30qi0	160	9	are	be	VBP
cord-321267-ihd30qi0	160	10	no	no	RB
cord-321267-ihd30qi0	160	11	longer	long	RBR
cord-321267-ihd30qi0	160	12	effective	effective	JJ
cord-321267-ihd30qi0	160	13	.	.	.
cord-321267-ihd30qi0	161	1	The	the	DT
cord-321267-ihd30qi0	161	2	author	author	NN
cord-321267-ihd30qi0	161	3	declares	declare	VBZ
cord-321267-ihd30qi0	161	4	no	no	DT
cord-321267-ihd30qi0	161	5	conflict	conflict	NN
cord-321267-ihd30qi0	161	6	of	of	IN
cord-321267-ihd30qi0	161	7	interest	interest	NN
cord-321267-ihd30qi0	161	8	.	.	.
cord-321267-ihd30qi0	162	1	The	the	DT
cord-321267-ihd30qi0	162	2	work	work	NN
cord-321267-ihd30qi0	162	3	had	have	VBD
cord-321267-ihd30qi0	162	4	no	no	DT
cord-321267-ihd30qi0	162	5	affiliation	affiliation	NN
cord-321267-ihd30qi0	162	6	with	with	IN
cord-321267-ihd30qi0	162	7	any	any	DT
cord-321267-ihd30qi0	162	8	public	public	JJ
cord-321267-ihd30qi0	162	9	or	or	CC
cord-321267-ihd30qi0	162	10	private	private	JJ
cord-321267-ihd30qi0	162	11	agency	agency	NN
cord-321267-ihd30qi0	162	12	.	.	.
cord-321267-ihd30qi0	163	1	The	the	DT
cord-321267-ihd30qi0	163	2	concept	concept	NN
cord-321267-ihd30qi0	163	3	and	and	CC
cord-321267-ihd30qi0	163	4	ideas	idea	NNS
cord-321267-ihd30qi0	163	5	presented	present	VBN
cord-321267-ihd30qi0	163	6	did	do	VBD
cord-321267-ihd30qi0	163	7	not	not	RB
cord-321267-ihd30qi0	163	8	originate	originate	VB
cord-321267-ihd30qi0	163	9	from	from	IN
cord-321267-ihd30qi0	163	10	any	any	DT
cord-321267-ihd30qi0	163	11	prior	prior	JJ
cord-321267-ihd30qi0	163	12	published	publish	VBN
cord-321267-ihd30qi0	163	13	works	work	NNS
cord-321267-ihd30qi0	163	14	.	.	.
cord-321267-ihd30qi0	164	1	Could	Could	MD
cord-321267-ihd30qi0	164	2	reveal	reveal	VB
cord-321267-ihd30qi0	164	3	potential	potential	JJ
cord-321267-ihd30qi0	164	4	contraindications	contraindication	NNS
cord-321267-ihd30qi0	164	5	and	and	CC
cord-321267-ihd30qi0	164	6	warn	warn	VBP
cord-321267-ihd30qi0	164	7	of	of	IN
cord-321267-ihd30qi0	164	8	those	those	DT
cord-321267-ihd30qi0	164	9	drugs	drug	NNS
cord-321267-ihd30qi0	164	10	to	to	TO
cord-321267-ihd30qi0	164	11	AVOID	avoid	VB
cord-321267-ihd30qi0	164	12	during	during	IN
cord-321267-ihd30qi0	164	13	or	or	CC
cord-321267-ihd30qi0	164	14	for	for	IN
cord-321267-ihd30qi0	164	15	Covid-19	covid-19	JJ
cord-321267-ihd30qi0	164	16	treatment	treatment	NN
cord-321267-ihd30qi0	164	17	.	.	.
cord-321267-ihd30qi0	165	1	Any	any	DT
cord-321267-ihd30qi0	165	2	knowledge	knowledge	NN
cord-321267-ihd30qi0	165	3	of	of	IN
cord-321267-ihd30qi0	165	4	the	the	DT
cord-321267-ihd30qi0	165	5	pathogen	pathogen	NN
cord-321267-ihd30qi0	165	6	itself	-PRON-	PRP
cord-321267-ihd30qi0	165	7	or	or	CC
cord-321267-ihd30qi0	165	8	disease	disease	NN
cord-321267-ihd30qi0	165	9	progression	progression	NN
cord-321267-ihd30qi0	165	10	would	would	MD
cord-321267-ihd30qi0	165	11	not	not	RB
cord-321267-ihd30qi0	165	12	be	be	VB
cord-321267-ihd30qi0	165	13	needed	need	VBN
cord-321267-ihd30qi0	165	14	because	because	IN
cord-321267-ihd30qi0	165	15	NERD	NERD	NNP
cord-321267-ihd30qi0	165	16	would	would	MD
cord-321267-ihd30qi0	165	17	rely	rely	VB
cord-321267-ihd30qi0	165	18	solely	solely	RB
cord-321267-ihd30qi0	165	19	on	on	IN
cord-321267-ihd30qi0	165	20	real	real	JJ
cord-321267-ihd30qi0	165	21	-	-	HYPH
cord-321267-ihd30qi0	165	22	time	time	NN
cord-321267-ihd30qi0	165	23	,	,	,
cord-321267-ihd30qi0	165	24	real	real	JJ
cord-321267-ihd30qi0	165	25	-	-	HYPH
cord-321267-ihd30qi0	165	26	world	world	NN
cord-321267-ihd30qi0	165	27	evidence	evidence	NN
cord-321267-ihd30qi0	165	28	for	for	IN
cord-321267-ihd30qi0	165	29	selecting	select	VBG
cord-321267-ihd30qi0	165	30	drug	drug	NN
cord-321267-ihd30qi0	165	31	candidates	candidate	NNS
cord-321267-ihd30qi0	165	32	.	.	.
cord-321267-ihd30qi0	166	1	Because	because	IN
cord-321267-ihd30qi0	166	2	of	of	IN
cord-321267-ihd30qi0	166	3	this	this	DT
cord-321267-ihd30qi0	166	4	natural	natural	JJ
cord-321267-ihd30qi0	166	5	process	process	NN
cord-321267-ihd30qi0	166	6	of	of	IN
cord-321267-ihd30qi0	166	7	drug	drug	NN
cord-321267-ihd30qi0	166	8	selection	selection	NN
cord-321267-ihd30qi0	166	9	,	,	,
cord-321267-ihd30qi0	166	10	any	any	DT
cord-321267-ihd30qi0	166	11	selected	select	VBN
cord-321267-ihd30qi0	166	12	drug	drug	NN
cord-321267-ihd30qi0	166	13	candidates	candidate	NNS
cord-321267-ihd30qi0	166	14	for	for	IN
cord-321267-ihd30qi0	166	15	repurposing	repurpose	VBG
cord-321267-ihd30qi0	166	16	would	would	MD
cord-321267-ihd30qi0	166	17	have	have	VB
cord-321267-ihd30qi0	166	18	a	a	DT
cord-321267-ihd30qi0	166	19	higher	high	JJR
cord-321267-ihd30qi0	166	20	probability	probability	NN
cord-321267-ihd30qi0	166	21	of	of	IN
cord-321267-ihd30qi0	166	22	success	success	NN
cord-321267-ihd30qi0	166	23	in	in	IN
cord-321267-ihd30qi0	166	24	phase	phase	NN
cord-321267-ihd30qi0	166	25	3	3	CD
cord-321267-ihd30qi0	166	26	-	-	SYM
cord-321267-ihd30qi0	166	27	4	4	CD
cord-321267-ihd30qi0	166	28	clinical	clinical	JJ
cord-321267-ihd30qi0	166	29	trials	trial	NNS
cord-321267-ihd30qi0	166	30	or	or	CC
cord-321267-ihd30qi0	166	31	for	for	IN
cord-321267-ihd30qi0	166	32	compassionate	compassionate	JJ
cord-321267-ihd30qi0	166	33	use	use	NN
cord-321267-ihd30qi0	166	34	.	.	.
cord-321267-ihd30qi0	167	1	As	as	IN
cord-321267-ihd30qi0	167	2	testing	testing	NN
cord-321267-ihd30qi0	167	3	of	of	IN
cord-321267-ihd30qi0	167	4	a	a	DT
cord-321267-ihd30qi0	167	5	population	population	NN
cord-321267-ihd30qi0	167	6	expands	expand	VBZ
cord-321267-ihd30qi0	167	7	,	,	,
cord-321267-ihd30qi0	167	8	the	the	DT
cord-321267-ihd30qi0	167	9	test	test	NN
cord-321267-ihd30qi0	167	10	population	population	NN
cord-321267-ihd30qi0	167	11	size	size	NN
cord-321267-ihd30qi0	167	12	could	could	MD
cord-321267-ihd30qi0	167	13	be	be	VB
cord-321267-ihd30qi0	167	14	orders	order	NNS
cord-321267-ihd30qi0	167	15	of	of	IN
cord-321267-ihd30qi0	167	16	magnitude	magnitude	NN
cord-321267-ihd30qi0	167	17	larger	large	JJR
cord-321267-ihd30qi0	167	18	than	than	IN
cord-321267-ihd30qi0	167	19	possible	possible	JJ
cord-321267-ihd30qi0	167	20	in	in	IN
cord-321267-ihd30qi0	167	21	any	any	DT
cord-321267-ihd30qi0	167	22	clinical	clinical	JJ
cord-321267-ihd30qi0	167	23	trial	trial	NN
cord-321267-ihd30qi0	167	24	.	.	.
cord-321267-ihd30qi0	168	1	The	the	DT
cord-321267-ihd30qi0	168	2	predictive	predictive	JJ
cord-321267-ihd30qi0	168	3	power	power	NN
cord-321267-ihd30qi0	168	4	of	of	IN
cord-321267-ihd30qi0	168	5	NERD	NERD	NNP
cord-321267-ihd30qi0	168	6	would	would	MD
cord-321267-ihd30qi0	168	7	increase	increase	VB
cord-321267-ihd30qi0	168	8	as	as	IN
cord-321267-ihd30qi0	168	9	the	the	DT
cord-321267-ihd30qi0	168	10	incidence	incidence	NN
cord-321267-ihd30qi0	168	11	of	of	IN
cord-321267-ihd30qi0	168	12	testing	testing	NN
cord-321267-ihd30qi0	168	13	covers	cover	VBZ
cord-321267-ihd30qi0	168	14	an	an	DT
cord-321267-ihd30qi0	168	15	increasingly	increasingly	RB
cord-321267-ihd30qi0	168	16	larger	large	JJR
cord-321267-ihd30qi0	168	17	percentage	percentage	NN
cord-321267-ihd30qi0	168	18	of	of	IN
cord-321267-ihd30qi0	168	19	the	the	DT
cord-321267-ihd30qi0	168	20	randomly	randomly	RB
cord-321267-ihd30qi0	168	21	selected	select	VBN
cord-321267-ihd30qi0	168	22	general	general	JJ
cord-321267-ihd30qi0	168	23	population	population	NN
cord-321267-ihd30qi0	168	24	.	.	.
cord-321267-ihd30qi0	169	1	The	the	DT
cord-321267-ihd30qi0	169	2	approach	approach	NN
cord-321267-ihd30qi0	169	3	naturally	naturally	RB
cord-321267-ihd30qi0	169	4	incorporates	incorporate	VBZ
cord-321267-ihd30qi0	169	5	its	-PRON-	PRP$
cord-321267-ihd30qi0	169	6	own	own	JJ
cord-321267-ihd30qi0	169	7	inherent	inherent	JJ
cord-321267-ihd30qi0	169	8	natural	natural	JJ
cord-321267-ihd30qi0	169	9	control	control	NN
cord-321267-ihd30qi0	169	10	group	group	NN
cord-321267-ihd30qi0	169	11	as	as	IN
cord-321267-ihd30qi0	169	12	a	a	DT
cord-321267-ihd30qi0	169	13	result	result	NN
cord-321267-ihd30qi0	169	14	of	of	IN
cord-321267-ihd30qi0	169	15	the	the	DT
cord-321267-ihd30qi0	169	16	diagnostic	diagnostic	JJ
cord-321267-ihd30qi0	169	17	testing	testing	NN
cord-321267-ihd30qi0	169	18	-namely	-namely	RB
cord-321267-ihd30qi0	169	19	,	,	,
cord-321267-ihd30qi0	169	20	the	the	DT
cord-321267-ihd30qi0	169	21	negative	negative	JJ
cord-321267-ihd30qi0	169	22	-	-	HYPH
cord-321267-ihd30qi0	169	23	test	test	NN
cord-321267-ihd30qi0	169	24	group	group	NN
cord-321267-ihd30qi0	169	25	with	with	IN
cord-321267-ihd30qi0	169	26	positive	positive	JJ
cord-321267-ihd30qi0	169	27	antibody	antibody	NN
cord-321267-ihd30qi0	169	28	test	test	NN
cord-321267-ihd30qi0	169	29	.	.	.
cord-321267-ihd30qi0	170	1	A	a	DT
cord-321267-ihd30qi0	170	2	major	major	JJ
cord-321267-ihd30qi0	170	3	advantage	advantage	NN
cord-321267-ihd30qi0	170	4	might	may	MD
cord-321267-ihd30qi0	170	5	be	be	VB
cord-321267-ihd30qi0	170	6	the	the	DT
cord-321267-ihd30qi0	170	7	ability	ability	NN
cord-321267-ihd30qi0	170	8	to	to	TO
cord-321267-ihd30qi0	170	9	reveal	reveal	VB
cord-321267-ihd30qi0	170	10	combinations	combination	NNS
cord-321267-ihd30qi0	170	11	of	of	IN
cord-321267-ihd30qi0	170	12	drugs	drug	NNS
cord-321267-ihd30qi0	170	13	that	that	WDT
cord-321267-ihd30qi0	170	14	could	could	MD
cord-321267-ihd30qi0	170	15	possess	possess	VB
cord-321267-ihd30qi0	170	16	synergistic	synergistic	JJ
cord-321267-ihd30qi0	170	17	therapeutic	therapeutic	JJ
cord-321267-ihd30qi0	170	18	potential	potential	NN
cord-321267-ihd30qi0	170	19	.	.	.
cord-321267-ihd30qi0	171	1	Potential	potential	JJ
cord-321267-ihd30qi0	171	2	combination	combination	NN
cord-321267-ihd30qi0	171	3	drug	drug	NN
cord-321267-ihd30qi0	171	4	treatments	treatment	NNS
cord-321267-ihd30qi0	171	5	are	be	VBP
cord-321267-ihd30qi0	171	6	extremely	extremely	RB
cord-321267-ihd30qi0	171	7	difficult	difficult	JJ
cord-321267-ihd30qi0	171	8	to	to	TO
cord-321267-ihd30qi0	171	9	predict	predict	VB
cord-321267-ihd30qi0	171	10	with	with	IN
cord-321267-ihd30qi0	171	11	virtual	virtual	JJ
cord-321267-ihd30qi0	171	12	screening	screening	NN
cord-321267-ihd30qi0	171	13	approaches	approach	NNS
cord-321267-ihd30qi0	171	14	.	.	.
cord-321267-ihd30qi0	172	1	Association	Association	NNP
cord-321267-ihd30qi0	172	2	with	with	IN
cord-321267-ihd30qi0	172	3	the	the	DT
cord-321267-ihd30qi0	172	4	positive	positive	JJ
cord-321267-ihd30qi0	172	5	-	-	HYPH
cord-321267-ihd30qi0	172	6	test	test	NN
cord-321267-ihd30qi0	172	7	group	group	NN
cord-321267-ihd30qi0	172	8	might	may	MD
cord-321267-ihd30qi0	172	9	indicate	indicate	VB
cord-321267-ihd30qi0	172	10	a	a	DT
cord-321267-ihd30qi0	172	11	drug	drug	NN
cord-321267-ihd30qi0	172	12	that	that	WDT
cord-321267-ihd30qi0	172	13	makes	make	VBZ
cord-321267-ihd30qi0	172	14	Covid-19-exposed	covid-19-expose	VBN
cord-321267-ihd30qi0	172	15	individuals	individual	NNS
cord-321267-ihd30qi0	172	16	more	more	RBR
cord-321267-ihd30qi0	172	17	susceptible	susceptible	JJ
cord-321267-ihd30qi0	172	18	to	to	IN
cord-321267-ihd30qi0	172	19	developing	develop	VBG
cord-321267-ihd30qi0	172	20	serious	serious	JJ
cord-321267-ihd30qi0	172	21	morbidities	morbidity	NNS
cord-321267-ihd30qi0	172	22	.	.	.
cord-321267-ihd30qi0	173	1	This	this	DT
cord-321267-ihd30qi0	173	2	would	would	MD
cord-321267-ihd30qi0	173	3	allow	allow	VB
cord-321267-ihd30qi0	173	4	for	for	IN
cord-321267-ihd30qi0	173	5	more	more	JJR
cord-321267-ihd30qi0	173	6	vigilance	vigilance	NN
cord-321267-ihd30qi0	173	7	against	against	IN
cord-321267-ihd30qi0	173	8	pathogen	pathogen	NN
cord-321267-ihd30qi0	173	9	exposure	exposure	NN
cord-321267-ihd30qi0	173	10	if	if	IN
cord-321267-ihd30qi0	173	11	the	the	DT
cord-321267-ihd30qi0	173	12	drug	drug	NN
cord-321267-ihd30qi0	173	13	is	be	VBZ
cord-321267-ihd30qi0	173	14	medically	medically	RB
cord-321267-ihd30qi0	173	15	necessary	necessary	JJ
cord-321267-ihd30qi0	173	16	or	or	CC
cord-321267-ihd30qi0	173	17	in	in	IN
cord-321267-ihd30qi0	173	18	cessation	cessation	NN
cord-321267-ihd30qi0	173	19	of	of	IN
cord-321267-ihd30qi0	173	20	the	the	DT
cord-321267-ihd30qi0	173	21	drug	drug	NN
cord-321267-ihd30qi0	173	22	if	if	IN
cord-321267-ihd30qi0	173	23	possible	possible	JJ
cord-321267-ihd30qi0	173	24	.	.	.
cord-321267-ihd30qi0	174	1	Unproven	unproven	JJ
cord-321267-ihd30qi0	174	2	off	off	IN
cord-321267-ihd30qi0	174	3	-	-	HYPH
cord-321267-ihd30qi0	174	4	label	label	NN
cord-321267-ihd30qi0	174	5	drug	drug	NN
cord-321267-ihd30qi0	174	6	therapies	therapy	NNS
cord-321267-ihd30qi0	174	7	that	that	WDT
cord-321267-ihd30qi0	174	8	could	could	MD
cord-321267-ihd30qi0	174	9	cause	cause	VB
cord-321267-ihd30qi0	174	10	harm	harm	NN
cord-321267-ihd30qi0	174	11	(	(	-LRB-
cord-321267-ihd30qi0	174	12	such	such	JJ
cord-321267-ihd30qi0	174	13	as	as	IN
cord-321267-ihd30qi0	174	14	during	during	IN
cord-321267-ihd30qi0	174	15	compassionate	compassionate	JJ
cord-321267-ihd30qi0	174	16	use	use	NN
cord-321267-ihd30qi0	174	17	)	)	-RRB-
cord-321267-ihd30qi0	174	18	could	could	MD
cord-321267-ihd30qi0	174	19	be	be	VB
cord-321267-ihd30qi0	174	20	potentially	potentially	RB
cord-321267-ihd30qi0	174	21	avoided	avoid	VBN
cord-321267-ihd30qi0	174	22	;	;	:
cord-321267-ihd30qi0	174	23	some	some	DT
cord-321267-ihd30qi0	174	24	known	know	VBN
cord-321267-ihd30qi0	174	25	examples	example	NNS
cord-321267-ihd30qi0	174	26	include	include	VBP
cord-321267-ihd30qi0	174	27	the	the	DT
cord-321267-ihd30qi0	174	28	use	use	NN
cord-321267-ihd30qi0	174	29	of	of	IN
cord-321267-ihd30qi0	174	30	IL-6	IL-6	NNP
cord-321267-ihd30qi0	174	31	inhibitors	inhibitor	NNS
cord-321267-ihd30qi0	174	32	and	and	CC
cord-321267-ihd30qi0	174	33	steroids	steroid	NNS
cord-321267-ihd30qi0	174	34	for	for	IN
cord-321267-ihd30qi0	174	35	end	end	NN
cord-321267-ihd30qi0	174	36	-	-	HYPH
cord-321267-ihd30qi0	174	37	stage	stage	NN
cord-321267-ihd30qi0	174	38	Covid-19	covid-19	NN
cord-321267-ihd30qi0	174	39	(	(	-LRB-
cord-321267-ihd30qi0	174	40	e.g.	e.g.	RB
cord-321267-ihd30qi0	174	41	,	,	,
cord-321267-ihd30qi0	174	42	see	see	VB
cord-321267-ihd30qi0	174	43	:	:	:
cord-321267-ihd30qi0	174	44	Kalil	Kalil	NNP
cord-321267-ihd30qi0	174	45	2020	2020	CD
cord-321267-ihd30qi0	174	46	)	)	-RRB-
cord-321267-ihd30qi0	174	47	.	.	.
cord-321267-ihd30qi0	175	1	Furthermore	furthermore	RB
cord-321267-ihd30qi0	175	2	,	,	,
cord-321267-ihd30qi0	175	3	by	by	IN
cord-321267-ihd30qi0	175	4	revealing	reveal	VBG
cord-321267-ihd30qi0	175	5	combinations	combination	NNS
cord-321267-ihd30qi0	175	6	of	of	IN
cord-321267-ihd30qi0	175	7	drugs	drug	NNS
cord-321267-ihd30qi0	175	8	that	that	WDT
cord-321267-ihd30qi0	175	9	significantly	significantly	RB
cord-321267-ihd30qi0	175	10	correlate	correlate	VBP
cord-321267-ihd30qi0	175	11	with	with	IN
cord-321267-ihd30qi0	175	12	the	the	DT
cord-321267-ihd30qi0	175	13	positive	positive	JJ
cord-321267-ihd30qi0	175	14	-	-	HYPH
cord-321267-ihd30qi0	175	15	test	test	NN
cord-321267-ihd30qi0	175	16	group	group	NN
cord-321267-ihd30qi0	175	17	,	,	,
cord-321267-ihd30qi0	175	18	further	further	JJ
cord-321267-ihd30qi0	175	19	harmful	harmful	JJ
cord-321267-ihd30qi0	175	20	experimental	experimental	JJ
cord-321267-ihd30qi0	175	21	therapies	therapy	NNS
cord-321267-ihd30qi0	175	22	could	could	MD
cord-321267-ihd30qi0	175	23	be	be	VB
cord-321267-ihd30qi0	175	24	avoided	avoid	VBN
cord-321267-ihd30qi0	175	25	.	.	.
cord-321267-ihd30qi0	176	1	One	one	CD
cord-321267-ihd30qi0	176	2	of	of	IN
cord-321267-ihd30qi0	176	3	the	the	DT
cord-321267-ihd30qi0	176	4	major	major	JJ
cord-321267-ihd30qi0	176	5	obstacles	obstacle	NNS
cord-321267-ihd30qi0	176	6	to	to	IN
cord-321267-ihd30qi0	176	7	implementing	implement	VBG
cord-321267-ihd30qi0	176	8	NERD	NERD	NNP
cord-321267-ihd30qi0	176	9	would	would	MD
cord-321267-ihd30qi0	176	10	be	be	VB
cord-321267-ihd30qi0	176	11	the	the	DT
cord-321267-ihd30qi0	176	12	practical	practical	JJ
cord-321267-ihd30qi0	176	13	difficulties	difficulty	NNS
cord-321267-ihd30qi0	176	14	in	in	IN
cord-321267-ihd30qi0	176	15	collecting	collect	VBG
cord-321267-ihd30qi0	176	16	the	the	DT
cord-321267-ihd30qi0	176	17	needed	need	VBN
cord-321267-ihd30qi0	176	18	drug	drug	NN
cord-321267-ihd30qi0	176	19	usage	usage	NN
cord-321267-ihd30qi0	176	20	information	information	NN
cord-321267-ihd30qi0	176	21	from	from	IN
cord-321267-ihd30qi0	176	22	each	each	DT
cord-321267-ihd30qi0	176	23	patient	patient	NN
cord-321267-ihd30qi0	176	24	during	during	IN
cord-321267-ihd30qi0	176	25	or	or	CC
cord-321267-ihd30qi0	176	26	after	after	IN
cord-321267-ihd30qi0	176	27	Covid-19	covid-19	JJ
cord-321267-ihd30qi0	176	28	testing	testing	NN
cord-321267-ihd30qi0	176	29	.	.	.
cord-321267-ihd30qi0	177	1	Collecting	collect	VBG
cord-321267-ihd30qi0	177	2	drug	drug	NN
cord-321267-ihd30qi0	177	3	usage	usage	NN
cord-321267-ihd30qi0	177	4	information	information	NN
cord-321267-ihd30qi0	177	5	has	have	VBZ
cord-321267-ihd30qi0	177	6	long	long	RB
cord-321267-ihd30qi0	177	7	been	be	VBN
cord-321267-ihd30qi0	177	8	the	the	DT
cord-321267-ihd30qi0	177	9	initial	initial	JJ
cord-321267-ihd30qi0	177	10	step	step	NN
cord-321267-ihd30qi0	177	11	in	in	IN
cord-321267-ihd30qi0	177	12	the	the	DT
cord-321267-ihd30qi0	177	13	conduct	conduct	NN
cord-321267-ihd30qi0	177	14	of	of	IN
cord-321267-ihd30qi0	177	15	"	"	``
cord-321267-ihd30qi0	177	16	medication	medication	NN
cord-321267-ihd30qi0	177	17	reconciliation	reconciliation	NN
cord-321267-ihd30qi0	177	18	"	"	''
cord-321267-ihd30qi0	177	19	reviews	review	NNS
cord-321267-ihd30qi0	177	20	between	between	IN
cord-321267-ihd30qi0	177	21	the	the	DT
cord-321267-ihd30qi0	177	22	physician	physician	NN
cord-321267-ihd30qi0	177	23	and	and	CC
cord-321267-ihd30qi0	177	24	patient	patient	JJ
cord-321267-ihd30qi0	177	25	during	during	IN
cord-321267-ihd30qi0	177	26	normal	normal	JJ
cord-321267-ihd30qi0	177	27	visits	visit	NNS
cord-321267-ihd30qi0	177	28	.	.	.
cord-321267-ihd30qi0	178	1	The	the	DT
cord-321267-ihd30qi0	178	2	collection	collection	NN
cord-321267-ihd30qi0	178	3	step	step	NN
cord-321267-ihd30qi0	178	4	has	have	VBZ
cord-321267-ihd30qi0	178	5	been	be	VBN
cord-321267-ihd30qi0	178	6	problematic	problematic	JJ
cord-321267-ihd30qi0	178	7	(	(	-LRB-
cord-321267-ihd30qi0	178	8	PSNet	psnet	JJ
cord-321267-ihd30qi0	178	9	2019	2019	CD
cord-321267-ihd30qi0	178	10	)	)	-RRB-
cord-321267-ihd30qi0	178	11	.	.	.
cord-321267-ihd30qi0	179	1	One	one	CD
cord-321267-ihd30qi0	179	2	possible	possible	JJ
cord-321267-ihd30qi0	179	3	means	mean	NNS
cord-321267-ihd30qi0	179	4	of	of	IN
cord-321267-ihd30qi0	179	5	addressing	address	VBG
cord-321267-ihd30qi0	179	6	this	this	DT
cord-321267-ihd30qi0	179	7	weakness	weakness	NN
cord-321267-ihd30qi0	179	8	would	would	MD
cord-321267-ihd30qi0	179	9	be	be	VB
cord-321267-ihd30qi0	179	10	public	public	JJ
cord-321267-ihd30qi0	179	11	service	service	NN
cord-321267-ihd30qi0	179	12	announcements	announcement	NNS
cord-321267-ihd30qi0	179	13	urging	urge	VBG
cord-321267-ihd30qi0	179	14	everyone	everyone	NN
cord-321267-ihd30qi0	179	15	to	to	TO
cord-321267-ihd30qi0	179	16	maintain	maintain	VB
cord-321267-ihd30qi0	179	17	a	a	DT
cord-321267-ihd30qi0	179	18	list	list	NN
cord-321267-ihd30qi0	179	19	of	of	IN
cord-321267-ihd30qi0	179	20	all	all	DT
cord-321267-ihd30qi0	179	21	medications	medication	NNS
cord-321267-ihd30qi0	179	22	used	use	VBN
cord-321267-ihd30qi0	179	23	in	in	IN
cord-321267-ihd30qi0	179	24	the	the	DT
cord-321267-ihd30qi0	179	25	preceding	precede	VBG
cord-321267-ihd30qi0	179	26	months	month	NNS
cord-321267-ihd30qi0	179	27	during	during	IN
cord-321267-ihd30qi0	179	28	epidemics	epidemic	NNS
cord-321267-ihd30qi0	179	29	.	.	.
cord-321267-ihd30qi0	180	1	As	as	IN
cord-321267-ihd30qi0	180	2	with	with	IN
cord-321267-ihd30qi0	180	3	many	many	JJ
cord-321267-ihd30qi0	180	4	epidemics	epidemic	NNS
cord-321267-ihd30qi0	180	5	,	,	,
cord-321267-ihd30qi0	180	6	a	a	DT
cord-321267-ihd30qi0	180	7	major	major	JJ
cord-321267-ihd30qi0	180	8	problem	problem	NN
cord-321267-ihd30qi0	180	9	is	be	VBZ
cord-321267-ihd30qi0	180	10	inaccurate	inaccurate	JJ
cord-321267-ihd30qi0	180	11	case	case	NN
cord-321267-ihd30qi0	180	12	counts	count	NNS
cord-321267-ihd30qi0	180	13	and	and	CC
cord-321267-ihd30qi0	180	14	under	under	RB
cord-321267-ihd30qi0	180	15	-	-	HYPH
cord-321267-ihd30qi0	180	16	reporting	reporting	NN
cord-321267-ihd30qi0	181	1	(	(	-LRB-
cord-321267-ihd30qi0	181	2	Weinberger	Weinberger	NNP
cord-321267-ihd30qi0	181	3	et	et	NNP
cord-321267-ihd30qi0	181	4	al	al	NNP
cord-321267-ihd30qi0	181	5	.	.	NNP
cord-321267-ihd30qi0	181	6	2020	2020	CD
cord-321267-ihd30qi0	181	7	)	)	-RRB-
cord-321267-ihd30qi0	181	8	.	.	.
cord-321267-ihd30qi0	182	1	With	with	IN
cord-321267-ihd30qi0	182	2	overwhelmed	overwhelmed	JJ
cord-321267-ihd30qi0	182	3	health	health	NN
cord-321267-ihd30qi0	182	4	care	care	NN
cord-321267-ihd30qi0	182	5	systems	system	NNS
cord-321267-ihd30qi0	182	6	,	,	,
cord-321267-ihd30qi0	182	7	an	an	DT
cord-321267-ihd30qi0	182	8	unknown	unknown	JJ
cord-321267-ihd30qi0	182	9	but	but	CC
cord-321267-ihd30qi0	182	10	possibly	possibly	RB
cord-321267-ihd30qi0	182	11	very	very	RB
cord-321267-ihd30qi0	182	12	large	large	JJ
cord-321267-ihd30qi0	182	13	percentage	percentage	NN
cord-321267-ihd30qi0	182	14	of	of	IN
cord-321267-ihd30qi0	182	15	positive	positive	JJ
cord-321267-ihd30qi0	182	16	cases	case	NNS
cord-321267-ihd30qi0	182	17	will	will	MD
cord-321267-ihd30qi0	182	18	go	go	VB
cord-321267-ihd30qi0	182	19	undetected	undetected	JJ
cord-321267-ihd30qi0	182	20	.	.	.
cord-321267-ihd30qi0	183	1	Many	many	JJ
cord-321267-ihd30qi0	183	2	will	will	MD
cord-321267-ihd30qi0	183	3	die	die	VB
cord-321267-ihd30qi0	183	4	from	from	IN
cord-321267-ihd30qi0	183	5	unknown	unknown	JJ
cord-321267-ihd30qi0	183	6	causes	cause	NNS
cord-321267-ihd30qi0	183	7	(	(	-LRB-
cord-321267-ihd30qi0	183	8	because	because	IN
cord-321267-ihd30qi0	183	9	of	of	IN
cord-321267-ihd30qi0	183	10	unavailable	unavailable	JJ
cord-321267-ihd30qi0	183	11	testing	testing	NN
cord-321267-ihd30qi0	183	12	)	)	-RRB-
cord-321267-ihd30qi0	183	13	and	and	CC
cord-321267-ihd30qi0	183	14	many	many	JJ
cord-321267-ihd30qi0	183	15	cases	case	NNS
cord-321267-ihd30qi0	183	16	will	will	MD
cord-321267-ihd30qi0	183	17	be	be	VB
cord-321267-ihd30qi0	183	18	endured	endure	VBN
cord-321267-ihd30qi0	183	19	solely	solely	RB
cord-321267-ihd30qi0	183	20	at	at	IN
cord-321267-ihd30qi0	183	21	home	home	NN
cord-321267-ihd30qi0	183	22	,	,	,
cord-321267-ihd30qi0	183	23	with	with	IN
cord-321267-ihd30qi0	183	24	only	only	JJ
cord-321267-ihd30qi0	183	25	mild	mild	JJ
cord-321267-ihd30qi0	183	26	symptoms	symptom	NNS
cord-321267-ihd30qi0	183	27	.	.	.
cord-321267-ihd30qi0	184	1	Very	very	RB
cord-321267-ihd30qi0	184	2	valuable	valuable	JJ
cord-321267-ihd30qi0	184	3	data	datum	NNS
cord-321267-ihd30qi0	184	4	are	be	VBP
cord-321267-ihd30qi0	184	5	therefore	therefore	RB
cord-321267-ihd30qi0	184	6	lost	lose	VBN
cord-321267-ihd30qi0	184	7	simply	simply	RB
cord-321267-ihd30qi0	184	8	because	because	IN
cord-321267-ihd30qi0	184	9	of	of	IN
cord-321267-ihd30qi0	184	10	incomplete	incomplete	JJ
cord-321267-ihd30qi0	184	11	medical	medical	JJ
cord-321267-ihd30qi0	184	12	records	record	NNS
cord-321267-ihd30qi0	184	13	and	and	CC
cord-321267-ihd30qi0	184	14	lack	lack	NN
cord-321267-ihd30qi0	184	15	of	of	IN
cord-321267-ihd30qi0	184	16	widespread	widespread	JJ
cord-321267-ihd30qi0	184	17	testing	testing	NN
cord-321267-ihd30qi0	184	18	(	(	-LRB-
cord-321267-ihd30qi0	184	19	Kliff	Kliff	NNP
cord-321267-ihd30qi0	184	20	and	and	CC
cord-321267-ihd30qi0	184	21	Bosman	Bosman	NNP
cord-321267-ihd30qi0	184	22	2020	2020	CD
cord-321267-ihd30qi0	184	23	)	)	-RRB-
cord-321267-ihd30qi0	184	24	.	.	.
cord-321267-ihd30qi0	185	1	Many	many	JJ
cord-321267-ihd30qi0	185	2	mild	mild	JJ
cord-321267-ihd30qi0	185	3	cases	case	NNS
cord-321267-ihd30qi0	185	4	can	can	MD
cord-321267-ihd30qi0	185	5	be	be	VB
cord-321267-ihd30qi0	185	6	missed	miss	VBN
cord-321267-ihd30qi0	185	7	when	when	WRB
cord-321267-ihd30qi0	185	8	they	-PRON-	PRP
cord-321267-ihd30qi0	185	9	are	be	VBP
cord-321267-ihd30qi0	185	10	advised	advise	VBN
cord-321267-ihd30qi0	185	11	to	to	TO
cord-321267-ihd30qi0	185	12	avoid	avoid	VB
cord-321267-ihd30qi0	185	13	testing	testing	NN
cord-321267-ihd30qi0	185	14	when	when	WRB
cord-321267-ihd30qi0	185	15	testing	testing	NN
cord-321267-ihd30qi0	185	16	is	be	VBZ
cord-321267-ihd30qi0	185	17	in	in	IN
cord-321267-ihd30qi0	185	18	short	short	JJ
cord-321267-ihd30qi0	185	19	supply	supply	NN
cord-321267-ihd30qi0	185	20	.	.	.
cord-321267-ihd30qi0	186	1	In	in	IN
cord-321267-ihd30qi0	186	2	the	the	DT
cord-321267-ihd30qi0	186	3	absence	absence	NN
cord-321267-ihd30qi0	186	4	of	of	IN
cord-321267-ihd30qi0	186	5	widespread	widespread	JJ
cord-321267-ihd30qi0	186	6	randomized	randomized	JJ
cord-321267-ihd30qi0	186	7	testing	testing	NN
cord-321267-ihd30qi0	186	8	of	of	IN
cord-321267-ihd30qi0	186	9	the	the	DT
cord-321267-ihd30qi0	186	10	asymptomatic	asymptomatic	JJ
cord-321267-ihd30qi0	186	11	population	population	NN
cord-321267-ihd30qi0	186	12	,	,	,
cord-321267-ihd30qi0	186	13	drug	drug	NN
cord-321267-ihd30qi0	186	14	usage	usage	NN
cord-321267-ihd30qi0	186	15	data	datum	NNS
cord-321267-ihd30qi0	186	16	from	from	IN
cord-321267-ihd30qi0	186	17	a	a	DT
cord-321267-ihd30qi0	186	18	large	large	JJ
cord-321267-ihd30qi0	186	19	percentage	percentage	NN
cord-321267-ihd30qi0	186	20	of	of	IN
cord-321267-ihd30qi0	186	21	the	the	DT
cord-321267-ihd30qi0	186	22	population	population	NN
cord-321267-ihd30qi0	186	23	belonging	belong	VBG
cord-321267-ihd30qi0	186	24	to	to	TO
cord-321267-ihd30qi0	186	25	test	test	VB
cord-321267-ihd30qi0	186	26	Option	option	NN
cord-321267-ihd30qi0	186	27	#	#	NN
cord-321267-ihd30qi0	186	28	1	1	CD
cord-321267-ihd30qi0	186	29	would	would	MD
cord-321267-ihd30qi0	186	30	never	never	RB
cord-321267-ihd30qi0	186	31	be	be	VB
cord-321267-ihd30qi0	186	32	acquired	acquire	VBN
cord-321267-ihd30qi0	186	33	.	.	.
cord-321267-ihd30qi0	187	1	This	this	DT
cord-321267-ihd30qi0	187	2	reduces	reduce	VBZ
cord-321267-ihd30qi0	187	3	the	the	DT
cord-321267-ihd30qi0	187	4	predictive	predictive	JJ
cord-321267-ihd30qi0	187	5	value	value	NN
cord-321267-ihd30qi0	187	6	of	of	IN
cord-321267-ihd30qi0	187	7	NERD	nerd	NN
cord-321267-ihd30qi0	187	8	for	for	IN
cord-321267-ihd30qi0	187	9	potentially	potentially	RB
cord-321267-ihd30qi0	187	10	beneficial	beneficial	JJ
cord-321267-ihd30qi0	187	11	drugs	drug	NNS
cord-321267-ihd30qi0	187	12	.	.	.
cord-321267-ihd30qi0	188	1	NERD	NERD	NNP
cord-321267-ihd30qi0	188	2	as	as	IN
cord-321267-ihd30qi0	188	3	presented	present	VBN
cord-321267-ihd30qi0	188	4	here	here	RB
cord-321267-ihd30qi0	188	5	makes	make	VBZ
cord-321267-ihd30qi0	188	6	a	a	DT
cord-321267-ihd30qi0	188	7	liberal	liberal	JJ
cord-321267-ihd30qi0	188	8	assumption	assumption	NN
cord-321267-ihd30qi0	188	9	that	that	IN
cord-321267-ihd30qi0	188	10	the	the	DT
cord-321267-ihd30qi0	188	11	total	total	JJ
cord-321267-ihd30qi0	188	12	population	population	NN
cord-321267-ihd30qi0	188	13	has	have	VBZ
cord-321267-ihd30qi0	188	14	full	full	JJ
cord-321267-ihd30qi0	188	15	access	access	NN
cord-321267-ihd30qi0	188	16	to	to	IN
cord-321267-ihd30qi0	188	17	Rx	Rx	NNP
cord-321267-ihd30qi0	188	18	and	and	CC
cord-321267-ihd30qi0	188	19	OTC	OTC	NNP
cord-321267-ihd30qi0	188	20	drugs	drug	NNS
cord-321267-ihd30qi0	188	21	.	.	.
cord-321267-ihd30qi0	189	1	This	this	DT
cord-321267-ihd30qi0	189	2	is	be	VBZ
cord-321267-ihd30qi0	189	3	overly	overly	RB
cord-321267-ihd30qi0	189	4	simplistic	simplistic	JJ
cord-321267-ihd30qi0	189	5	for	for	IN
cord-321267-ihd30qi0	189	6	populations	population	NNS
cord-321267-ihd30qi0	189	7	under	under	RB
cord-321267-ihd30qi0	189	8	-	-	HYPH
cord-321267-ihd30qi0	189	9	served	serve	VBN
cord-321267-ihd30qi0	189	10	by	by	IN
cord-321267-ihd30qi0	189	11	healthcare	healthcare	NN
cord-321267-ihd30qi0	189	12	.	.	.
cord-321267-ihd30qi0	190	1	For	for	IN
cord-321267-ihd30qi0	190	2	some	some	DT
cord-321267-ihd30qi0	190	3	pathogens	pathogen	NNS
cord-321267-ihd30qi0	190	4	,	,	,
cord-321267-ihd30qi0	190	5	specific	specific	JJ
cord-321267-ihd30qi0	190	6	sub	sub	NN
cord-321267-ihd30qi0	190	7	-	-	NNS
cord-321267-ihd30qi0	190	8	groups	group	NNS
cord-321267-ihd30qi0	190	9	of	of	IN
cord-321267-ihd30qi0	190	10	the	the	DT
cord-321267-ihd30qi0	190	11	population	population	NN
cord-321267-ihd30qi0	190	12	can	can	MD
cord-321267-ihd30qi0	190	13	be	be	VB
cord-321267-ihd30qi0	190	14	more	more	RBR
cord-321267-ihd30qi0	190	15	susceptible	susceptible	JJ
cord-321267-ihd30qi0	190	16	or	or	CC
cord-321267-ihd30qi0	190	17	less	less	RBR
cord-321267-ihd30qi0	190	18	susceptible	susceptible	JJ
cord-321267-ihd30qi0	190	19	to	to	IN
cord-321267-ihd30qi0	190	20	serious	serious	JJ
cord-321267-ihd30qi0	190	21	complications	complication	NNS
cord-321267-ihd30qi0	190	22	or	or	CC
cord-321267-ihd30qi0	190	23	higher	high	JJR
cord-321267-ihd30qi0	190	24	death	death	NN
cord-321267-ihd30qi0	190	25	rates	rate	NNS
cord-321267-ihd30qi0	190	26	,	,	,
cord-321267-ihd30qi0	190	27	often	often	RB
cord-321267-ihd30qi0	190	28	because	because	IN
cord-321267-ihd30qi0	190	29	of	of	IN
cord-321267-ihd30qi0	190	30	added	add	VBN
cord-321267-ihd30qi0	190	31	risk	risk	NN
cord-321267-ihd30qi0	190	32	factors	factor	NNS
cord-321267-ihd30qi0	190	33	.	.	.
cord-321267-ihd30qi0	191	1	This	this	DT
cord-321267-ihd30qi0	191	2	means	mean	VBZ
cord-321267-ihd30qi0	191	3	that	that	IN
cord-321267-ihd30qi0	191	4	those	those	DT
cord-321267-ihd30qi0	191	5	drugs	drug	NNS
cord-321267-ihd30qi0	191	6	having	have	VBG
cord-321267-ihd30qi0	191	7	higher	high	JJR
cord-321267-ihd30qi0	191	8	usage	usage	NN
cord-321267-ihd30qi0	191	9	rates	rate	NNS
cord-321267-ihd30qi0	191	10	among	among	IN
cord-321267-ihd30qi0	191	11	those	those	DT
cord-321267-ihd30qi0	191	12	vulnerable	vulnerable	JJ
cord-321267-ihd30qi0	191	13	groups	group	NNS
cord-321267-ihd30qi0	191	14	could	could	MD
cord-321267-ihd30qi0	191	15	bias	bias	VB
cord-321267-ihd30qi0	191	16	the	the	DT
cord-321267-ihd30qi0	191	17	results	result	NNS
cord-321267-ihd30qi0	191	18	for	for	IN
cord-321267-ihd30qi0	191	19	negative	negative	JJ
cord-321267-ihd30qi0	191	20	-	-	HYPH
cord-321267-ihd30qi0	191	21	and	and	CC
cord-321267-ihd30qi0	191	22	positive	positive	JJ
cord-321267-ihd30qi0	191	23	-	-	HYPH
cord-321267-ihd30qi0	191	24	test	test	NN
cord-321267-ihd30qi0	191	25	groups	group	NNS
cord-321267-ihd30qi0	191	26	unless	unless	IN
cord-321267-ihd30qi0	191	27	the	the	DT
cord-321267-ihd30qi0	191	28	drug	drug	NN
cord-321267-ihd30qi0	191	29	usage	usage	NN
cord-321267-ihd30qi0	191	30	data	datum	NNS
cord-321267-ihd30qi0	191	31	collected	collect	VBN
cord-321267-ihd30qi0	191	32	from	from	IN
cord-321267-ihd30qi0	191	33	patients	patient	NNS
cord-321267-ihd30qi0	191	34	were	be	VBD
cord-321267-ihd30qi0	191	35	also	also	RB
cord-321267-ihd30qi0	191	36	coded	code	VBN
cord-321267-ihd30qi0	191	37	for	for	IN
cord-321267-ihd30qi0	191	38	the	the	DT
cord-321267-ihd30qi0	191	39	known	know	VBN
cord-321267-ihd30qi0	191	40	risk	risk	NN
cord-321267-ihd30qi0	191	41	factors	factor	NNS
cord-321267-ihd30qi0	191	42	.	.	.
cord-321267-ihd30qi0	192	1	NERD	NERD	NNP
cord-321267-ihd30qi0	192	2	would	would	MD
cord-321267-ihd30qi0	192	3	not	not	RB
cord-321267-ihd30qi0	192	4	be	be	VB
cord-321267-ihd30qi0	192	5	suitable	suitable	JJ
cord-321267-ihd30qi0	192	6	for	for	IN
cord-321267-ihd30qi0	192	7	screening	screening	NN
cord-321267-ihd30qi0	192	8	of	of	IN
cord-321267-ihd30qi0	192	9	those	those	DT
cord-321267-ihd30qi0	192	10	drugs	drug	NNS
cord-321267-ihd30qi0	192	11	where	where	WRB
cord-321267-ihd30qi0	192	12	efficacy	efficacy	NN
cord-321267-ihd30qi0	192	13	is	be	VBZ
cord-321267-ihd30qi0	192	14	determined	determine	VBN
cord-321267-ihd30qi0	192	15	by	by	IN
cord-321267-ihd30qi0	192	16	the	the	DT
cord-321267-ihd30qi0	192	17	timing	timing	NN
cord-321267-ihd30qi0	192	18	of	of	IN
cord-321267-ihd30qi0	192	19	administration	administration	NN
cord-321267-ihd30qi0	192	20	.	.	.
cord-321267-ihd30qi0	193	1	Examples	example	NNS
cord-321267-ihd30qi0	193	2	for	for	IN
cord-321267-ihd30qi0	194	1	Covid-19	Covid-19	NNP
cord-321267-ihd30qi0	194	2	are	be	VBP
cord-321267-ihd30qi0	194	3	drugs	drug	NNS
cord-321267-ihd30qi0	194	4	used	use	VBN
cord-321267-ihd30qi0	194	5	for	for	IN
cord-321267-ihd30qi0	194	6	reducing	reduce	VBG
cord-321267-ihd30qi0	194	7	lung	lung	NN
cord-321267-ihd30qi0	194	8	inflammation	inflammation	NN
cord-321267-ihd30qi0	194	9	and	and	CC
cord-321267-ihd30qi0	194	10	damage	damage	NN
cord-321267-ihd30qi0	194	11	,	,	,
cord-321267-ihd30qi0	194	12	such	such	JJ
cord-321267-ihd30qi0	194	13	as	as	IN
cord-321267-ihd30qi0	194	14	those	those	DT
cord-321267-ihd30qi0	194	15	required	require	VBN
cord-321267-ihd30qi0	194	16	to	to	TO
cord-321267-ihd30qi0	194	17	fight	fight	VB
cord-321267-ihd30qi0	194	18	cytokine	cytokine	NN
cord-321267-ihd30qi0	194	19	storm	storm	NN
cord-321267-ihd30qi0	194	20	(	(	-LRB-
cord-321267-ihd30qi0	194	21	e.g.	e.g.	RB
cord-321267-ihd30qi0	194	22	,	,	,
cord-321267-ihd30qi0	194	23	Geraci	Geraci	NNP
cord-321267-ihd30qi0	194	24	and	and	CC
cord-321267-ihd30qi0	194	25	Hawill	Hawill	NNP
cord-321267-ihd30qi0	194	26	2020	2020	CD
cord-321267-ihd30qi0	194	27	)	)	-RRB-
cord-321267-ihd30qi0	194	28	.	.	.
cord-321267-ihd30qi0	195	1	This	this	DT
cord-321267-ihd30qi0	195	2	is	be	VBZ
cord-321267-ihd30qi0	195	3	especially	especially	RB
cord-321267-ihd30qi0	195	4	true	true	JJ
cord-321267-ihd30qi0	195	5	if	if	IN
cord-321267-ihd30qi0	195	6	premature	premature	JJ
cord-321267-ihd30qi0	195	7	timing	timing	NN
cord-321267-ihd30qi0	195	8	could	could	MD
cord-321267-ihd30qi0	195	9	worsen	worsen	VB
cord-321267-ihd30qi0	195	10	clinical	clinical	JJ
cord-321267-ihd30qi0	195	11	outcomes	outcome	NNS
cord-321267-ihd30qi0	195	12	.	.	.
cord-321267-ihd30qi0	196	1	This	this	DT
cord-321267-ihd30qi0	196	2	could	could	MD
cord-321267-ihd30qi0	196	3	confound	confound	VB
cord-321267-ihd30qi0	196	4	NERD	NERD	NNP
cord-321267-ihd30qi0	196	5	's	's	POS
cord-321267-ihd30qi0	196	6	usefulness	usefulness	NN
cord-321267-ihd30qi0	196	7	for	for	IN
cord-321267-ihd30qi0	196	8	these	these	DT
cord-321267-ihd30qi0	196	9	types	type	NNS
cord-321267-ihd30qi0	196	10	of	of	IN
cord-321267-ihd30qi0	196	11	drugs	drug	NNS
cord-321267-ihd30qi0	196	12	.	.	.
cord-321267-ihd30qi0	197	1	The	the	DT
cord-321267-ihd30qi0	197	2	collection	collection	NN
cord-321267-ihd30qi0	197	3	of	of	IN
cord-321267-ihd30qi0	197	4	usage	usage	NN
cord-321267-ihd30qi0	197	5	data	datum	NNS
cord-321267-ihd30qi0	197	6	on	on	IN
cord-321267-ihd30qi0	197	7	biologics	biologic	NNS
cord-321267-ihd30qi0	197	8	and	and	CC
cord-321267-ihd30qi0	197	9	biosimilars	biosimilar	NNS
cord-321267-ihd30qi0	197	10	,	,	,
cord-321267-ihd30qi0	197	11	which	which	WDT
cord-321267-ihd30qi0	197	12	continue	continue	VBP
cord-321267-ihd30qi0	197	13	to	to	TO
cord-321267-ihd30qi0	197	14	be	be	VB
cord-321267-ihd30qi0	197	15	a	a	DT
cord-321267-ihd30qi0	197	16	rapidly	rapidly	RB
cord-321267-ihd30qi0	197	17	growing	grow	VBG
cord-321267-ihd30qi0	197	18	class	class	NN
cord-321267-ihd30qi0	197	19	of	of	IN
cord-321267-ihd30qi0	197	20	therapeutics	therapeutic	NNS
cord-321267-ihd30qi0	197	21	,	,	,
cord-321267-ihd30qi0	197	22	could	could	MD
cord-321267-ihd30qi0	197	23	prove	prove	VB
cord-321267-ihd30qi0	197	24	difficult	difficult	JJ
cord-321267-ihd30qi0	197	25	,	,	,
cord-321267-ihd30qi0	197	26	if	if	IN
cord-321267-ihd30qi0	197	27	not	not	RB
cord-321267-ihd30qi0	197	28	just	just	RB
cord-321267-ihd30qi0	197	29	for	for	IN
cord-321267-ihd30qi0	197	30	the	the	DT
cord-321267-ihd30qi0	197	31	fact	fact	NN
cord-321267-ihd30qi0	197	32	that	that	IN
cord-321267-ihd30qi0	197	33	the	the	DT
cord-321267-ihd30qi0	197	34	naming	naming	NN
cord-321267-ihd30qi0	197	35	conventions	convention	NNS
cord-321267-ihd30qi0	197	36	are	be	VBP
cord-321267-ihd30qi0	197	37	complex	complex	JJ
cord-321267-ihd30qi0	197	38	(	(	-LRB-
cord-321267-ihd30qi0	197	39	Jordan	Jordan	NNP
cord-321267-ihd30qi0	197	40	2019	2019	CD
cord-321267-ihd30qi0	197	41	For	for	IN
cord-321267-ihd30qi0	197	42	drugs	drug	NNS
cord-321267-ihd30qi0	197	43	associated	associate	VBN
cord-321267-ihd30qi0	197	44	with	with	IN
cord-321267-ihd30qi0	197	45	the	the	DT
cord-321267-ihd30qi0	197	46	positive	positive	JJ
cord-321267-ihd30qi0	197	47	-	-	HYPH
cord-321267-ihd30qi0	197	48	test	test	NN
cord-321267-ihd30qi0	197	49	group	group	NN
cord-321267-ihd30qi0	197	50	,	,	,
cord-321267-ihd30qi0	197	51	they	-PRON-	PRP
cord-321267-ihd30qi0	197	52	might	may	MD
cord-321267-ihd30qi0	197	53	simply	simply	RB
cord-321267-ihd30qi0	197	54	be	be	VB
cord-321267-ihd30qi0	197	55	serving	serve	VBG
cord-321267-ihd30qi0	197	56	as	as	IN
cord-321267-ihd30qi0	197	57	PROXIES	proxy	NNS
cord-321267-ihd30qi0	197	58	for	for	IN
cord-321267-ihd30qi0	197	59	co	co	NNS
cord-321267-ihd30qi0	197	60	-	-	NNS
cord-321267-ihd30qi0	197	61	morbidities	morbidity	NNS
cord-321267-ihd30qi0	197	62	that	that	WDT
cord-321267-ihd30qi0	197	63	make	make	VBP
cord-321267-ihd30qi0	197	64	patients	patient	NNS
cord-321267-ihd30qi0	197	65	more	more	RBR
cord-321267-ihd30qi0	197	66	vulnerable	vulnerable	JJ
cord-321267-ihd30qi0	197	67	to	to	IN
cord-321267-ihd30qi0	197	68	Covid-19	covid-19	VB
cord-321267-ihd30qi0	197	69	.	.	.
cord-321267-ihd30qi0	198	1	A	a	DT
cord-321267-ihd30qi0	198	2	very	very	RB
cord-321267-ihd30qi0	198	3	important	important	JJ
cord-321267-ihd30qi0	198	4	factor	factor	NN
cord-321267-ihd30qi0	198	5	that	that	WDT
cord-321267-ihd30qi0	198	6	NERD	nerd	NN
cord-321267-ihd30qi0	198	7	would	would	MD
cord-321267-ihd30qi0	198	8	not	not	RB
cord-321267-ihd30qi0	198	9	be	be	VB
cord-321267-ihd30qi0	198	10	able	able	JJ
cord-321267-ihd30qi0	198	11	to	to	TO
cord-321267-ihd30qi0	198	12	address	address	VB
cord-321267-ihd30qi0	198	13	is	be	VBZ
cord-321267-ihd30qi0	198	14	whether	whether	IN
cord-321267-ihd30qi0	198	15	a	a	DT
cord-321267-ihd30qi0	198	16	drug	drug	NN
cord-321267-ihd30qi0	198	17	might	may	MD
cord-321267-ihd30qi0	198	18	have	have	VB
cord-321267-ihd30qi0	198	19	an	an	DT
cord-321267-ihd30qi0	198	20	impact	impact	NN
cord-321267-ihd30qi0	198	21	on	on	IN
cord-321267-ihd30qi0	198	22	increasing	increase	VBG
cord-321267-ihd30qi0	198	23	or	or	CC
cord-321267-ihd30qi0	198	24	decreasing	decrease	VBG
cord-321267-ihd30qi0	198	25	the	the	DT
cord-321267-ihd30qi0	198	26	overall	overall	JJ
cord-321267-ihd30qi0	198	27	level	level	NN
cord-321267-ihd30qi0	198	28	or	or	CC
cord-321267-ihd30qi0	198	29	rate	rate	NN
cord-321267-ihd30qi0	198	30	of	of	IN
cord-321267-ihd30qi0	198	31	virus	virus	NN
cord-321267-ihd30qi0	198	32	shedding	shedding	NN
cord-321267-ihd30qi0	198	33	,	,	,
cord-321267-ihd30qi0	198	34	which	which	WDT
cord-321267-ihd30qi0	198	35	is	be	VBZ
cord-321267-ihd30qi0	198	36	a	a	DT
cord-321267-ihd30qi0	198	37	key	key	JJ
cord-321267-ihd30qi0	198	38	parameter	parameter	NN
cord-321267-ihd30qi0	198	39	in	in	IN
cord-321267-ihd30qi0	198	40	inter	inter	JJ
cord-321267-ihd30qi0	198	41	-	-	JJ
cord-321267-ihd30qi0	198	42	individual	individual	JJ
cord-321267-ihd30qi0	198	43	transmission	transmission	NN
cord-321267-ihd30qi0	198	44	.	.	.
cord-321267-ihd30qi0	199	1	Because	because	IN
cord-321267-ihd30qi0	199	2	the	the	DT
cord-321267-ihd30qi0	199	3	more	more	RBR
cord-321267-ihd30qi0	199	4	limited	limited	JJ
cord-321267-ihd30qi0	199	5	classes	class	NNS
cord-321267-ihd30qi0	199	6	of	of	IN
cord-321267-ihd30qi0	199	7	drugs	drug	NNS
cord-321267-ihd30qi0	199	8	used	use	VBN
cord-321267-ihd30qi0	199	9	in	in	IN
cord-321267-ihd30qi0	199	10	pediatric	pediatric	JJ
cord-321267-ihd30qi0	199	11	populations	population	NNS
cord-321267-ihd30qi0	199	12	,	,	,
cord-321267-ihd30qi0	199	13	it	-PRON-	PRP
cord-321267-ihd30qi0	199	14	would	would	MD
cord-321267-ihd30qi0	199	15	probably	probably	RB
cord-321267-ihd30qi0	199	16	be	be	VB
cord-321267-ihd30qi0	199	17	more	more	RBR
cord-321267-ihd30qi0	199	18	representative	representative	JJ
cord-321267-ihd30qi0	199	19	to	to	TO
cord-321267-ihd30qi0	199	20	normalize	normalize	VB
cord-321267-ihd30qi0	199	21	group	group	NN
cord-321267-ihd30qi0	199	22	drug	drug	NN
cord-321267-ihd30qi0	199	23	-	-	HYPH
cord-321267-ihd30qi0	199	24	usage	usage	NN
cord-321267-ihd30qi0	199	25	rates	rate	NNS
cord-321267-ihd30qi0	199	26	against	against	IN
cord-321267-ihd30qi0	199	27	pediatric	pediatric	JJ
cord-321267-ihd30qi0	199	28	and	and	CC
cord-321267-ihd30qi0	199	29	non	non	JJ
cord-321267-ihd30qi0	199	30	-	-	JJ
cord-321267-ihd30qi0	199	31	pediatric	pediatric	JJ
cord-321267-ihd30qi0	199	32	populations	population	NNS
cord-321267-ihd30qi0	199	33	.	.	.
cord-321267-ihd30qi0	200	1	As	as	IN
cord-321267-ihd30qi0	200	2	the	the	DT
cord-321267-ihd30qi0	200	3	ranked	ranked	JJ
cord-321267-ihd30qi0	200	4	,	,	,
cord-321267-ihd30qi0	200	5	overall	overall	JJ
cord-321267-ihd30qi0	200	6	nation	nation	NN
cord-321267-ihd30qi0	200	7	-	-	HYPH
cord-321267-ihd30qi0	200	8	wide	wide	JJ
cord-321267-ihd30qi0	200	9	usage	usage	NN
cord-321267-ihd30qi0	200	10	rate	rate	NN
cord-321267-ihd30qi0	200	11	for	for	IN
cord-321267-ihd30qi0	200	12	each	each	DT
cord-321267-ihd30qi0	200	13	drug	drug	NN
cord-321267-ihd30qi0	200	14	trends	trend	NNS
cord-321267-ihd30qi0	200	15	downward	downward	RB
cord-321267-ihd30qi0	200	16	,	,	,
cord-321267-ihd30qi0	200	17	the	the	DT
cord-321267-ihd30qi0	200	18	confidence	confidence	NN
cord-321267-ihd30qi0	200	19	intervals	interval	VBZ
cord-321267-ihd30qi0	200	20	for	for	IN
cord-321267-ihd30qi0	200	21	distinguishing	distinguish	VBG
cord-321267-ihd30qi0	200	22	significant	significant	JJ
cord-321267-ihd30qi0	200	23	differences	difference	NNS
cord-321267-ihd30qi0	200	24	between	between	IN
cord-321267-ihd30qi0	200	25	the	the	DT
cord-321267-ihd30qi0	200	26	tested	test	VBN
cord-321267-ihd30qi0	200	27	groups	group	NNS
cord-321267-ihd30qi0	200	28	will	will	MD
cord-321267-ihd30qi0	200	29	increase	increase	VB
cord-321267-ihd30qi0	200	30	accordingly	accordingly	RB
cord-321267-ihd30qi0	200	31	,	,	,
cord-321267-ihd30qi0	200	32	simply	simply	RB
cord-321267-ihd30qi0	200	33	because	because	IN
cord-321267-ihd30qi0	200	34	there	there	EX
cord-321267-ihd30qi0	200	35	would	would	MD
cord-321267-ihd30qi0	200	36	be	be	VB
cord-321267-ihd30qi0	200	37	less	less	RBR
cord-321267-ihd30qi0	200	38	collected	collect	VBN
cord-321267-ihd30qi0	200	39	drug	drug	NN
cord-321267-ihd30qi0	200	40	usage	usage	NN
cord-321267-ihd30qi0	200	41	data	datum	NNS
cord-321267-ihd30qi0	200	42	.	.	.
cord-321267-ihd30qi0	201	1	So	so	RB
cord-321267-ihd30qi0	201	2	it	-PRON-	PRP
cord-321267-ihd30qi0	201	3	would	would	MD
cord-321267-ihd30qi0	201	4	become	become	VB
cord-321267-ihd30qi0	201	5	increasingly	increasingly	RB
cord-321267-ihd30qi0	201	6	more	more	RBR
cord-321267-ihd30qi0	201	7	difficult	difficult	JJ
cord-321267-ihd30qi0	201	8	to	to	TO
cord-321267-ihd30qi0	201	9	detect	detect	VB
cord-321267-ihd30qi0	201	10	associations	association	NNS
cord-321267-ihd30qi0	201	11	for	for	IN
cord-321267-ihd30qi0	201	12	drugs	drug	NNS
cord-321267-ihd30qi0	201	13	with	with	IN
cord-321267-ihd30qi0	201	14	less	less	JJR
cord-321267-ihd30qi0	201	15	market	market	NN
cord-321267-ihd30qi0	201	16	penetration	penetration	NN
cord-321267-ihd30qi0	201	17	.	.	.
cord-321267-ihd30qi0	202	1	All	all	DT
cord-321267-ihd30qi0	202	2	types	type	NNS
cord-321267-ihd30qi0	202	3	of	of	IN
cord-321267-ihd30qi0	202	4	diagnostic	diagnostic	JJ
cord-321267-ihd30qi0	202	5	tests	test	NNS
cord-321267-ihd30qi0	202	6	have	have	VBP
cord-321267-ihd30qi0	202	7	a	a	DT
cord-321267-ihd30qi0	202	8	range	range	NN
cord-321267-ihd30qi0	202	9	of	of	IN
cord-321267-ihd30qi0	202	10	rates	rate	NNS
cord-321267-ihd30qi0	202	11	for	for	IN
cord-321267-ihd30qi0	202	12	false	false	JJ
cord-321267-ihd30qi0	202	13	-	-	HYPH
cord-321267-ihd30qi0	202	14	negatives	negative	NNS
cord-321267-ihd30qi0	202	15	and	and	CC
cord-321267-ihd30qi0	202	16	false	false	JJ
cord-321267-ihd30qi0	202	17	-	-	HYPH
cord-321267-ihd30qi0	202	18	positives	positive	NNS
cord-321267-ihd30qi0	202	19	.	.	.
cord-321267-ihd30qi0	203	1	This	this	DT
cord-321267-ihd30qi0	203	2	could	could	MD
cord-321267-ihd30qi0	203	3	be	be	VB
cord-321267-ihd30qi0	203	4	a	a	DT
cord-321267-ihd30qi0	203	5	major	major	JJ
cord-321267-ihd30qi0	203	6	contributor	contributor	NN
cord-321267-ihd30qi0	203	7	of	of	IN
cord-321267-ihd30qi0	203	8	error	error	NN
cord-321267-ihd30qi0	203	9	in	in	IN
cord-321267-ihd30qi0	203	10	the	the	DT
cord-321267-ihd30qi0	203	11	confidence	confidence	NN
cord-321267-ihd30qi0	203	12	of	of	IN
cord-321267-ihd30qi0	203	13	any	any	DT
cord-321267-ihd30qi0	203	14	NERD	nerd	NN
cord-321267-ihd30qi0	203	15	conclusions	conclusion	NNS
cord-321267-ihd30qi0	203	16	regarding	regard	VBG
cord-321267-ihd30qi0	203	17	drug	drug	NN
cord-321267-ihd30qi0	203	18	usage	usage	NN
cord-321267-ihd30qi0	203	19	rates	rate	NNS
cord-321267-ihd30qi0	203	20	.	.	.
cord-321267-ihd30qi0	204	1	Among	among	IN
cord-321267-ihd30qi0	204	2	the	the	DT
cord-321267-ihd30qi0	204	3	active	active	JJ
cord-321267-ihd30qi0	204	4	infection	infection	NN
cord-321267-ihd30qi0	204	5	test	test	NN
cord-321267-ihd30qi0	204	6	group	group	NN
cord-321267-ihd30qi0	204	7	,	,	,
cord-321267-ihd30qi0	204	8	a	a	DT
cord-321267-ihd30qi0	204	9	very	very	RB
cord-321267-ihd30qi0	204	10	small	small	JJ
cord-321267-ihd30qi0	204	11	portion	portion	NN
cord-321267-ihd30qi0	204	12	of	of	IN
cord-321267-ihd30qi0	204	13	the	the	DT
cord-321267-ihd30qi0	204	14	negative	negative	JJ
cord-321267-ihd30qi0	204	15	-	-	HYPH
cord-321267-ihd30qi0	204	16	test	test	NN
cord-321267-ihd30qi0	204	17	group	group	NN
cord-321267-ihd30qi0	204	18	may	may	MD
cord-321267-ihd30qi0	204	19	actually	actually	RB
cord-321267-ihd30qi0	204	20	comprise	comprise	VB
cord-321267-ihd30qi0	204	21	newly	newly	RB
cord-321267-ihd30qi0	204	22	infected	infect	VBN
cord-321267-ihd30qi0	204	23	cases	case	NNS
cord-321267-ihd30qi0	204	24	(	(	-LRB-
cord-321267-ihd30qi0	204	25	covert	covert	JJ
cord-321267-ihd30qi0	204	26	virus	virus	NN
cord-321267-ihd30qi0	204	27	)	)	-RRB-
cord-321267-ihd30qi0	204	28	whose	whose	WP$
cord-321267-ihd30qi0	204	29	viral	viral	JJ
cord-321267-ihd30qi0	204	30	titers	titer	NNS
cord-321267-ihd30qi0	204	31	are	be	VBP
cord-321267-ihd30qi0	204	32	insufficient	insufficient	JJ
cord-321267-ihd30qi0	204	33	to	to	TO
cord-321267-ihd30qi0	204	34	meet	meet	VB
cord-321267-ihd30qi0	204	35	the	the	DT
cord-321267-ihd30qi0	204	36	minimum	minimum	JJ
cord-321267-ihd30qi0	204	37	sensitivity	sensitivity	NN
cord-321267-ihd30qi0	204	38	for	for	IN
cord-321267-ihd30qi0	204	39	a	a	DT
cord-321267-ihd30qi0	204	40	positive	positive	JJ
cord-321267-ihd30qi0	204	41	test	test	NN
cord-321267-ihd30qi0	204	42	(	(	-LRB-
cord-321267-ihd30qi0	204	43	resulting	result	VBG
cord-321267-ihd30qi0	204	44	in	in	IN
cord-321267-ihd30qi0	204	45	a	a	DT
cord-321267-ihd30qi0	204	46	false	false	JJ
cord-321267-ihd30qi0	204	47	-	-	HYPH
cord-321267-ihd30qi0	204	48	negative	negative	JJ
cord-321267-ihd30qi0	204	49	test	test	NN
cord-321267-ihd30qi0	204	50	)	)	-RRB-
cord-321267-ihd30qi0	204	51	;	;	:
cord-321267-ihd30qi0	204	52	re	re	IN
cord-321267-ihd30qi0	204	53	-	-	NN
cord-321267-ihd30qi0	204	54	testing	test	VBG
cord-321267-ihd30qi0	204	55	these	these	DT
cord-321267-ihd30qi0	204	56	cases	case	NNS
cord-321267-ihd30qi0	204	57	days	day	NNS
cord-321267-ihd30qi0	204	58	later	later	RB
cord-321267-ihd30qi0	204	59	can	can	MD
cord-321267-ihd30qi0	204	60	yield	yield	VB
cord-321267-ihd30qi0	204	61	a	a	DT
cord-321267-ihd30qi0	204	62	positive	positive	JJ
cord-321267-ihd30qi0	204	63	test	test	NN
cord-321267-ihd30qi0	204	64	.	.	.
cord-321267-ihd30qi0	204	65	 	 	_SP
cord-321267-ihd30qi0	205	1	CRISPR	CRISPR	NNP
cord-321267-ihd30qi0	205	2	-	-	HYPH
cord-321267-ihd30qi0	205	3	Cas12-based	cas12-base	VBN
cord-321267-ihd30qi0	205	4	detection	detection	NN
cord-321267-ihd30qi0	205	5	of	of	IN
cord-321267-ihd30qi0	205	6	SARS	SARS	NNP
cord-321267-ihd30qi0	205	7	-	-	HYPH
cord-321267-ihd30qi0	205	8	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	205	9	Wastewater	Wastewater	NNP
cord-321267-ihd30qi0	205	10	-	-	HYPH
cord-321267-ihd30qi0	205	11	based	base	VBN
cord-321267-ihd30qi0	205	12	epidemiology	epidemiology	NN
cord-321267-ihd30qi0	205	13	biomarkers	biomarker	NNS
cord-321267-ihd30qi0	205	14	:	:	:
cord-321267-ihd30qi0	206	1	Past	past	JJ
cord-321267-ihd30qi0	206	2	,	,	,
cord-321267-ihd30qi0	206	3	present	present	JJ
cord-321267-ihd30qi0	206	4	and	and	CC
cord-321267-ihd30qi0	206	5	future	future	JJ
cord-321267-ihd30qi0	206	6	Biologics	Biologics	NNPS
cord-321267-ihd30qi0	206	7	and	and	CC
cord-321267-ihd30qi0	206	8	Biosimilars	Biosimilars	NNP
cord-321267-ihd30qi0	206	9	:	:	:
cord-321267-ihd30qi0	207	1	Background	background	NN
cord-321267-ihd30qi0	207	2	and	and	CC
cord-321267-ihd30qi0	207	3	Key	Key	NNP
cord-321267-ihd30qi0	207	4	Issues	Issues	NNPS
cord-321267-ihd30qi0	207	5	Monitoring	monitor	VBG
cord-321267-ihd30qi0	207	6	Wastewater	Wastewater	NNP
cord-321267-ihd30qi0	207	7	for	for	IN
cord-321267-ihd30qi0	207	8	Assessing	Assessing	NNP
cord-321267-ihd30qi0	207	9	Community	Community	NNP
cord-321267-ihd30qi0	207	10	Health	Health	NNP
cord-321267-ihd30qi0	207	11	:	:	:
cord-321267-ihd30qi0	207	12	Sewage	Sewage	NNP
cord-321267-ihd30qi0	207	13	Chemical	Chemical	NNP
cord-321267-ihd30qi0	207	14	-	-	HYPH
cord-321267-ihd30qi0	207	15	Information	information	NN
cord-321267-ihd30qi0	207	16	Mining	Mining	NNP
cord-321267-ihd30qi0	207	17	(	(	-LRB-
cord-321267-ihd30qi0	207	18	SCIM	SCIM	NNP
cord-321267-ihd30qi0	207	19	)	)	-RRB-
cord-321267-ihd30qi0	208	1	The	the	DT
cord-321267-ihd30qi0	208	2	international	international	JJ
cord-321267-ihd30qi0	208	3	imperative	imperative	NN
cord-321267-ihd30qi0	208	4	to	to	IN
cord-321267-ihd30qi0	208	5	rapidly	rapidly	RB
cord-321267-ihd30qi0	208	6	and	and	CC
cord-321267-ihd30qi0	208	7	inexpensively	inexpensively	RB
cord-321267-ihd30qi0	208	8	monitor	monitor	VB
cord-321267-ihd30qi0	208	9	communitywide	communitywide	NN
cord-321267-ihd30qi0	208	10	Covid-19	covid-19	NN
cord-321267-ihd30qi0	208	11	infection	infection	NN
cord-321267-ihd30qi0	208	12	status	status	NN
cord-321267-ihd30qi0	208	13	and	and	CC
cord-321267-ihd30qi0	208	14	trends	trend	NNS
cord-321267-ihd30qi0	208	15	A	a	DT
cord-321267-ihd30qi0	208	16	bibliometric	bibliometric	JJ
cord-321267-ihd30qi0	208	17	review	review	NN
cord-321267-ihd30qi0	208	18	of	of	IN
cord-321267-ihd30qi0	208	19	drug	drug	NN
cord-321267-ihd30qi0	208	20	repurposing	repurpose	VBG
cord-321267-ihd30qi0	208	21	Scientists	scientist	NNS
cord-321267-ihd30qi0	208	22	to	to	TO
cord-321267-ihd30qi0	208	23	Stop	stop	VB
cord-321267-ihd30qi0	208	24	Covid-19	Covid-19	NNP
cord-321267-ihd30qi0	208	25	Diagnostics	Diagnostics	NNPS
cord-321267-ihd30qi0	208	26	Resource	Resource	NNP
cord-321267-ihd30qi0	208	27	Centre	Centre	NNP
cord-321267-ihd30qi0	208	28	.	.	.
cord-321267-ihd30qi0	209	1	Foundation	foundation	NN
cord-321267-ihd30qi0	209	2	for	for	IN
cord-321267-ihd30qi0	209	3	Innovative	Innovative	NNP
cord-321267-ihd30qi0	209	4	New	New	NNP
cord-321267-ihd30qi0	209	5	Diagnostics	Diagnostics	NNPS
cord-321267-ihd30qi0	209	6	.	.	.
cord-321267-ihd30qi0	210	1	Geneva	Geneva	NNP
cord-321267-ihd30qi0	210	2	Switzerland	Switzerland	NNP
cord-321267-ihd30qi0	210	3	2020	2020	CD
cord-321267-ihd30qi0	210	4	Candidate	Candidate	NNP
cord-321267-ihd30qi0	210	5	Drug	Drug	NNP
cord-321267-ihd30qi0	210	6	,	,	,
cord-321267-ihd30qi0	210	7	Dupilumab	Dupilumab	NNP
cord-321267-ihd30qi0	210	8	,	,	,
cord-321267-ihd30qi0	211	1	To	to	TO
cord-321267-ihd30qi0	211	2	Mitigate	mitigate	VB
cord-321267-ihd30qi0	211	3	COVID-19	COVID-19	NNP
cord-321267-ihd30qi0	211	4	Patients	patient	NNS
cord-321267-ihd30qi0	211	5	With	with	IN
cord-321267-ihd30qi0	211	6	Severe	severe	JJ
cord-321267-ihd30qi0	211	7	Acute	acute	JJ
cord-321267-ihd30qi0	211	8	Respiratory	respiratory	JJ
cord-321267-ihd30qi0	211	9	Syndrome	syndrome	NN
cord-321267-ihd30qi0	211	10	By	by	IN
cord-321267-ihd30qi0	211	11	Mitigating	mitigate	VBG
cord-321267-ihd30qi0	211	12	Cytokine	cytokine	NN
cord-321267-ihd30qi0	211	13	Storm	storm	NN
cord-321267-ihd30qi0	211	14	Developing	develop	VBG
cord-321267-ihd30qi0	211	15	a	a	DT
cord-321267-ihd30qi0	211	16	National	National	NNP
cord-321267-ihd30qi0	211	17	Strategy	Strategy	NNP
cord-321267-ihd30qi0	211	18	for	for	IN
cord-321267-ihd30qi0	211	19	Serology	Serology	NNP
cord-321267-ihd30qi0	211	20	(	(	-LRB-
cord-321267-ihd30qi0	211	21	Antibody	Antibody	NNP
cord-321267-ihd30qi0	211	22	Testing	Testing	NNP
cord-321267-ihd30qi0	211	23	)	)	-RRB-
cord-321267-ihd30qi0	211	24	in	in	IN
cord-321267-ihd30qi0	211	25	the	the	DT
cord-321267-ihd30qi0	211	26	United	United	NNP
cord-321267-ihd30qi0	211	27	States	States	NNP
cord-321267-ihd30qi0	211	28	.	.	.
cord-321267-ihd30qi0	212	1	The	the	DT
cord-321267-ihd30qi0	212	2	Johns	Johns	NNP
cord-321267-ihd30qi0	212	3	Hopkins	Hopkins	NNP
cord-321267-ihd30qi0	212	4	Center	Center	NNP
cord-321267-ihd30qi0	212	5	for	for	IN
cord-321267-ihd30qi0	212	6	Health	Health	NNP
cord-321267-ihd30qi0	212	7	Security	Security	NNP
cord-321267-ihd30qi0	212	8	Large	large	JJ
cord-321267-ihd30qi0	212	9	scale	scale	NN
cord-321267-ihd30qi0	212	10	testing	testing	NN
cord-321267-ihd30qi0	212	11	of	of	IN
cord-321267-ihd30qi0	212	12	general	general	JJ
cord-321267-ihd30qi0	212	13	population	population	NN
cord-321267-ihd30qi0	212	14	in	in	IN
cord-321267-ihd30qi0	212	15	Iceland	Iceland	NNP
cord-321267-ihd30qi0	213	1	underway	underway	JJ
cord-321267-ihd30qi0	213	2	biologics	biologic	NNS
cord-321267-ihd30qi0	213	3	and	and	CC
cord-321267-ihd30qi0	213	4	biosimilars	biosimilar	NNS
cord-321267-ihd30qi0	213	5	need	need	VBP
cord-321267-ihd30qi0	213	6	distinguishable	distinguishable	JJ
cord-321267-ihd30qi0	213	7	names	name	NNS
cord-321267-ihd30qi0	213	8	.	.	.
cord-321267-ihd30qi0	214	1	STAT	STAT	NNP
cord-321267-ihd30qi0	214	2	News	News	NNP
cord-321267-ihd30qi0	215	1	Treating	treat	VBG
cord-321267-ihd30qi0	215	2	COVID-19-Off	COVID-19-Off	NNP
cord-321267-ihd30qi0	215	3	-	-	HYPH
cord-321267-ihd30qi0	215	4	Label	Label	NNP
cord-321267-ihd30qi0	215	5	Drug	drug	NN
cord-321267-ihd30qi0	215	6	Use	Use	NNP
cord-321267-ihd30qi0	215	7	,	,	,
cord-321267-ihd30qi0	215	8	Compassionate	compassionate	JJ
cord-321267-ihd30qi0	215	9	Use	Use	NNP
cord-321267-ihd30qi0	215	10	,	,	,
cord-321267-ihd30qi0	215	11	and	and	CC
cord-321267-ihd30qi0	215	12	Randomized	Randomized	NNP
cord-321267-ihd30qi0	215	13	Clinical	Clinical	NNP
cord-321267-ihd30qi0	215	14	Trials	Trials	NNPS
cord-321267-ihd30qi0	215	15	During	during	IN
cord-321267-ihd30qi0	215	16	Pandemics	pandemic	NNS
cord-321267-ihd30qi0	215	17	An	an	DT
cord-321267-ihd30qi0	215	18	overview	overview	NN
cord-321267-ihd30qi0	215	19	of	of	IN
cord-321267-ihd30qi0	215	20	FDA	FDA	NNP
cord-321267-ihd30qi0	215	21	-	-	HYPH
cord-321267-ihd30qi0	215	22	approved	approve	VBN
cord-321267-ihd30qi0	215	23	new	new	JJ
cord-321267-ihd30qi0	215	24	molecular	molecular	JJ
cord-321267-ihd30qi0	215	25	entities	entity	NNS
cord-321267-ihd30qi0	216	1	An	an	DT
cord-321267-ihd30qi0	216	2	overview	overview	NN
cord-321267-ihd30qi0	216	3	of	of	IN
cord-321267-ihd30qi0	216	4	FDA	FDA	NNP
cord-321267-ihd30qi0	216	5	-	-	HYPH
cord-321267-ihd30qi0	216	6	approved	approve	VBN
cord-321267-ihd30qi0	216	7	biologics	biologic	NNS
cord-321267-ihd30qi0	216	8	medicines	medicine	NNS
cord-321267-ihd30qi0	216	9	Official	Official	NNP
cord-321267-ihd30qi0	216	10	Counts	Counts	NNPS
cord-321267-ihd30qi0	216	11	Understate	understate	VBP
cord-321267-ihd30qi0	216	12	the	the	DT
cord-321267-ihd30qi0	216	13	U.S.	U.S.	NNP
cord-321267-ihd30qi0	217	1	Coronavirus	Coronavirus	NNP
cord-321267-ihd30qi0	217	2	Death	Death	NNP
cord-321267-ihd30qi0	217	3	Toll	toll	NN
cord-321267-ihd30qi0	217	4	Coronavirus	Coronavirus	NNP
cord-321267-ihd30qi0	217	5	disease	disease	NN
cord-321267-ihd30qi0	217	6	2019	2019	CD
cord-321267-ihd30qi0	218	1	(	(	-LRB-
cord-321267-ihd30qi0	218	2	COVID-19	COVID-19	NNP
cord-321267-ihd30qi0	218	3	)	)	-RRB-
cord-321267-ihd30qi0	218	4	:	:	:
cord-321267-ihd30qi0	219	1	the	the	DT
cord-321267-ihd30qi0	219	2	portrait	portrait	NN
cord-321267-ihd30qi0	219	3	of	of	IN
cord-321267-ihd30qi0	219	4	a	a	DT
cord-321267-ihd30qi0	219	5	perfect	perfect	JJ
cord-321267-ihd30qi0	219	6	storm	storm	NN
cord-321267-ihd30qi0	219	7	Presence	Presence	NNP
cord-321267-ihd30qi0	219	8	of	of	IN
cord-321267-ihd30qi0	219	9	SARS	SARS	NNP
cord-321267-ihd30qi0	219	10	-	-	HYPH
cord-321267-ihd30qi0	219	11	Coronavirus-2	Coronavirus-2	NNP
cord-321267-ihd30qi0	219	12	in	in	IN
cord-321267-ihd30qi0	219	13	sewage	sewage	NN
cord-321267-ihd30qi0	219	14	Rapid	Rapid	NNP
cord-321267-ihd30qi0	219	15	Expert	Expert	NNP
cord-321267-ihd30qi0	219	16	Consultation	Consultation	NNP
cord-321267-ihd30qi0	219	17	on	on	IN
cord-321267-ihd30qi0	219	18	SARS	SARS	NNP
cord-321267-ihd30qi0	219	19	-	-	HYPH
cord-321267-ihd30qi0	219	20	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	219	21	Laboratory	Laboratory	NNP
cord-321267-ihd30qi0	219	22	Testing	Testing	NNP
cord-321267-ihd30qi0	219	23	for	for	IN
cord-321267-ihd30qi0	219	24	the	the	DT
cord-321267-ihd30qi0	219	25	COVID-19	COVID-19	NNP
cord-321267-ihd30qi0	219	26	Expert	Expert	NNP
cord-321267-ihd30qi0	219	27	Consultation	Consultation	NNP
cord-321267-ihd30qi0	219	28	on	on	IN
cord-321267-ihd30qi0	219	29	SARS	SARS	NNP
cord-321267-ihd30qi0	219	30	-	-	HYPH
cord-321267-ihd30qi0	219	31	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	219	32	Viral	Viral	NNP
cord-321267-ihd30qi0	219	33	Shedding	Shedding	NNP
cord-321267-ihd30qi0	219	34	and	and	CC
cord-321267-ihd30qi0	219	35	Antibody	Antibody	NNP
cord-321267-ihd30qi0	219	36	Response	Response	NNP
cord-321267-ihd30qi0	219	37	for	for	IN
cord-321267-ihd30qi0	219	38	the	the	DT
cord-321267-ihd30qi0	219	39	COVID-19	COVID-19	NNP
cord-321267-ihd30qi0	219	40	Pandemic	Pandemic	NNP
cord-321267-ihd30qi0	219	41	COVID-19	COVID-19	NNP
cord-321267-ihd30qi0	219	42	:	:	:
cord-321267-ihd30qi0	219	43	Abnormal	abnormal	JJ
cord-321267-ihd30qi0	219	44	Clotting	clotting	NN
cord-321267-ihd30qi0	219	45	Common	common	JJ
cord-321267-ihd30qi0	219	46	in	in	IN
cord-321267-ihd30qi0	219	47	More	More	JJR
cord-321267-ihd30qi0	219	48	Severe	severe	JJ
cord-321267-ihd30qi0	219	49	Disease	Disease	NNP
cord-321267-ihd30qi0	219	50	Drug	Drug	NNP
cord-321267-ihd30qi0	219	51	Repurposing	Repurposing	NNP
cord-321267-ihd30qi0	219	52	Approaches	approach	NNS
cord-321267-ihd30qi0	219	53	for	for	IN
cord-321267-ihd30qi0	219	54	the	the	DT
cord-321267-ihd30qi0	219	55	Treatment	Treatment	NNP
cord-321267-ihd30qi0	219	56	of	of	IN
cord-321267-ihd30qi0	219	57	Influenza	Influenza	NNP
cord-321267-ihd30qi0	219	58	Viral	Viral	NNP
cord-321267-ihd30qi0	219	59	Infection	infection	NN
cord-321267-ihd30qi0	219	60	:	:	:
cord-321267-ihd30qi0	219	61	Reviving	revive	VBG
cord-321267-ihd30qi0	219	62	Old	old	JJ
cord-321267-ihd30qi0	219	63	Drugs	drug	NNS
cord-321267-ihd30qi0	219	64	to	to	TO
cord-321267-ihd30qi0	219	65	Fight	fight	VB
cord-321267-ihd30qi0	219	66	Against	against	IN
cord-321267-ihd30qi0	219	67	a	a	DT
cord-321267-ihd30qi0	219	68	Long	long	RB
cord-321267-ihd30qi0	219	69	-	-	HYPH
cord-321267-ihd30qi0	219	70	Lived	Lived	NNP
cord-321267-ihd30qi0	219	71	Enemy	Enemy	NNP
cord-321267-ihd30qi0	219	72	Agency	Agency	NNP
cord-321267-ihd30qi0	219	73	for	for	IN
cord-321267-ihd30qi0	219	74	Healthcare	Healthcare	NNP
cord-321267-ihd30qi0	219	75	Research	Research	NNP
cord-321267-ihd30qi0	219	76	and	and	CC
cord-321267-ihd30qi0	219	77	Quality	Quality	NNP
cord-321267-ihd30qi0	219	78	(	(	-LRB-
cord-321267-ihd30qi0	219	79	AHRQ	AHRQ	NNP
cord-321267-ihd30qi0	219	80	)	)	-RRB-
cord-321267-ihd30qi0	220	1	Patient	Patient	NNP
cord-321267-ihd30qi0	220	2	Safety	Safety	NNP
cord-321267-ihd30qi0	220	3	Network	Network	NNP
cord-321267-ihd30qi0	220	4	Systematic	systematic	JJ
cord-321267-ihd30qi0	220	5	analyses	analysis	NNS
cord-321267-ihd30qi0	220	6	of	of	IN
cord-321267-ihd30qi0	220	7	drugs	drug	NNS
cord-321267-ihd30qi0	220	8	and	and	CC
cord-321267-ihd30qi0	220	9	disease	disease	NN
cord-321267-ihd30qi0	220	10	indications	indication	NNS
cord-321267-ihd30qi0	220	11	in	in	IN
cord-321267-ihd30qi0	220	12	Repurpose	Repurpose	NNP
cord-321267-ihd30qi0	220	13	DB	DB	NNP
cord-321267-ihd30qi0	220	14	reveal	reveal	VB
cord-321267-ihd30qi0	220	15	pharmacological	pharmacological	JJ
cord-321267-ihd30qi0	220	16	,	,	,
cord-321267-ihd30qi0	220	17	biological	biological	JJ
cord-321267-ihd30qi0	220	18	and	and	CC
cord-321267-ihd30qi0	220	19	epidemiological	epidemiological	JJ
cord-321267-ihd30qi0	220	20	factors	factor	NNS
cord-321267-ihd30qi0	220	21	influencing	influence	VBG
cord-321267-ihd30qi0	220	22	drug	drug	NN
cord-321267-ihd30qi0	220	23	repositioning	reposition	VBG
cord-321267-ihd30qi0	220	24	Fast	fast	RB
cord-321267-ihd30qi0	220	25	,	,	,
cord-321267-ihd30qi0	220	26	portable	portable	JJ
cord-321267-ihd30qi0	220	27	tests	test	NNS
cord-321267-ihd30qi0	220	28	come	come	VBP
cord-321267-ihd30qi0	220	29	online	online	RB
cord-321267-ihd30qi0	220	30	to	to	TO
cord-321267-ihd30qi0	220	31	curb	curb	VB
cord-321267-ihd30qi0	220	32	coronavirus	coronavirus	NN
cord-321267-ihd30qi0	220	33	pandemic	pandemic	NN
cord-321267-ihd30qi0	220	34	Future	future	JJ
cord-321267-ihd30qi0	220	35	Perspectives	Perspectives	NNPS
cord-321267-ihd30qi0	220	36	of	of	IN
cord-321267-ihd30qi0	220	37	Wastewater	Wastewater	NNP
cord-321267-ihd30qi0	220	38	-	-	HYPH
cord-321267-ihd30qi0	220	39	Based	base	VBN
cord-321267-ihd30qi0	220	40	Epidemiology	epidemiology	NN
cord-321267-ihd30qi0	220	41	:	:	:
cord-321267-ihd30qi0	220	42	Monitoring	Monitoring	NNP
cord-321267-ihd30qi0	220	43	Infectious	Infectious	NNP
cord-321267-ihd30qi0	220	44	Disease	Disease	NNP
cord-321267-ihd30qi0	220	45	Spread	Spread	NNP
cord-321267-ihd30qi0	220	46	and	and	CC
cord-321267-ihd30qi0	220	47	Resistance	Resistance	NNP
cord-321267-ihd30qi0	220	48	to	to	IN
cord-321267-ihd30qi0	220	49	the	the	DT
cord-321267-ihd30qi0	220	50	Community	Community	NNP
cord-321267-ihd30qi0	220	51	Level	Level	NNP
cord-321267-ihd30qi0	220	52	Repurposing	Repurposing	NNP
cord-321267-ihd30qi0	220	53	Therapeutics	Therapeutics	NNP
cord-321267-ihd30qi0	220	54	for	for	IN
cord-321267-ihd30qi0	220	55	COVID-19	COVID-19	NNP
cord-321267-ihd30qi0	220	56	:	:	:
cord-321267-ihd30qi0	220	57	Supercomputer	Supercomputer	NNP
cord-321267-ihd30qi0	220	58	-	-	HYPH
cord-321267-ihd30qi0	220	59	Based	base	VBN
cord-321267-ihd30qi0	220	60	Docking	Docking	NNP
cord-321267-ihd30qi0	220	61	to	to	IN
cord-321267-ihd30qi0	220	62	the	the	DT
cord-321267-ihd30qi0	220	63	SARS	SARS	NNP
cord-321267-ihd30qi0	220	64	-	-	HYPH
cord-321267-ihd30qi0	220	65	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	220	66	Viral	Viral	NNP
cord-321267-ihd30qi0	220	67	Spike	Spike	NNP
cord-321267-ihd30qi0	220	68	Protein	Protein	NNP
cord-321267-ihd30qi0	220	69	and	and	CC
cord-321267-ihd30qi0	220	70	Viral	Viral	NNP
cord-321267-ihd30qi0	220	71	Spike	Spike	NNP
cord-321267-ihd30qi0	220	72	Protein	Protein	NNP
cord-321267-ihd30qi0	220	73	-	-	HYPH
cord-321267-ihd30qi0	220	74	Human	Human	NNP
cord-321267-ihd30qi0	220	75	ACE2	ACE2	NNP
cord-321267-ihd30qi0	220	76	Interface	Interface	NNP
cord-321267-ihd30qi0	220	77	ddPCR	ddpcr	NN
cord-321267-ihd30qi0	220	78	:	:	:
cord-321267-ihd30qi0	220	79	a	a	DT
cord-321267-ihd30qi0	220	80	more	more	RBR
cord-321267-ihd30qi0	220	81	sensitive	sensitive	JJ
cord-321267-ihd30qi0	220	82	and	and	CC
cord-321267-ihd30qi0	220	83	accurate	accurate	JJ
cord-321267-ihd30qi0	220	84	tool	tool	NN
cord-321267-ihd30qi0	220	85	for	for	IN
cord-321267-ihd30qi0	220	86	SARS	SARS	NNP
cord-321267-ihd30qi0	220	87	-	-	HYPH
cord-321267-ihd30qi0	220	88	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	220	89	detection	detection	NN
cord-321267-ihd30qi0	220	90	in	in	IN
cord-321267-ihd30qi0	220	91	low	low	JJ
cord-321267-ihd30qi0	220	92	viral	viral	JJ
cord-321267-ihd30qi0	220	93	load	load	NN
cord-321267-ihd30qi0	220	94	specimens	specimen	NNS
cord-321267-ihd30qi0	220	95	COVID-19	covid-19	VBP
cord-321267-ihd30qi0	220	96	)	)	-RRB-
cord-321267-ihd30qi0	220	97	Update	update	NN
cord-321267-ihd30qi0	220	98	:	:	:
cord-321267-ihd30qi0	220	99	FDA	FDA	NNP
cord-321267-ihd30qi0	220	100	Continues	continue	VBZ
cord-321267-ihd30qi0	220	101	to	to	TO
cord-321267-ihd30qi0	220	102	Accelerate	accelerate	VB
cord-321267-ihd30qi0	220	103	Development	Development	NNP
cord-321267-ihd30qi0	220	104	of	of	IN
cord-321267-ihd30qi0	220	105	Novel	Novel	NNP
cord-321267-ihd30qi0	220	106	Therapies	Therapies	NNPS
cord-321267-ihd30qi0	220	107	for	for	IN
cord-321267-ihd30qi0	220	108	COVID-19	COVID-19	NNP
cord-321267-ihd30qi0	220	109	COVID-19	COVID-19	NNP
cord-321267-ihd30qi0	220	110	)	)	-RRB-
cord-321267-ihd30qi0	220	111	Update	update	NN
cord-321267-ihd30qi0	220	112	:	:	:
cord-321267-ihd30qi0	221	1	FDA	FDA	NNP
cord-321267-ihd30qi0	221	2	Authorizes	authorize	VBZ
cord-321267-ihd30qi0	221	3	First	First	NNP
cord-321267-ihd30qi0	221	4	Antigen	Antigen	NNP
cord-321267-ihd30qi0	221	5	Test	test	NN
cord-321267-ihd30qi0	221	6	to	to	TO
cord-321267-ihd30qi0	221	7	Help	help	VB
cord-321267-ihd30qi0	221	8	in	in	IN
cord-321267-ihd30qi0	221	9	the	the	DT
cord-321267-ihd30qi0	221	10	Rapid	Rapid	NNP
cord-321267-ihd30qi0	221	11	Detection	Detection	NNP
cord-321267-ihd30qi0	221	12	of	of	IN
cord-321267-ihd30qi0	221	13	the	the	DT
cord-321267-ihd30qi0	221	14	Virus	virus	NN
cord-321267-ihd30qi0	221	15	that	that	WDT
cord-321267-ihd30qi0	221	16	Causes	cause	VBZ
cord-321267-ihd30qi0	221	17	COVID-19	covid-19	VBP
cord-321267-ihd30qi0	221	18	in	in	IN
cord-321267-ihd30qi0	221	19	Patients	patient	NNS
cord-321267-ihd30qi0	221	20	.	.	.
cord-321267-ihd30qi0	222	1	US	US	NNP
cord-321267-ihd30qi0	222	2	Food	Food	NNP
cord-321267-ihd30qi0	222	3	&	&	CC
cord-321267-ihd30qi0	222	4	Drug	Drug	NNP
cord-321267-ihd30qi0	222	5	Administration	Administration	NNP
cord-321267-ihd30qi0	222	6	,	,	,
cord-321267-ihd30qi0	222	7	2020b	2020b	CD
cord-321267-ihd30qi0	222	8	Estimating	estimate	VBG
cord-321267-ihd30qi0	222	9	the	the	DT
cord-321267-ihd30qi0	222	10	early	early	JJ
cord-321267-ihd30qi0	222	11	death	death	NN
cord-321267-ihd30qi0	222	12	toll	toll	NN
cord-321267-ihd30qi0	222	13	of	of	IN
cord-321267-ihd30qi0	222	14	COVID-19	COVID-19	NNP
cord-321267-ihd30qi0	222	15	in	in	IN
cord-321267-ihd30qi0	222	16	the	the	DT
cord-321267-ihd30qi0	222	17	United	United	NNP
cord-321267-ihd30qi0	222	18	States	States	NNP
cord-321267-ihd30qi0	222	19	SARS	SARS	NNP
cord-321267-ihd30qi0	222	20	-	-	HYPH
cord-321267-ihd30qi0	222	21	CoV-2	CoV-2	NNP
cord-321267-ihd30qi0	222	22	titers	titer	NNS
cord-321267-ihd30qi0	222	23	in	in	IN
cord-321267-ihd30qi0	222	24	wastewater	wastewater	NN
cord-321267-ihd30qi0	222	25	are	be	VBP
cord-321267-ihd30qi0	222	26	higher	high	JJR
cord-321267-ihd30qi0	222	27	than	than	IN
cord-321267-ihd30qi0	222	28	expected	expect	VBN
cord-321267-ihd30qi0	222	29	from	from	IN
cord-321267-ihd30qi0	222	30	clinically	clinically	RB
cord-321267-ihd30qi0	222	31	confirmed	confirm	VBN
cord-321267-ihd30qi0	222	32	cases	case	NNS
cord-321267-ihd30qi0	222	33	.	.	.
cord-321267-ihd30qi0	223	1	medRxiv	medRxiv	NNP
cord-321267-ihd30qi0	223	2	Use	Use	NNP
cord-321267-ihd30qi0	223	3	of	of	IN
cord-321267-ihd30qi0	223	4	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-321267-ihd30qi0	223	5	and	and	CC
cord-321267-ihd30qi0	223	6	Chloroquine	Chloroquine	NNP
cord-321267-ihd30qi0	223	7	During	during	IN
cord-321267-ihd30qi0	223	8	the	the	DT
cord-321267-ihd30qi0	223	9	COVID-19	COVID-19	NNP
cord-321267-ihd30qi0	223	10	Pandemic	Pandemic	NNP
cord-321267-ihd30qi0	223	11	:	:	:
cord-321267-ihd30qi0	224	1	What	what	WP
cord-321267-ihd30qi0	224	2	Every	every	DT
cord-321267-ihd30qi0	224	3	Clinician	clinician	NN
cord-321267-ihd30qi0	224	4	Should	Should	MD
cord-321267-ihd30qi0	224	5	Know	know	VB
cord-321267-ihd30qi0	224	6	.	.	.
cord-321267-ihd30qi0	225	1	Annals	Annals	NNP
cord-321267-ihd30qi0	225	2	of	of	IN
cord-321267-ihd30qi0	225	3	Internal	Internal	NNP
cord-321267-ihd30qi0	225	4	Medicine	Medicine	NNP
cord-321267-ihd30qi0	226	1	This	this	DT
cord-321267-ihd30qi0	226	2	work	work	NN
cord-321267-ihd30qi0	226	3	was	be	VBD
cord-321267-ihd30qi0	226	4	unfunded	unfunded	JJ
cord-321267-ihd30qi0	226	5	.	.	.